Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.7658975369154664,-2.3515664420408586,0.0,0.0,0.0,7/22,8.24%,ALDH1A2;RBP1;PTGDS;RBP4;CYP26B1;ABCA4;CRABP2
prerank,I-SMAD binding (GO:0070411),-0.7691109411591815,-2.069507928329293,0.0,0.011413717729071899,0.022,5/13,4.30%,SMAD6;CTNNB1;SMAD7;SMAD9;TGFBR1
prerank,insulin-like growth factor I binding (GO:0031994),-0.7100175815194775,-1.9037283395365883,0.0030303030303030303,0.07939977550658711,0.192,6/13,5.61%,IGF1R;IGFBP2;IGFBP3;ITGA6;IGFBP5;INSR
prerank,serine-type peptidase activity (GO:0008236),0.598333269285999,1.8250523659609372,0.0,0.5383071703754816,0.36,13/96,7.65%,HGFAC;KLK12;MMP2;FAP;HTRA3;CORIN;PARL;HTRA1;NAALAD2;PCSK4;PCSK6;KLK1;KLK6
prerank,voltage-gated ion channel activity (GO:0005244),0.8123429199919033,1.8097753139752015,0.004451038575667656,0.3438349337780078,0.431,5/14,6.96%,KCNK15;CACNA1E;VDAC2;ANO6;KCND2
prerank,neuropeptide receptor activity (GO:0008188),0.6859445631752876,1.789783012181353,0.0038363171355498722,0.3097521706629866,0.535,4/29,2.43%,SSTR1;SORCS2;SORCS1;SORCS3
prerank,insulin-like growth factor binding (GO:0005520),-0.6400030879628636,-1.7603867546812966,0.013029315960912053,0.2716961068116028,0.612,6/15,5.61%,IGF1R;IGFBP2;IGFBP3;ITGA6;IGFBP5;INSR
prerank,serine-type endopeptidase activity (GO:0004252),0.5869688364708389,1.7590107944284705,0.0,0.3618787495447837,0.688,10/80,7.65%,HGFAC;KLK12;MMP2;FAP;CORIN;PARL;PCSK4;PCSK6;KLK1;KLK6
prerank,solute:anion antiporter activity (GO:0140323),-0.6358828321718342,-1.7526774600887287,0.006756756756756757,0.23184734447923436,0.631,4/14,7.94%,SLC7A11;SLC26A7;SLC26A2;SLC4A3
prerank,ligand-gated channel activity (GO:0022834),0.6739065915280674,1.7450073160536157,0.0,0.35265635481954266,0.76,12/29,14.11%,GRIA1;GRIK3;GRIA3;CHRNA4;GRIN2B;GRIK2;GRIK5;GRID2;GRIK1;ANXA6;GRIN2D;GRIN2A
prerank,ligand-gated ion channel activity (GO:0015276),0.6712187415735168,1.7440145929498587,0.0,0.29805710488822446,0.764,12/30,14.11%,GRIA1;GRIK3;GRIA3;CHRNA4;GRIN2B;GRIK2;GRIK5;GRID2;GRIK1;ANXA6;GRIN2D;GRIN2A
prerank,acetylcholine receptor activity (GO:0015464),0.6899343693509983,1.7381487280358514,0.009497964721845319,0.2749533831127759,0.797,3/22,4.19%,CHRM3;ANXA9;CHRNA4
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.45080295983256025,-1.732713329365528,0.0,0.23389850534648784,0.697,19/55,14.66%,SLC13A3;SLC7A2;SLC16A12;SLC16A6;SLC6A12;SLC6A6;SLC22A4;SLC6A13;SLC38A11;SLC7A5;SLC16A11;PDPN;SLC38A7;SLC16A2;SLC6A11;SLC38A5;SLC16A9;SLC38A10;SLC36A4
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7202948279793316,1.7232433194747783,0.007022471910112359,0.28707209667835853,0.86,9/17,14.11%,GRIA1;GRIK3;GRIA3;GRIN2B;GRIK2;GRIK5;GRIK1;GRIN2D;GRIN2A
prerank,pyridoxal phosphate binding (GO:0030170),0.7083182797387669,1.6793881520966876,0.002728512960436562,0.4436328283893116,0.974,9/20,13.48%,PYGL;CTH;CBS;PDXK;PSAT1;PNPO;OAT;PLPBP;SRR
prerank,chemokine receptor binding (GO:0042379),0.6274138174213667,1.6750061073070863,0.006321112515802781,0.422325532363483,0.976,3/35,4.22%,CCL11;CXCL10;CCL4
prerank,chemokine activity (GO:0008009),0.637174453059926,1.6630633342725507,0.005148005148005148,0.43460079490785025,0.988,3/31,4.22%,CCL11;CXCL10;CCL4
prerank,transcription corepressor binding (GO:0001222),0.6386586907674928,1.6495187806286198,0.02127659574468085,0.4610362000779458,0.993,9/27,13.89%,RORA;USP11;EED;ZBTB16;ESR1;HDAC6;PER3;PER1;LCOR
prerank,ephrin receptor binding (GO:0046875),0.6735876858893797,1.6467638506848277,0.024623803009575923,0.43952884560095185,0.993,13/21,19.02%,EFNA4;EFNA5;CHN1;FYN;ANKS1B;PTPN1;CBL;EFNB1;ANKS1A;EFNB3;ABL1;EFNB2;GRB2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.6689184485496539,1.6400129154018426,0.013531799729364006,0.4357008688128232,0.994,8/23,8.90%,RAG2;PLEKHA5;PLEKHA4;SESTD1;WIPI1;MAPKAP1;GBF1;HIP1
prerank,NAD binding (GO:0051287),-0.4948481882601047,-1.6253335816858634,0.016260162601626018,0.4952560997223371,0.941,11/26,17.22%,ALDH1A1;ZC3HAV1;CRYL1;ME1;ALDH2;SIRT3;SORD;BDH2;HPGD;NNT;QDPR
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5880231480935543,-1.6250761589942786,0.02181818181818182,0.4338453358539612,0.941,5/15,10.21%,SLC26A7;SLC26A2;SLC4A3;SLC39A8;SLC4A8
prerank,lipoprotein particle receptor binding (GO:0070325),0.6497844523958644,1.6123260472519825,0.01303780964797914,0.5324262230144583,0.999,5/27,9.06%,RELN;HSPG2;LRP1;SYT1;ANKRA2
prerank,tau-protein kinase activity (GO:0050321),-0.5367319907071004,-1.5954268510017444,0.015625,0.4801480868828893,0.969,8/20,10.39%,ROCK2;SIK3;MARK1;ROCK1;TTBK2;GSK3B;GSK3A;MARK2
prerank,steroid hydroxylase activity (GO:0008395),0.6956099421055164,1.5856638126489802,0.03188405797101449,0.648700237670826,1.0,5/16,14.19%,CYP2S1;CYP39A1;CYP1B1;CYP7B1;CYP27A1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.48903758115114027,-1.5834866561142682,0.0371900826446281,0.4687564246470137,0.976,9/25,16.67%,ZC3HAV1;PARP3;PARP4;PARP10;PARP1;SIRT3;PARP6;PARP14;SIRT4
prerank,sodium channel activity (GO:0005272),0.5884081421061982,1.5810244154234352,0.013647642679900745,0.6383147244292461,1.0,9/37,8.06%,SCN7A;SCN2A;KCNK1;GRIK3;GRIK2;GRIK5;SCN5A;SCN3A;GRIK1
prerank,sterol binding (GO:0032934),0.5529957809999733,1.5801035451950092,0.013953488372093023,0.6070296044995602,1.0,9/56,6.49%,RORA;APOD;PTCH1;VDAC2;ERLIN2;NPC1;OSBPL5;GRAMD1A;RORC
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.5412886352757756,-1.57669485233846,0.035842293906810034,0.4459019210835835,0.977,7/17,15.27%,LBR;PTGR2;BLVRA;BDH2;DECR2;DHCR24;PECR
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7430349331393629,1.5743976610277937,0.03153153153153153,0.6076334099004627,1.0,1/11,0.04%,ROR2
prerank,translation elongation factor activity (GO:0003746),-0.5670596092726861,-1.558426618503904,0.03197674418604651,0.46142848703255157,0.989,9/14,16.61%,GTPBP2;GTPBP1;EEF1A1;GFM2;GFM1;EIF5AL1;EIF5A;TSFM;EEF1B2
prerank,microtubule plus-end binding (GO:0051010),-0.5225416268062985,-1.5579367661591992,0.04411764705882353,0.4281480202316736,0.989,9/20,14.14%,CLIP4;TTBK2;CLIP1;CLIP3;PAFAH1B1;DCTN1;NUMA1;STIM1;KIF18A
prerank,potassium channel regulator activity (GO:0015459),0.5587090089117701,1.5552988566369468,0.007159904534606206,0.680602706380695,1.0,15/49,14.47%,WNK2;SLC5A3;WNK3;RASA1;DPP10;ENSA;KCNMB2;KCNMB3;FLNA;SGK3;SGK2;KCNAB2;KCNIP4;NEDD4L;SUMO1
prerank,chemoattractant activity (GO:0042056),0.6145360638825571,1.55513998298951,0.032981530343007916,0.6491477529428195,1.0,5/26,3.17%,LGALS3;CXCL10;FGF2;FGF10;VEGFA
prerank,alpha-tubulin binding (GO:0043014),0.5913916832582873,1.550764522800039,0.036989795918367346,0.6443373706009552,1.0,13/31,16.46%,DLEC1;EFHC1;TBCE;FYN;PACRG;SETD2;HDAC6;CDK5R1;ARL8A;TRAPPC14;SNCA;WASHC1;DIP2B
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6327041287578273,-1.5446925462781074,0.05483028720626632,0.43549359012228983,0.992,7/10,18.17%,SHANK3;SHISA6;NSF;SHANK2;SQSTM1;GNAS;SHISA7
prerank,telomerase RNA binding (GO:0070034),-0.5088337826037282,-1.5364496527535842,0.026615969581749048,0.4282294558988598,0.993,12/22,19.43%,XRN1;DCP2;NAF1;DKC1;SNRPD3;WRAP53;SNRPB;TERT;EXOSC10;PINX1;GAR1;TENT4B
prerank,sodium channel regulator activity (GO:0017080),0.5696187870931184,1.5329324224551129,0.029850746268656716,0.7149099275903996,1.0,12/37,16.87%,FXYD3;FGF13;FGF12;FGF14;SGK3;SGK2;FXYD6;FXYD1;NEDD4L;PKP2;GPLD1;SGK1
prerank,microtubule minus-end binding (GO:0051011),-0.5606366599505869,-1.5317587696349058,0.051829268292682924,0.4137472676788563,0.995,7/13,16.74%,MACF1;TUBGCP4;TUBGCP3;TUBGCP6;NUMA1;HAUS7;TUBGCP2
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6355998298592063,1.5296062356175937,0.04628330995792426,0.7032911339837336,1.0,5/19,9.96%,ERBB3;EFNA5;NRG3;ALKAL2;GRM5
prerank,CXCR chemokine receptor binding (GO:0045236),0.7155638185370022,1.5248019746037116,0.02631578947368421,0.7029870622735898,1.0,2/11,11.85%,CXCL10;YARS1
prerank,glutamate receptor activity (GO:0008066),0.6410936619911832,1.524055941890919,0.040446304044630406,0.6797275042056826,1.0,8/19,13.79%,GRIA1;GRIK3;GRIK2;GRIK5;GRID2;GRIK1;GRM5;GRIN2D
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6329656644842733,-1.5149999491899384,0.052486187845303865,0.4338380380804771,0.998,4/10,4.91%,SLCO3A1;SLCO2A1;SLCO1C1;SLC22A6
prerank,tau protein binding (GO:0048156),-0.41996467422833944,-1.5096786273084237,0.017142857142857144,0.42363088556743667,0.999,21/40,25.91%,ROCK2;MARK1;MAP2;ROCK1;TTBK2;STUB1;GSK3B;GSK3A;MARK2;DCTN1;PPP2CB;LGMN;HSP90AA1;TAOK2;HSP90AB1;APOE;MARK3;CLU;BRSK2;PPP2CA;BAG2
prerank,LRR domain binding (GO:0030275),-0.5466305180765184,-1.507035833939844,0.059006211180124224,0.40749845310979343,0.999,2/14,0.38%,PAWR;ROBO1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5690258277067142,-1.499946551804667,0.07624633431085044,0.40389673303007034,0.999,6/12,22.40%,AOX1;SDHB;ISCA1;XDH;FXN;CIAPIN1
prerank,transaminase activity (GO:0008483),0.711875764830598,1.493874597787559,0.06431852986217458,0.8316862489538012,1.0,4/11,10.43%,AADAT;PSAT1;GOT2;OAT
prerank,heme binding (GO:0020037),0.5182662623593146,1.4929758481753634,0.020737327188940093,0.8074249543414629,1.0,11/65,8.31%,CYP2S1;CYB561D2;STEAP4;SUOX;CBS;PXDN;PGRMC2;CYP1B1;PTGES2;SDHC;RSAD1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.6483035810058602,1.4921570265416593,0.059154929577464786,0.7591768411502757,1.0,5/16,13.29%,ANO2;ANO6;TTYH3;TTYH1;ANO10
prerank,intracellular chloride channel activity (GO:0061778),0.6483035810058602,1.4921570265416593,0.059154929577464786,0.7591768411502757,1.0,5/16,13.29%,ANO2;ANO6;TTYH3;TTYH1;ANO10
prerank,endodeoxyribonuclease activity (GO:0004520),0.6109964477956146,1.489902014352631,0.04178272980501393,0.7481716225732875,1.0,6/20,10.25%,ZRANB3;MBD4;ERCC5;ERCC4;SETMAR;ENDOV
prerank,deoxyribonuclease activity (GO:0004536),0.6526085675314824,1.4888036091151713,0.05847076461769116,0.7306805603473061,1.0,4/14,5.72%,ZRANB3;MBD4;ERCC5;ERCC4
prerank,ion gated channel activity (GO:0022839),0.5947606294366713,1.4805992569120376,0.05748663101604278,0.7534963806311056,1.0,7/24,13.29%,ANO2;TMEM63A;ANO6;TTYH3;TTYH1;KCNT2;ANO10
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.651805525948924,1.4781401821986704,0.06423357664233577,0.7448675842023312,1.0,8/15,20.30%,KMT2A;SETD3;CXXC1;SETMAR;PRDM9;ASH2L;SETD4;KMT2D
prerank,death receptor binding (GO:0005123),0.6630756211842035,1.4774312752836967,0.07102272727272728,0.7273089802881074,1.0,3/15,2.73%,EDA;NGF;FADD
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.595850662938194,1.4765768984590395,0.06344827586206897,0.7111156898949434,1.0,4/21,9.96%,GRIA1;ANXA9;CHRNA4;GRM5
prerank,potassium channel activity (GO:0005267),0.4899594448966212,1.4694868244024737,0.021834061135371178,0.7284716491547611,1.0,17/89,9.82%,KCNK15;KCNA2;KCNH8;KCNK1;GRIK3;KCNA1;KCNA6;GRIK2;GRIK5;KCND1;KCND2;KCND3;GRIK1;KCNMB2;KCNMB3;KCNT2;TMEM38B
prerank,CCR chemokine receptor binding (GO:0048020),0.5838331492043286,1.468703149338887,0.05326231691078562,0.7127043429400365,1.0,6/28,15.65%,CCL11;CCL4;CCR2;NES;CCL14;CNIH4
prerank,carbohydrate:cation symporter activity (GO:0005402),0.6897342644106532,1.4660747924065234,0.07863501483679525,0.7080269930364806,1.0,2/11,2.55%,SLC5A3;SLC17A5
prerank,sodium:proton antiporter activity (GO:0015385),-0.5964336924398193,-1.4577269509345823,0.06567164179104477,0.49587050274709044,0.999,6/11,11.69%,SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC9A9;SLC9A7
prerank,peptidase inhibitor activity (GO:0030414),0.5537744603391918,1.4547641982950092,0.04950495049504951,0.7474650681386924,1.0,5/33,6.50%,GPC3;A2M;RECK;CSTB;UCHL5
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.6961985467783951,1.447844610950204,0.08598726114649681,0.7643683093722433,1.0,2/10,2.10%,CDKN2B;KAT2B
prerank,active ion transmembrane transporter activity (GO:0022853),-0.4130363679769357,-1.4472626185454633,0.02912621359223301,0.5027900556937007,0.999,17/37,22.64%,SLCO3A1;SLC22A8;SLCO2A1;SLC22A4;SLCO1C1;SLC22A6;COX6B1;COX6A1;COX4I1;UQCR11;COX5A;COX5B;SLC16A7;UQCR10;UQCRH;SLCO5A1;UQCRFS1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6450057510331568,1.4408917645674737,0.0832072617246596,0.7830681898044327,1.0,3/14,9.97%,CAPN5;CAPN1;CAPN6
prerank,platelet-derived growth factor binding (GO:0048407),0.6783679649811766,1.433282130854402,0.08083832335329341,0.80551416820337,1.0,4/11,12.66%,PDGFRA;COL3A1;COL1A2;COL1A1
prerank,cholesterol binding (GO:0015485),0.5143280070577775,1.4324044869687285,0.04738760631834751,0.7914445908106422,1.0,7/47,5.39%,APOD;PTCH1;VDAC2;ERLIN2;NPC1;OSBPL5;GRAMD1A
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3878423993775896,-1.4264390651861032,0.025,0.5386670639395255,1.0,16/47,14.66%,SLC7A11;SLC7A2;SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC38A11;SLC7A5;PDPN;SLC38A7;SLC16A2;SLC66A1;SLC38A5;SLC6A1;SLC38A10;SLC36A4
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5520373707131312,1.4257246999287752,0.06624203821656051,0.8078728674048092,1.0,12/29,20.24%,DUSP4;MAPK7;MAPKAPK3;MAPKAPK2;DUSP6;PTPRJ;MAPK14;PRMT1;ABL1;NBR1;DUSP16;DUSP1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.4903964264726023,-1.4237150195440358,0.07612456747404844,0.5250723695870503,1.0,7/18,15.00%,ALDH1A2;ALDH1A1;ALDH2;FAR2;ALDH3A2;ALDH9A1;ALDH18A1
prerank,peptidase activator activity (GO:0016504),-0.452047132297443,-1.423531092919147,0.06181818181818182,0.504704673007621,1.0,14/22,33.67%,PSMD14;MAL;PCOLCE2;APH1B;CAV1;PINK1;PCOLCE;PSENEN;CASP8AP2;ADRM1;VCP;PSME3;VSIR;PSME2
prerank,phosphatase binding (GO:0019902),0.46759029877594027,1.418904076675516,0.0334051724137931,0.8246328894088981,1.0,42/105,22.81%,LGALS3;ANK1;ERBB2;EGFR;PTPRT;EIF2AK3;MAST2;SH3YL1;SPRED1;PDLIM4;RCAN3;SHOC2;PIK3R1;ANAPC7;MAPK14;MAPK1;MAGI2;TBK1;FBXL2;PPP1R3F;HSP90B1;RPA2;CRY1;IQGAP1;MET;ELL;JUP;SYTL2;TP53;TERF2IP;VRK3;STX17;KIF3A;STAT3;CDC27;SIRPA;ANAPC4;PXN;DLG4;STAT6;KIFAP3;ANAPC5
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.48839512318017075,1.4152169770569123,0.04838709677419355,0.8271361929684832,1.0,13/60,7.52%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;EPHB6;ERBB2;EGFR;ACVR1;EPHB2;NTRK2;TGFBR2;FGFR1
prerank,filamin binding (GO:0031005),-0.5403172501853413,-1.4142306749306794,0.09340659340659341,0.511441438575603,1.0,4/11,20.89%,NEBL;SYNPO2;CEACAM1;RFLNA
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4233338010519304,-1.4117563955849963,0.06329113924050633,0.4997407166722461,1.0,12/26,12.30%,ABCG2;SLC16A12;SLC16A6;SLC6A12;SLC6A6;SLC6A13;SLC16A11;SLC16A2;SLC6A11;SLC6A1;SLC16A9;SLC5A6
prerank,ADP binding (GO:0043531),-0.44208515247341057,-1.4084841735204956,0.07169811320754717,0.49011638211141967,1.0,8/25,14.77%,PRKAG2;MYH9;ME1;PGK1;ABCG1;ATP5F1D;MYH10;ERN1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6275385887979413,1.40026502999781,0.11312217194570136,0.8870707390157105,1.0,3/12,4.26%,BACE2;HM13;PSEN1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4796905544979515,1.393050198625229,0.06011560693641618,0.9082872249584096,1.0,11/60,4.62%,ROR2;ROR1;EFEMP1;PDGFRA;ERBB3;NTRK3;EPHB6;ERBB2;EGFR;EPHB2;NTRK2
prerank,methylated histone binding (GO:0035064),0.4799136475992788,1.3930307280890046,0.06098964326812428,0.8901816265117973,1.0,26/62,24.56%,RAG2;LRWD1;KDM8;CXXC1;KAT8;SPIN1;ATRX;MBTD1;CDYL;MSH6;ING4;PHF8;TAF7;MSL3;PYGO1;PHF19;ING1;ZMYND11;KMT2E;TAF1;DPF2;CBX5;MPHOSPH8;RRP8;CHD1;FMR1
prerank,mechanosensitive ion channel activity (GO:0008381),0.6389835246365604,1.3924667468558047,0.1078125,0.875832665306937,1.0,2/12,2.97%,PIEZO2;TMEM63A
prerank,growth factor receptor binding (GO:0070851),0.46739744941544775,1.3875292950002294,0.04171240395170143,0.8848216879051793,1.0,19/95,11.39%,EFEMP1;PDGFRA;GLMN;FGF2;PYCARD;FGF10;VEGFA;PSEN1;ATXN2;FYN;BTC;HIP1;TRIP6;ERBB4;PTPRJ;NCSTN;ARF4;IL6ST;FGF7
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6106536687420319,1.3850593285383377,0.11566617862371889,0.881366636180284,1.0,2/15,1.57%,SLC1A3;SLC1A5
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4907362272471909,-1.3841759406278604,0.10576923076923077,0.5167932888284988,1.0,4/16,0.60%,PTPRK;PTPRM;PTPRB;PTPRG
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4907362272471909,-1.3841759406278604,0.10576923076923077,0.5167932888284988,1.0,4/16,0.60%,PTPRK;PTPRM;PTPRB;PTPRG
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5727053566873207,-1.3827008098155706,0.12534059945504086,0.5035482536966137,1.0,4/10,11.85%,SLC6A12;SLC6A13;SLC6A11;SLC6A1
prerank,symporter activity (GO:0015293),0.6664703725173484,1.3801506110098047,0.11942675159235669,0.890774176511052,1.0,1/10,0.37%,SLC28A1
prerank,pentosyltransferase activity (GO:0016763),-0.38722858955159856,-1.3762347367453678,0.07211538461538461,0.5043436521533645,1.0,12/36,21.16%,ZC3HAV1;PARP3;PARP4;PARP10;PARP1;SIRT3;PARP6;PARP14;SIRT4;QTRT2;QPRT;LARGE1
prerank,methylation-dependent protein binding (GO:0140034),0.4796333052269621,1.3752050724281855,0.06705882352941177,0.9012248062825948,1.0,18/57,18.90%,RAG2;LRWD1;KDM8;CXXC1;KAT8;SPIN1;ATRX;MBTD1;CDYL;MSH6;ING4;PHF8;MSL3;PYGO1;PHF19;ING1;ZMYND11;KMT2E
prerank,solute:sodium symporter activity (GO:0015370),0.5444708967036136,1.3750901215238018,0.09762532981530343,0.8857043257185572,1.0,2/27,2.55%,SLC28A1;SLC5A3
prerank,protein phosphatase 2A binding (GO:0051721),-0.4342396821077723,-1.374101848045823,0.08300395256916997,0.4940530728207222,1.0,14/23,25.86%,MFHAS1;PTPA;PPME1;STRN4;CTTNBP2NL;ARPP19;MAPT;IGBP1;SPHK1;MASTL;GRIN3A;BOD1;SMG5;BOD1L1
prerank,phospholipid transfer activity (GO:0120014),-0.4450140133431396,-1.3714611125329474,0.09363295880149813,0.4855938476294399,1.0,10/21,18.72%,PITPNM2;ABCA3;PLTP;PITPNA;GLTP;OSBPL2;TNFAIP8L3;C2CD2L;PRELID2;CERT1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.5419891688993351,-1.357260518322242,0.11042944785276074,0.506854138358835,1.0,3/11,9.80%,ITPR1;RASA3;MCOLN1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5414958982126228,1.3566035029872394,0.11870967741935484,0.967788676067913,1.0,7/25,8.90%,RAG2;PLEKHA4;SESTD1;NCF1;MAPKAP1;GAB2;HIP1
prerank,poly(A) binding (GO:0008143),0.5575455251832611,1.3539446340882038,0.10833333333333334,0.9656898104912238,1.0,5/21,4.63%,PABPC5;RBMS3;HNRNPDL;ELAVL4;PABPC1
prerank,chloride transmembrane transporter activity (GO:0015108),-0.4654214823181603,-1.3537553254070884,0.12333333333333334,0.5003840018904708,1.0,7/16,30.60%,SLC26A7;SLC26A2;SLC4A8;SLC26A6;SLC1A1;SLC26A8;CLCN6
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.4536195064867497,1.3535523043846778,0.06580366774541532,0.9514629782857359,1.0,15/91,8.90%,STXBP6;RAG2;PLEKHA5;PLEKHA4;SESTD1;GSN;ANXA9;PLCB1;WIPI1;MAPKAP1;LAPTM4B;GBF1;FZD7;RPH3A;HIP1
prerank,serotonin receptor activity (GO:0099589),0.5548982218923968,1.3525965526759238,0.13202247191011235,0.9105336278868751,1.0,3/22,10.08%,CHRM3;HRH1;HTR2C
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5548982218923968,1.3525965526759238,0.13202247191011235,0.9105336278868751,1.0,3/22,10.08%,CHRM3;HRH1;HTR2C
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5548982218923968,1.3525965526759238,0.13202247191011235,0.9105336278868751,1.0,3/22,10.08%,CHRM3;HRH1;HTR2C
prerank,endopeptidase activity (GO:0004175),0.4219922371036841,1.3474347405214342,0.014084507042253521,0.9223826774111404,1.0,68/257,21.24%,HGFAC;KLK12;MMP2;ADAMTS12;FAP;ADAM19;ADAMTS20;BACE2;HTRA3;CORIN;USP35;USP11;PARL;KDM8;MIPEP;PSEN1;PCSK4;PCSK6;MMP15;ADAMTS1;CTSK;CTSO;CASP6;KLK1;KLK6;CTSB;ADAMTS4;UCHL1;PSMB7;USP46;PMPCB;THOP1;MMP16;USP33;ADAMTSL1;USP48;GZMM;MALT1;MMP19;USP40;TYSND1;ADAM33;PSEN2;USP14;ADAMTS2;CASP2;USP25;USP1;USP2;THSD4;PSMB2;ADAMTSL4;USP37;CASP7;ADAMTS14;PIK3IP1;KLK2;MASP2;SENP1;USP5;MBTPS1;CPNE1;PLAT;PCSK7;PSMA8;USP13;FURIN;RHBDD1
prerank,single-stranded DNA binding (GO:0003697),0.4490285758158707,1.3456945315166318,0.06862745098039216,0.9172429645122957,1.0,31/93,21.77%,DDX11;RAD23B;SSBP2;MEIOB;APTX;ERCC5;ERCC4;STN1;SETMAR;RPA3;TDP1;REXO4;FBH1;MCM4;RPA2;POLR2G;RAD52;BLM;FUBP1;HNRNPU;FAM111A;PARK7;TOP1;HMCES;RBMS1;FUBP3;HSPD1;CTC1;SSBP1;MLH1;TOP3A
prerank,nucleosomal DNA binding (GO:0031492),0.5465496248635437,1.342765013159414,0.14380825565912117,0.9179675605861564,1.0,11/21,20.68%,MTA2;MBD2;RCC1;HDAC2;SMARCC2;SMARCC1;RBBP4;SMARCE1;SMARCA4;GATAD2B;HNRNPC
prerank,leak channel activity (GO:0022840),0.5682687830315507,1.341882553700067,0.13983050847457626,0.9085699151250299,1.0,2/18,3.04%,KCNK15;KCNK1
prerank,potassium:proton antiporter activity (GO:0015386),-0.5626565578315905,-1.3409520557910186,0.1543026706231454,0.5182176564228906,1.0,5/10,11.69%,SLC9A6;SLC9A2;SLC9A8;SLC9A9;SLC9A7
prerank,glucuronosyltransferase activity (GO:0015020),0.5600189590187427,1.339926640806046,0.13324175824175824,0.9047642015327308,1.0,3/19,8.43%,EXT1;CSGALNACT1;CHSY1
prerank,ubiquitin-specific protease binding (GO:1990381),0.564377739267918,1.339176003308223,0.13623595505617977,0.894702015128402,1.0,7/19,14.47%,PTEN;PRKN;RHBDD2;DERL2;SELENOS;LCOR;SUMO1
prerank,metalloendopeptidase activity (GO:0004222),0.4554955849471539,1.338717724267956,0.08800880088008801,0.8841905566680751,1.0,18/76,18.23%,MMP2;ADAMTS12;ADAM19;ADAMTS20;MIPEP;MMP15;ADAMTS1;ADAMTS4;PMPCB;THOP1;MMP16;ADAMTSL1;MMP19;ADAM33;ADAMTS2;THSD4;ADAMTSL4;ADAMTS14
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.4745836581410759,-1.3384330005384086,0.1196319018404908,0.5108487530043873,1.0,5/15,12.39%,ALDH1A2;ALDH1A1;ALDH2;ALDH3A2;ALDH9A1
prerank,endonuclease activity (GO:0004519),0.4754197001103991,1.3378676952077553,0.11203814064362336,0.8753255515304851,1.0,10/49,10.65%,ZRANB3;INTS11;MBD4;ERCC5;ERCC4;SETMAR;NOB1;ZC3H12B;REXO4;RCL1
prerank,phospholipase A2 activity (GO:0004623),0.5269614173126849,1.3352218229148707,0.13031914893617022,0.8750968271052725,1.0,6/26,13.78%,PRDX6;PLA2G7;PLA2G12A;PLAAT5;PLAAT3;PNPLA8
prerank,WW domain binding (GO:0050699),0.5293137979005929,1.3348137344885376,0.12677878395860284,0.8646412735833988,1.0,3/26,4.70%,ENAH;KIF20B;TRAF4
prerank,anion channel activity (GO:0005253),0.4573929500183151,1.333591587833877,0.09843400447427293,0.8589487975856929,1.0,7/61,6.94%,FXYD3;ANO2;VDAC2;CLCN5;ANO6;LRRC8D;TTYH3
prerank,cytokine activity (GO:0005125),0.43547796611947254,1.332997394910526,0.05241090146750524,0.8500913022734655,1.0,11/131,5.26%,CCL11;BMP5;IL16;CXCL10;FGF2;CRLF1;VEGFA;TGFB1;CCL4;GDF9;WNT5A
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5270311245662032,1.3295640864291745,0.13478818998716302,0.8555976462921434,1.0,3/28,4.70%,EDA;FADD;TRAF4
prerank,transcription coactivator binding (GO:0001223),0.5506300778387156,1.3292051719775613,0.150997150997151,0.846225941629417,1.0,2/20,2.30%,RORA;VGLL4
prerank,low-density lipoprotein particle binding (GO:0030169),-0.47039037609196704,-1.319143426377394,0.12258064516129032,0.5422851975223926,1.0,5/16,11.71%,CDH13;PLTP;THBS1;SCARF1;STAB1
prerank,gated channel activity (GO:0022836),0.582077253349025,1.318572376471819,0.15123456790123457,0.884511494102662,1.0,2/14,2.97%,PIEZO2;TMEM63A
prerank,voltage-gated anion channel activity (GO:0008308),0.5834813080156691,1.3169056670236359,0.15844544095665172,0.880844080369697,1.0,3/15,3.49%,VDAC2;CLCN5;ANO6
prerank,protease binding (GO:0002020),0.43267920865558235,1.315847206557415,0.08315334773218143,0.8745921249824404,1.0,27/99,16.20%,A2M;FAP;PYCARD;PTEN;BCL2;PRKN;FADD;ANXA9;RHBDD2;NTRK2;PRNP;CSTB;BIN1;COL3A1;ADAMTS4;DERL2;COL1A2;SELENOS;NFRKB;COL1A1;LCOR;TYSND1;SUMO1;ITGB1;CRADD;POLG;TP53
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5302847174727836,1.3127936044799906,0.1550068587105624,0.8767038985682248,1.0,7/22,14.38%,RBMS3;ELAVL4;EXOSC8;CPEB3;ZFP36L2;CPEB1;KHSRP
prerank,potassium ion leak channel activity (GO:0022841),0.5806189242168647,1.3127453928222992,0.17673048600883653,0.8660536538813297,1.0,2/15,3.04%,KCNK15;KCNK1
prerank,voltage-gated cation channel activity (GO:0022843),0.43556207673963854,1.3104036198052944,0.08681672025723473,0.8661153816126742,1.0,31/97,23.10%,KCNA2;CACNA1E;CACNA2D1;KCNH8;CACNG7;KCNK1;NCS1;KCNA1;CACNA1A;KCNA6;GRIN2B;KCND1;CACNB4;KCND2;KCND3;TPCN2;GRIN2D;GRIN2A;KCNH2;CACNA2D2;KCNMA1;CACNA2D4;KCNA5;KCNS3;HCN1;KCNH7;PKD2;LRRC55;KCNQ3;KCNC1;KCNA4
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.502745474332672,1.3102575891646113,0.14377406931964057,0.856320365124462,1.0,6/28,8.06%,GRIK3;CHRNA4;GRIK2;GRIK5;GRID2;GRIK1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.44925771569743117,1.3064069208225173,0.10231023102310231,0.8633941976921105,1.0,11/72,8.90%,STXBP6;RAG2;PLEKHA4;SESTD1;GSN;ANXA9;PLCB1;MAPKAP1;FZD7;RPH3A;HIP1
prerank,actin monomer binding (GO:0003785),-0.42515563818375235,-1.3051148781608761,0.12601626016260162,0.5639369055355349,1.0,10/22,26.83%,MTSS1;NOS3;ABL2;PFN2;TMSB4X;LIMA1;ABITRAM;TMSB10;MYL4;TWF2
prerank,poly(U) RNA binding (GO:0008266),0.5297557414549754,1.301891449629121,0.16643741403026135,0.8731437829573783,1.0,9/20,20.68%,PABPC5;RBMS3;PABPC1;DAZAP1;PNPT1;SSB;MCRS1;RBMS1;HNRNPC
prerank,protein tyrosine kinase activity (GO:0004713),0.43225318525951506,1.3002615533685191,0.08081896551724138,0.8699380504662707,1.0,19/108,10.56%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;PKDCC;PEAK1;EPHB6;ERBB2;EGFR;EPHB2;TEC;NTRK2;CSK;FGFR1;FYN;ERBB4;STYK1;TYK2
prerank,lipoprotein particle binding (GO:0071813),-0.4274793462618226,-1.2992853491114236,0.15625,0.5648519395337511,1.0,8/20,21.53%,CDH13;PLTP;THBS1;SCARF1;STAB1;MAPT;LPL;COLEC12
prerank,phosphatidylglycerol binding (GO:1901611),-0.4846196889296046,-1.299200717009403,0.16614420062695925,0.5516866544573757,1.0,7/13,29.46%,PLTP;PITPNA;STOML2;GSDMD;GSDME;UQCC3;MME
prerank,dipeptidyl-peptidase activity (GO:0008239),0.6263570625800247,1.2953417861344996,0.19902912621359223,0.8819462262045525,1.0,3/10,7.29%,FAP;NAALAD2;DPP10
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6006689618787528,1.292870524072752,0.19809825673534073,0.8833495817237408,1.0,6/12,22.54%,SULF1;GALNS;IDS;SGSH;ARSK;SULF2
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.36876300706487575,-1.2884968386537816,0.09345794392523364,0.5668313043287112,1.0,4/35,3.37%,GPCPD1;MPPED2;PLCL1;PLCB3
prerank,cAMP response element binding (GO:0035497),0.6067586600506598,1.2862791327826386,0.20030349013657056,0.9025286875104586,1.0,3/10,10.37%,CREB3L1;CREB3L2;ATF2
prerank,tropomyosin binding (GO:0005523),-0.45344747723997214,-1.2825733304665365,0.14144736842105263,0.5689039028555777,1.0,3/16,0.81%,NEBL;CALD1;TMOD3
prerank,calcium ion binding (GO:0005509),0.3997331440614436,1.2822239020107438,0.023069207622868605,0.9112461106958261,1.0,67/323,16.33%,DCHS1;CDH19;PCDHA4;ASTN2;S100A4;DHH;PLSCR4;GSN;LRP1;C2CD5;EFHD1;ANXA9;NCS1;CAPN1;LETM1;CD320;HPCA;NUCB1;DSG2;CDH10;PRNP;NRXN1;CDH22;EML1;CABCOCO1;CDH8;SYT1;AOC1;ITSN1;PPP3CB;S100A6;RCN1;RPH3A;PPP3CA;S100A16;RCN3;SPARC;ANXA11;FKBP9;CDH20;CDH7;SYT11;SYT12;MCTP1;GLCE;SCUBE1;CALU;ANXA6;ADGRL3;CDK5R1;SLC25A23;HSP90B1;OTOF;SRR;GALNT3;CCDC47;SNCA;SMOC2;KCNIP4;PVALB;CALM1;IQGAP1;IDS;CALM2;CDH18;LRP2;SLC25A24
prerank,epidermal growth factor receptor binding (GO:0005154),0.5084112192775034,1.2787797781515653,0.1774193548387097,0.9161036939025553,1.0,11/25,22.44%,EFEMP1;ATXN2;BTC;HIP1;ERBB4;ARF4;SNX1;HBEGF;GRB2;CCDC88A;SNX4
prerank,monocarboxylic acid binding (GO:0033293),0.5400371894696138,1.276197148379723,0.20422535211267606,0.9183822800232337,1.0,1/18,0.78%,PYGL
prerank,aspartic-type peptidase activity (GO:0070001),0.6001720885867444,1.2743542599066486,0.1796042617960426,0.9169793876410758,1.0,2/10,4.26%,BACE2;PSEN1
prerank,poly-pyrimidine tract binding (GO:0008187),0.5052118264941677,1.2736819943718396,0.18592297476759628,0.9103595607249367,1.0,10/23,20.68%,PABPC5;RBMS3;PABPC1;DAZAP1;PNPT1;HNRNPU;SSB;MCRS1;RBMS1;HNRNPC
prerank,syntaxin-1 binding (GO:0017075),-0.4146791536182036,-1.2727904384444688,0.15384615384615385,0.5816474665721431,1.0,6/22,10.24%,UNC13C;DAPK1;STXBP1;NSF;CPLX1;UNC13B
prerank,ion channel activity (GO:0005216),0.42538146834383317,1.2709949288401146,0.12349726775956284,0.9127954870789187,1.0,16/80,14.11%,PIEZO2;GRIA1;TMEM63A;GRIK3;CALHM6;GRIA3;CHRNA4;GRIN2B;GRIK2;GRIK5;GRID2;GRIK1;ANXA6;TMEM120A;GRIN2D;GRIN2A
prerank,alkali metal ion binding (GO:0031420),-0.45648729179111625,-1.2705780940632516,0.18787878787878787,0.575216851903699,1.0,5/13,11.47%,ATP1A2;DRG1;ATP1A1;HDAC4;IMPA1
prerank,transcription coregulator binding (GO:0001221),0.4503925827531333,1.2703141020733058,0.15274463007159905,0.9061169889917517,1.0,12/50,15.66%,RORA;USP11;VGLL4;EED;ZBTB16;ESR1;HDAC6;PER3;AHR;PER1;LCOR;MED25
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5232357675609829,-1.2691575824581054,0.19154929577464788,0.5667158976782655,1.0,5/10,20.67%,PML;ANKRD13B;ANKRD13A;LAPTM5;FAAP20
prerank,neuropeptide binding (GO:0042923),0.5435608684088559,1.267211596672237,0.17837078651685392,0.9104996244650776,1.0,3/18,16.65%,SSTR1;GPR37;OPRK1
prerank,receptor ligand activity (GO:0048018),0.4008464857746076,1.264221369434961,0.05432595573440644,0.9142916012934988,1.0,31/245,11.39%,CCL11;LGALS3;BMP5;EDA;IL16;CXCL10;CRH;FGF2;FGF10;SEMA3E;CRLF1;NGF;SEMA6C;NRG3;VEGFA;PTHLH;SEMA3A;TGFB1;CCL4;GDF9;WNT5A;TAFA4;TAFA1;IL18;BTC;EDN3;AMELX;GDNF;DAND5;BMP7;FGF7
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.5137441710575358,1.2605659921932542,0.1910569105691057,0.9115234508270561,1.0,6/21,9.08%,CDK13;CDK8;CDKL3;CDK6;CDK15;CDK19
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.5137441710575358,1.2605659921932542,0.1910569105691057,0.9115234508270561,1.0,6/21,9.08%,CDK13;CDK8;CDKL3;CDK6;CDK15;CDK19
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.4659159940905778,-1.259699928358482,0.1930379746835443,0.5799285165711586,1.0,4/13,11.61%,SLC7A2;SLC38A7;SLC66A1;SLC38A5
prerank,protein tyrosine phosphatase activity (GO:0004725),0.42316737287712075,1.2587486804500714,0.14798206278026907,0.9108553929396734,1.0,20/71,15.34%,PTPRH;UBASH3B;PTPDC1;PTEN;PTPN22;DUSP4;PTPRT;PTPN2;PTPN13;PTPN1;PTPRJ;DUSP11;PTPN11;CDC25B;PTPRA;PTPN18;PTPRZ1;PTPN21;PTPRF;CDC14A
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.43163187382070983,1.2569189895388981,0.15350389321468297,0.9101709508674571,1.0,14/73,19.18%,SORCS2;SORCS1;SORCS3;PTH2R;LGR5;TSHR;MAS1;GPR37;GLP2R;MC5R;OPRK1;APLNR;S1PR2;VIPR2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5241027844917344,1.2549382536397609,0.19577464788732393,0.9101032059323174,1.0,9/19,21.45%,GRIK3;GRIK2;GRIK5;GRID2;GRIK1;GABRG2;GABRA3;GABRA2;GRID1
prerank,"DNA binding, bending (GO:0008301)",-0.47283420335532644,-1.2527760398410843,0.16608996539792387,0.5863835461519634,1.0,6/14,23.72%,LEF1;FOXL1;HMGA2;HHEX;HMGB2;FOXD1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.586250440680054,1.2517140064233365,0.23583460949464014,0.9157236501638778,1.0,6/10,12.77%,SETD3;SETMAR;SETD2;PRDM9;NSD2;SETD5
prerank,metal ion transmembrane transporter activity (GO:0046873),0.49753363992865596,1.2498267483718375,0.18933333333333333,0.9145827845638093,1.0,9/27,13.59%,SLC12A3;MRS2;KCNA1;ATP2B3;SLC12A2;SLC8A2;MAGT1;ATP2B1;TUSC3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4658389028392344,1.2497515484551802,0.19070904645476772,0.9061910682493547,1.0,7/38,9.37%,PLEKHA5;PLEKHA4;SESTD1;WIPI1;BBS5;HIP1;LANCL2
prerank,leucine zipper domain binding (GO:0043522),-0.49858612916649125,-1.249323087271774,0.2096317280453258,0.5835486500856619,1.0,1/10,0.15%,PAWR
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.4312273486996843,-1.2447356168551638,0.16901408450704225,0.582712617155328,1.0,12/17,20.17%,ATP10A;PITPNM2;ABCA3;ABCA1;PLTP;PITPNA;ABCG1;ATP8B2;ABCB4;ATP10B;ABCA7;PCTP
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.46557266923602225,-1.2440252546148727,0.1891891891891892,0.5731671294381756,1.0,5/13,12.39%,ALDH1A2;ALDH1A1;ALDH2;ALDH3A2;ALDH9A1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.5491168974583241,1.2433298178142764,0.23224852071005916,0.9251905638878276,1.0,2/14,4.97%,AASS;ALDH1L1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5518556764954384,1.2419364494552287,0.21368715083798884,0.9226757170410976,1.0,3/14,3.53%,LXN;NGF;RECK
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5935050768762713,1.24170920242541,0.2346456692913386,0.906893116084077,1.0,4/10,20.24%,DUSP4;DUSP6;DUSP16;DUSP1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5935050768762713,1.24170920242541,0.2346456692913386,0.906893116084077,1.0,4/10,20.24%,DUSP4;DUSP6;DUSP16;DUSP1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5633628323700062,1.2408143836094165,0.21482602118003025,0.9024436546258178,1.0,2/12,11.03%,RHO;GPR88
prerank,chloride channel inhibitor activity (GO:0019869),0.5776288007501688,1.2390299676160557,0.23186119873817035,0.901438962681847,1.0,2/10,3.60%,WNK2;WNK3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.5852294959727525,1.2369162756549494,0.22923076923076924,0.9028649918777709,1.0,1/10,1.94%,DPEP1
prerank,chloride channel regulator activity (GO:0017081),0.5399714592398132,1.2301337430033652,0.24,0.9228374157366467,1.0,5/14,16.87%,WNK2;WNK3;SGK3;STX8;SGK1
prerank,histone acetyltransferase activity (GO:0004402),0.4806536259046608,1.2293021292553215,0.2056921086675291,0.9182820366023072,1.0,11/30,18.91%,KAT2B;BAZ1A;HAT1;KAT8;MCM3AP;ATF2;TAF9;EPC1;NCOA3;EPC2;TAF1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4766278433893858,1.2268115455065467,0.20286085825747724,0.9209518630656496,1.0,12/30,22.99%,DPEP1;MT3;CSTB;UBE2Z;PRDX3;SNCA;UBE2O;XIAP;CAST;PTTG1;RPS6KA3;CARD16
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.49668053173291365,-1.225044792478915,0.22955145118733508,0.6092809188401694,1.0,5/10,20.67%,USP15;ANKRD13B;ANKRD13A;LAPTM5;FAAP20
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.44726063810616545,1.2248886037618165,0.19833729216152018,0.9210314107847315,1.0,19/44,21.33%,PRDM16;SUV39H1;KMT2A;SETD3;CXXC1;EED;SETMAR;MEN1;SETD2;PRDM9;NSD2;SETD5;ASH2L;KMT2E;SETD4;N6AMT1;SETDB1;KMT2D;NSD1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5944009061493122,1.2248407432573014,0.2483974358974359,0.9134469351801228,1.0,4/10,15.72%,HAT1;KAT8;ATF2;MSL3
prerank,voltage-gated sodium channel activity (GO:0005248),0.49638364179275607,1.2222841033738563,0.22684563758389262,0.9162164434516259,1.0,4/22,7.11%,SCN7A;SCN2A;SCN5A;SCN3A
prerank,frizzled binding (GO:0005109),-0.34540226117778444,-1.2212434722969014,0.1674641148325359,0.6078861516446439,1.0,12/34,21.13%,WNT4;WNT5B;ZNRF3;WNT6;WNT9A;RYK;RNF43;FZD1;CCDC88C;WNT16;DVL2;WNT11
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.4735787760874839,1.220450759899536,0.2230769230769231,0.9160745021371207,1.0,13/31,21.85%,UBE2T;UBE2E2;UBE2K;UBE2Z;UBE2J2;AKTIP;UBE2O;UBE2Q1;TAF1;UBE2L3;UBE2G1;UBE2E1;UBE2D3
prerank,poly-purine tract binding (GO:0070717),0.48215834493609744,1.2198919074368713,0.23415977961432508,0.9106741985064628,1.0,5/27,4.63%,PABPC5;RBMS3;HNRNPDL;ELAVL4;PABPC1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5774793230962566,1.2185154158325928,0.25862068965517243,0.9087641274159456,1.0,3/10,10.06%,NCF1;NOX1;NCF2
prerank,ankyrin binding (GO:0030506),0.5095971879033644,1.2151118697157082,0.23512747875354106,0.9151327844714248,1.0,4/19,6.46%,NRCAM;SPTBN1;SCN5A;PLEC
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.36550742491136307,-1.214567383533533,0.17154811715481172,0.6133993565954339,1.0,10/27,11.69%,SLC8A3;SLC41A1;SLC8B1;SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC4A8;SLC9A9;SLC9A7
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.4697662036251823,1.2134747009685427,0.23766233766233766,0.9143331769058647,1.0,7/31,10.69%,KCNA2;SLC12A3;KCNK1;KCNA1;SLC12A2;TMEM38B;SLC12A4
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5039222757752049,1.21301047292662,0.23148148148148148,0.9089832825407779,1.0,6/22,18.23%,HSPG2;SYT1;ANKRA2;HSP90B1;APBB3;DNAJA1
prerank,GTPase inhibitor activity (GO:0005095),0.5472349640781855,1.2123056636481855,0.2613981762917933,0.9047127855160746,1.0,5/13,14.85%,RTKN;IQGAP2;ARL2;RHOH;IQGAP1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3856265954053292,1.208304959445104,0.11926605504587157,0.9133517487474666,1.0,29/173,13.72%,OSR2;CREB3L1;PRDM16;MYC;ZNF25;ZBTB20;OTP;ZBTB37;SATB1;NFX1;FOXP2;ZEB1;TRPS1;RORC;MLX;ZBTB16;TBX18;E2F6;LRRFIP1;ZBTB6;NFATC3;ZGPAT;PATZ1;FOXP4;ZBTB1;GATA3;ZEB2;ZBTB39;NACC2
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5064882504196057,1.2070622288242006,0.25517241379310346,0.9116590927059973,1.0,2/21,1.60%,FGF2;FGF10
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.36683854903276386,-1.2043707806888106,0.18454935622317598,0.6291368819046493,1.0,7/30,9.36%,SLC30A10;SLC31A1;ATP7A;SLC40A1;SLC39A8;SLC30A1;SLC39A6
prerank,FAD binding (GO:0071949),0.48900958359517205,1.2036583888445096,0.22418478260869565,0.9184706307295778,1.0,4/24,8.60%,STEAP4;SQLE;DAO;MTRR
prerank,ligand-gated cation channel activity (GO:0099094),0.41429929536131865,1.2023431024975664,0.19463087248322147,0.9165564416608059,1.0,14/75,16.33%,GRIA1;KCNK1;GRIK3;GRIA3;CHRNA4;GRIN2B;GRIK2;GRIK5;GRIK1;GRIN2D;KCNJ3;GRIN2A;KCNJ10;KCNH2
prerank,acid-thiol ligase activity (GO:0016878),0.5373051689292041,1.2005930332338395,0.26957831325301207,0.9162401716075833,1.0,3/13,7.30%,ACSS2;ACSS3;ACSS1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.5141756009232734,1.1962779602077485,0.2647058823529412,0.9263479339423795,1.0,4/18,6.16%,STXBP6;PAK4;CNN3;BAIAP2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.4327129102303173,-1.1961559356806086,0.20327868852459016,0.6400039799386219,1.0,6/15,14.75%,HS3ST3A1;HS3ST1;NDST3;NDST1;HS3ST2;HS3ST3B1
prerank,voltage-gated potassium channel activity (GO:0005249),0.40620690798201664,1.195622677145534,0.19230769230769232,0.9220887305377468,1.0,27/80,25.54%,KCNA2;KCNH8;KCNK1;KCNA1;KCNA6;KCND1;KCND2;KCND3;KCNT2;KCNJ3;KCNJ10;KCNH2;KCNMA1;KCNA5;KCNS3;HCN1;KCNH7;PKD2;LRRC55;KCNQ3;KCNK6;KCNC1;KCNA4;KCNJ13;KCNQ5;KCNN2;HCN2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.4755088980756227,-1.193389052796314,0.23404255319148937,0.6370634142962783,1.0,4/12,10.53%,PIK3R3;PIK3C2A;PIK3C2B;PIK3R6
prerank,metal ion binding (GO:0046872),0.36893999077653616,1.1930573426426705,0.069,0.9252991411180541,1.0,94/477,16.33%,DCHS1;CDH19;PCDHA4;ASTN2;S100A4;DHH;IDH2;PLSCR4;GSN;LRP1;PSPH;C2CD5;EFHD1;ANXA9;NCS1;IRAK3;PDXK;CAPN1;LETM1;SIK2;MAST2;CD320;HPCA;DXO;NUCB1;DSG2;CDH10;PRNP;GSS;NRXN1;PGM1;MT3;CDH22;EML1;ACVR1C;UBA2;CABCOCO1;CDH8;SYT1;AOC1;POSTN;HMGCLL1;ITSN1;PPP3CB;S100A6;NUDT22;RCN1;RPH3A;CSGALNACT1;PPP3CA;RPE;S100A16;RCN3;SPARC;ANXA11;FKBP9;CDH20;CDH7;SYT11;SYT12;MCTP1;ENDOV;GLCE;SCUBE1;PI4K2A;MSH6;CALU;ANXA6;ADGRL3;CDK5R1;SLC25A23;GNAI1;NUDT3;HSP90B1;OTOF;SRR;EXD2;GALNT3;CCDC47;SNCA;SMOC2;KCNIP4;IDH3A;PVALB;CALM1;IQGAP1;OPA1;IDS;CALM2;ABL1;PAPOLA;CDH18;LRP2;SLC25A24
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.4507099648504994,1.191764772016988,0.2425,0.9233013102420651,1.0,12/33,17.58%,WAC;ZNF326;ERCC5;RPRD1A;URI1;DRAP1;GTF2B;ELP2;ELP4;HNRNPU;CDC73;NCOA3
prerank,nucleotidase activity (GO:0008252),0.5158160943922723,1.1915623581421315,0.2658788774002954,0.9172125597982278,1.0,6/15,18.94%,NT5DC2;NT5C2;BPNT1;BPNT2;NT5C3B;NT5C
prerank,RNA polymerase core enzyme binding (GO:0043175),0.448849061423339,1.1905549327825335,0.24751243781094528,0.9145053633329094,1.0,12/33,17.58%,ERBB2;WAC;ZNF326;ERCC5;RPRD1A;URI1;GTF2B;ELP2;ELP4;HNRNPU;CDC73;NCOA3
prerank,NAD+ binding (GO:0070403),-0.46059978351982706,-1.188714068690895,0.2716049382716049,0.6376373920714374,1.0,4/12,14.55%,ZC3HAV1;CRYL1;SIRT3;HPGD
prerank,semaphorin receptor activity (GO:0017154),-0.46687636164778745,-1.1874841471857798,0.25892857142857145,0.6304011342825072,1.0,5/11,12.93%,PLXNA2;NRP1;PLXNB1;PLXNA4;PLXNA1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5467891784380844,1.186527217649555,0.2839506172839506,0.9231038904291936,1.0,5/12,11.33%,CDK13;CDK8;CDK6;CDK19;MAPK1
prerank,bHLH transcription factor binding (GO:0043425),-0.39441262674642824,-1.1861266983876928,0.22344322344322345,0.6232719672809083,1.0,6/19,19.86%,FHL2;KDM1A;LMO2;TCF12;CREBBP;TWIST1
prerank,chloride channel activity (GO:0005254),0.4105258949751301,1.1855669785666794,0.23672055427251731,0.9201624865365599,1.0,14/59,21.13%,FXYD3;ANO2;CLCN5;ANO6;TTYH3;TTYH1;FXYD1;CLIC1;CLCN2;GABRG2;TTYH2;GLRB;GABRA3;GABRA2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.550378872725969,1.1852956754673674,0.28278041074249605,0.9145350496014633,1.0,1/11,0.66%,SLC22A3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.4811762420169905,1.1851239478347206,0.2628120893561104,0.9088950114546627,1.0,2/23,4.99%,CHRM3;PLCB1
prerank,phosphate ion binding (GO:0042301),0.5574616870959745,1.1839346533920976,0.28314238952536824,0.9069982369057656,1.0,2/10,7.60%,ADSS1;RPH3A
prerank,sulfotransferase activity (GO:0008146),-0.34370018418103776,-1.1830364532474518,0.19457013574660634,0.6211111471079798,1.0,15/33,23.12%,HS3ST3A1;HS3ST1;CHST15;CHST11;TPST1;GAL3ST1;CHST2;UST;CHST3;CHST12;HS3ST2;CHST10;SULT4A1;GAL3ST2;CHST1
prerank,actin binding (GO:0003779),-0.24078188243153004,-1.1829258581523134,0.0,0.6114727949429904,1.0,41/170,15.73%,MACF1;PAWR;ABLIM1;CALD1;SORBS1;PHACTR1;CAPZB;PDLIM5;SYNE2;MYH9;MYRIP;MTSS1;PHACTR4;PARVB;NOS3;P4HB;MICAL3;ABL2;TPM1;GIPC1;MICAL2;EPS8;PFN2;EPS8L2;TMSB4X;MAEA;MAPT;PDLIM1;FXYD5;MYH10;DAG1;CAP1;KIF18A;SYNPO2;SHROOM2;AVIL;TPM2;CEACAM1;LIMA1;TMOD1;TRPV4
prerank,cytokine receptor activity (GO:0004896),0.39936302721380784,1.1801136882175989,0.2097130242825607,0.9151663528237618,1.0,14/83,17.26%,GFRA1;IL2RA;IL20RB;CRLF1;GFRA4;IL1RL2;CCR2;CSF3R;IL6ST;PRLR;ACKR4;GFRA2;IL1RAP;CD74
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3752239187173386,1.1765026697834078,0.1593011305241521,0.9225666559118488,1.0,58/188,21.48%,SOX6;KLF15;CREB3L1;PRDM16;ZBTB20;SUV39H1;SOX11;GLI1;RFX3;CREB3L2;GATA6;TBX18;MEN1;CHD3;ATMIN;SOX5;TFAM;BRCA1;CARM1;SOX12;ARID4B;PRDM9;ERBB4;NFE2L2;SP1;TAF2;TAF9;SFPQ;CREBZF;RUNX1;PER3;XRCC6;AHR;ATF5;PER1;GATA3;SNCA;TAF7;TP53;KCNH2;GABPB1;GABPB2;FOXJ1;PAX2;RNF10;ASH2L;EGR1;PPARG;STAT3;BCOR;JUN;KMT2D;TFE3;PBX1;NFKB1;ZBED4;HNRNPL;THRA
prerank,receptor tyrosine kinase binding (GO:0030971),0.420020372550752,1.1762760309657285,0.24707259953161592,0.9170406413146714,1.0,12/56,10.53%,SHC4;LRP4;CBLB;PTPN2;NRG3;SOCS5;ALKAL2;GAB2;GRB14;PTPN1;PIK3R1;CBL
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.4446839727397659,1.1716297518286385,0.25870646766169153,0.928666037043776,1.0,17/34,26.44%,UBE2T;UBE2E2;UBE2K;UBE2Z;UBE2J2;AKTIP;UBE2O;UBE2Q1;TAF1;UBE2L3;UBE2G1;UBE2E1;UBE2D3;UBE2Q2;UBE2R2;UBE2I;UBE2J1
prerank,hexose transmembrane transporter activity (GO:0015149),0.5310707815608834,1.1691941828702364,0.3013698630136986,0.9318546577966474,1.0,3/12,10.80%,SLC5A3;MFSD4A;SLC2A2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.5241386759561281,1.168078499641653,0.29819277108433734,0.9296561310318427,1.0,5/13,19.44%,AGPAT2;AGPAT5;GPAT3;GPAT4;LPCAT2
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5074081320926176,1.1651456840693146,0.28653295128939826,0.9348674524622973,1.0,5/15,21.44%,P2RY14;P2RY12;P2RY1;PTAFR;P2RX7
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.49015313620801065,1.1648299874534385,0.3028571428571429,0.9297577290935924,1.0,9/20,23.12%,MAGI3;DTYMK;DLG2;AK3;AK6;AK2;AK8;CARD11;CMPK1
prerank,receptor antagonist activity (GO:0048019),0.49616915460471445,1.1635491229079975,0.2847411444141689,0.9282673550539895,1.0,2/17,9.02%,PXDN;DKK3
prerank,mRNA 5'-UTR binding (GO:0048027),-0.36977984951305476,-1.1616937738693387,0.23773584905660378,0.6549240857801146,1.0,14/24,39.63%,RPS14;RPL5;MYH10;IGF2BP3;UTP23;RPL26;MRPS11;RPL41;IGF2BP2;SHMT2;SHMT1;IGF2BP1;RPS13;CCT5
prerank,metallopeptidase activity (GO:0008237),0.3794296071354837,1.1577435368316047,0.2346072186836518,0.9441281510803631,1.0,20/113,15.09%,MMP2;ADAMTS12;ADAM19;ADAMTS20;DPEP1;ADAM23;MIPEP;MMP15;ADAMTS1;ADAMTS4;PMPCB;LNPEP;THOP1;MMP16;MYSM1;ADAMTSL1;MMP19;ADAM33;PAPPA2;ADAMTS2
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4134815830796226,1.1563835963513458,0.2752941176470588,0.9428843757489067,1.0,8/53,8.60%,STEAP4;GCDH;POR;SQLE;ETFA;DAO;ACOX1;MTRR
prerank,transmitter-gated ion channel activity (GO:0022824),0.4417399561340183,1.1558966095697845,0.2803030303030303,0.93868850659432,1.0,10/29,21.45%,GRIK3;GRIK2;GRIK5;GRID2;GRIK1;GRIN2D;GABRG2;GABRA3;GABRA2;GRID1
prerank,methyl-CpG binding (GO:0008327),0.4728659797990624,1.1544116972718714,0.2884097035040431,0.9383430930471391,1.0,6/22,16.40%,LRWD1;MBD1;MBD2;ZBTB38;PRMT1;TET3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5139062861001888,1.1510913743729383,0.31268436578171094,0.9445307819596245,1.0,2/14,8.23%,RDH10;DHRS3
prerank,calcium activated cation channel activity (GO:0005227),0.4951574261685398,1.149233609724077,0.31457431457431456,0.9454550826189352,1.0,6/17,17.09%,TMEM63A;ANO6;KCNMB2;KCNMB3;ANO10;KCNMA1
prerank,ubiquitin protein ligase binding (GO:0031625),0.36310524264851,1.1449071128133597,0.17105263157894737,0.9556116493642014,1.0,71/254,20.72%,PRDX6;UBE2T;GLMN;ERBB3;BCL2;PTPN22;HM13;CBS;PRKN;EGFR;ERLIN2;FBXW7;BLZF1;TRAF4;FBXO7;SPOP;SCN5A;YWHAZ;LAPTM4B;RALB;NAE1;PACRG;BAG5;BRCA1;UBE2K;UCHL1;ANKRA2;CASC3;HIF1A;SYT11;CUL3;SLF2;GPR37;NGFR;UBE2J2;HDAC6;PATZ1;PRKACA;PER1;NEDD8;DET1;RPA2;SUMO1;RTN4;WASHC1;JKAMP;CCDC50;GABARAPL2;UBB;UBOX5;TP53;KCNH2;USP25;DBT;CUL4B;USP2;RIPK1;MID1;MDM2;NKD2;DNAJA1;HSPA9;POLR2A;MAGEC2;UBE2L3;RRAGA;BCL10;UBE2G1;JUN;HSPD1;USP13
prerank,tubulin binding (GO:0015631),0.35807996821547944,1.1444337583929725,0.1891348088531187,0.9515055077405153,1.0,73/295,18.85%,DLEC1;SGIP1;SAXO2;DNM1;FGF13;EFHC1;KIF20B;PRKN;KIF19;TTLL5;MAP4K4;MAP1B;GAS2L3;ARL3;MAST2;TBCE;TTLL11;STARD9;PRNP;EML1;CCDC170;PAK1;MACO1;NDE1;KIF21A;FYN;PACRG;CEP57;BRCA1;SETD2;CAPN6;CEP295NL;TUBGCP5;VAPA;DYNC1I1;AGBL4;KIF5C;MID2;TTLL4;CLASP1;STMN4;HDAC6;EMD;AGBL1;CDK5R1;APC2;RMDN2;KATNB1;UNC5C;ARL8A;CKAP5;ATF5;TRAPPC14;MDM1;SNCA;KIF22;TPGS1;WASHC1;OPA1;GABARAPL2;MAP6D1;NAV3;EML5;DIP2B;MID1;DCX;KIF3A;HTT;CAMSAP1;MAPRE3;HOOK2;KIF2A;KIF21B
prerank,sequence-specific mRNA binding (GO:1990825),0.5439613700349287,1.1443522630775305,0.3079268292682927,0.9458781242213405,1.0,3/10,24.56%,ETF1;SSB;FMR1
prerank,amyloid-beta binding (GO:0001540),0.3922700314438626,1.1441339850643246,0.2572383073496659,0.9407689396469201,1.0,20/79,18.54%,HSPG2;LRP1;GRIA1;EPHB2;GRIA3;CACNA1A;PRNP;GRIN2B;NLGN1;APBB2;GSAP;CRYAB;NGFR;APBA1;GRIN2A;CLSTN1;TM2D1;CD74;APBB3;PGRMC1
prerank,transcription cis-regulatory region binding (GO:0000976),0.35459950586081956,1.1435499916820766,0.14042126379137412,0.937016095312532,1.0,96/406,21.48%,RORA;OSR2;SOX6;KLF15;CREB3L1;LHX5;PRDM16;MYC;ZNF25;HOXB8;ZBTB20;SOX9;SUV39H1;OTP;SATB1;TFCP2;NFX1;SOX11;RFXANK;GLI1;E2F2;PHOX2A;HOXD3;TRPS1;RFX3;CREB3L2;MLX;XRN2;DRAP1;TWIST2;GATA6;TBX18;E2F6;FOXM1;MEN1;CHD3;ATMIN;SOX5;TFAM;BRCA1;CARM1;SOX12;BBX;HIF1A;ARID4B;PRDM9;ERBB4;ATF2;NFE2L2;SP1;TAF2;TAF9;RBAK;SFPQ;CREBZF;RUNX1;PER3;XRCC6;AHR;ATF5;PER1;GATA3;POLRMT;SALL2;SNCA;TAF7;CREM;TAF4;PURG;SP3;TP53;KCNH2;GABPB1;GABPB2;FOXJ1;PAX2;RNF10;NR5A1;ASH2L;PARK7;EGR1;PPARG;STAT3;PRDM2;BCOR;JUN;KMT2D;TFE3;SNAI1;PBX1;NFKB1;ZBED4;ZBTB10;HNRNPL;TIPARP;THRA
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.4517525649235575,-1.1421987034315806,0.28609625668449196,0.6953435339989367,1.0,4/11,8.57%,UBE4B;PPIL2;STUB1;UBE4A
prerank,RNA stem-loop binding (GO:0035613),0.521673019471586,1.1399889229533753,0.31437598736176936,0.9446927688310209,1.0,5/12,24.56%,EPRS1;CPEB3;RC3H1;CSDE1;FMR1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4676487420022439,-1.1387674590986894,0.3061797752808989,0.6936502736349136,1.0,3/10,10.28%,PIK3R3;PIK3C2A;PIK3C2B
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3494151166528495,-1.1384776025381464,0.27860696517412936,0.6840083272419141,1.0,9/27,13.39%,SLC22A8;SLC26A7;SLC26A2;ANO1;SLC22A6;SLC5A5;SLC39A8;SLC25A30;LRRC8A
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5555435354651106,1.1383587460895732,0.3261205564142195,0.9449592771328784,1.0,4/10,19.97%,KDM8;KDM4B;PHF8;RIOX2
prerank,protein kinase C activity (GO:0004697),0.5044998598536524,1.1372154260243021,0.3069164265129683,0.9434120980955552,1.0,3/14,5.78%,PRKCA;PRKCQ;PKN1
prerank,CoA-ligase activity (GO:0016405),0.5040764197109056,1.1354937518224153,0.3368421052631579,0.9444017228132817,1.0,3/14,7.30%,ACSS2;ACSS3;ACSS1
prerank,four-way junction DNA binding (GO:0000400),0.48959961110016237,1.1341855889429393,0.3352192362093352,0.9436927651223916,1.0,6/17,17.46%,MEN1;MSH6;XRCC3;ABL1;BLM;WRN
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3959876841744055,1.1320908784715102,0.3057176196032672,0.946309827287057,1.0,18/57,20.06%,CYB561D2;UQCRQ;CYBRD1;NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;COX10;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;CYB5A;NDUFA5
prerank,retinoic acid binding (GO:0001972),-0.42969438253946024,-1.1319868448937136,0.31339031339031337,0.6912013177693834,1.0,2/12,19.21%,CYP26B1;RARA
prerank,organic cation transmembrane transporter activity (GO:0015101),0.48813710589055004,1.1314905443651022,0.3251088534107402,0.9430414652572001,1.0,3/16,11.65%,SLC22A3;SLC44A2;SLC7A8
prerank,carbohydrate kinase activity (GO:0019200),0.5358674972196423,1.1308827209783872,0.324773413897281,0.9395756876725734,1.0,6/11,23.11%,NAGK;FGGY;GNE;GALK2;HK2;HK1
prerank,calcium channel inhibitor activity (GO:0019855),-0.44688720616640354,-1.1305901844089132,0.30513595166163143,0.6849093678481253,1.0,3/11,9.16%,ITPR1;MCUB;SLC30A1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.5012415014499287,1.130465193658624,0.3328488372093023,0.9356404351111233,1.0,3/15,9.37%,PLEKHA5;SESTD1;LANCL2
prerank,anion:anion antiporter activity (GO:0015301),-0.3859862661053164,-1.1292758545407855,0.2915129151291513,0.6785136172978081,1.0,3/17,7.94%,SLC26A7;SLC26A2;SLC4A3
prerank,FMN binding (GO:0010181),0.5342776873429528,1.128875535555776,0.35725429017160687,0.9358422716195983,1.0,3/11,8.60%,POR;PNPO;MTRR
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4946505499743694,1.128700669074989,0.32554744525547447,0.9311223143900201,1.0,8/14,27.45%,RPP38;PRORP;TSEN2;POP1;RPP21;TSEN34;RPP30;RPP14
prerank,DNA binding (GO:0003677),0.3500648932064858,1.1286717892072626,0.106,0.9258401701148544,1.0,159/694,20.74%,RORA;OSR2;RAG2;SOX6;NKX6-2;MEOX1;TSHZ3;MEOX2;GLI2;DDX11;SOX8;CRLF3;PRDM16;MYC;RAD23B;BCL2;CBFB;BANF2;SOX9;SSBP2;HMGN1;C1D;MEIOB;EGFR;OTP;HOXA7;SATB1;APTX;MBD4;TFCP2;FOXP2;KDM5B;CHTF18;RFX2;ERCC5;EZH1;TIPIN;MBD1;GLI1;E2F2;MPG;ERCC4;TIGD2;DDB2;RFX3;STN1;SETMAR;RPA3;MLXIPL;MLX;ZBTB16;DRAP1;DEDD;LRRFIP1;MEN1;CHD3;RARB;RARG;XPA;TFAM;BRCA1;SOX12;TDP1;HIF1A;CHD2;ZBTB6;REXO4;NHEJ1;PRDM9;ENDOV;HDAC2;FBH1;PSIP1;HUWE1;NFE2L2;LIN9;MCM4;SP1;MSH6;TAF9;SFPQ;CREBZF;ZMYM6;ZGPAT;PATZ1;NR6A1;XRCC6;AHR;DDB1;ATF5;GATA3;POLRMT;ZEB2;PDS5B;RPA2;ORC1;POLR2G;PAX3;CRY1;ZNF638;POLG2;CREM;CGAS;RAD52;SLTM;GTF3C1;ABL1;TAF4;POU3F1;MSL3;MEIS3;TAF4B;BLM;POLG;TRNP1;TP53;PHF19;QRICH1;FUBP1;HNRNPU;FAM111A;CUL4B;FOXJ1;PAX2;WRN;PCID2;AIFM1;NR5A1;ZNF496;CSRNP3;BATF;IRF3;MLF1;CGGBP1;PARK7;ZMYND11;RNF4;TAF1;POLR2A;EGR1;PPARG;STAT3;PRDM2;FOXJ3;CNBP;TOP1;CENPC;HMCES;HP1BP3;SMARCA4;JUN;MEIS1;KMT2D;RBMS1;MBD6;FUBP3;SPO11;HSPD1;PBX1
prerank,sequence-specific DNA binding (GO:0043565),0.3484763858353809,1.12797571441096,0.12112112112112113,0.9229383123728473,1.0,89/590,16.73%,RORA;OSR2;RAG2;ETV1;NKX6-2;KLF15;MEOX1;ETV4;MEOX2;CREB3L1;GLI2;LHX5;TLX3;SOX8;PRDM16;TGIF2;BCL2;CBFB;HOXB8;ZBTB20;LRWD1;SOX9;HIVEP1;KMT2A;ZBTB37;HOXA7;SATB1;EGR3;TFCP2;FOXP2;KDM5B;UPF3A;RFX2;ZNF276;MBD1;E2F2;CXXC1;PHOX2A;HOXD3;RFX3;STN1;RORC;MLX;GATA6;TBX18;RARB;MBD2;RARG;XPA;TFAM;SOX12;BBX;HIF1A;KLF5;ZBTB38;PRDM9;HDAC2;ATF2;NFATC3;NFE2L2;ESR1;SP1;PRMT1;UPF1;ZGPAT;ZNF250;KLF13;NR6A1;XRCC6;AHR;ATF5;GATA3;POLRMT;ZEB2;PAX3;CREM;SLTM;IRX5;HOXB7;ABL1;POU3F1;MEIS3;SP3;SMG6;TERF2IP;TET3;NFIX;HNRNPU;SREBF2
prerank,protein phosphatase binding (GO:0019903),0.367994088513418,1.1266642030325795,0.28616684266103487,0.9220173422163676,1.0,39/117,22.81%,LGALS3;ANK1;ERBB2;EGFR;PTPRT;EIF2AK3;PPP1R15A;PPP3CB;ENSA;PDLIM4;SHOC2;PIK3R1;ANAPC7;MAPK14;TBK1;FBXL2;PPP1R3F;STRN;HSP90B1;AKAP11;RPA2;IQGAP1;MET;JUP;TP53;SLC9A1;VRK3;STX17;KIF3A;STAT3;CDC27;ADCY8;SIRPA;ANAPC4;PXN;DLG4;STAT6;KIFAP3;ANAPC5
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4152560160870106,1.126394490325961,0.3143203883495146,0.9178955909506193,1.0,11/42,11.74%,STXBP6;PAK4;CNN3;LRRC4C;BAIAP2;NTNG1;CNTN6;CNTN2;PALLD;DSCAM;PPP1CA
prerank,cysteine-type endopeptidase activity (GO:0004197),0.3839555073752582,1.1259975074663788,0.2852422907488987,0.9141467873627864,1.0,26/78,19.36%,PYCARD;CAPN5;USP35;USP11;CAPN1;CTSK;CTSO;CASP6;CTSB;UCHL1;USP46;CAPN6;USP33;CASP12;USP48;MALT1;USP40;USP14;CASP2;USP25;USP1;USP2;USP37;CASP7;CAPN11;USP5
prerank,cysteine-type peptidase activity (GO:0008234),0.38496648836852215,1.1247388183656888,0.29464285714285715,0.913413571329677,1.0,24/73,18.15%,USP50;USP35;USP11;OTUD7B;CTSK;CTSO;CASP6;OTULIN;CTSB;UCHL1;USP46;USP33;USP48;MALT1;USP40;USP14;CASP2;USP25;USP21;USP1;USP2;ATG4C;USP37;CASP7
prerank,cation channel activity (GO:0005261),0.37652421926038715,1.119711857856876,0.29475982532751094,0.926143396861297,1.0,10/94,4.26%,PIEZO2;KCNA2;CACNA1E;TMEM63A;KCNK1;ANXA9;ANO6;KCNA1;CALHM6;PSEN1
prerank,gamma-tubulin binding (GO:0043015),-0.369747880503527,-1.1194069233682309,0.27755102040816326,0.6948878240197968,1.0,6/21,8.42%,NDRG1;DIXDC1;TUBGCP4;TUBGCP3;TUBGCP6;BRCA2
prerank,sialyltransferase activity (GO:0008373),-0.36967683100229565,-1.119359887462777,0.28846153846153844,0.6854020204407161,1.0,5/20,7.52%,ST6GALNAC3;ST3GAL6;ST8SIA4;ST3GAL1;ST6GALNAC2
prerank,ion channel inhibitor activity (GO:0008200),0.4217052327806019,1.118048364809337,0.31719745222929935,0.9272073370860419,1.0,9/35,15.36%,WNK2;WNK3;RASA1;ENSA;KCNMB2;STX8;NEDD4L;CALM1;CALM2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.29144697898518324,-1.1179436375608984,0.24087591240875914,0.6796158524396866,1.0,21/54,25.38%,HDAC8;ACER2;TGM2;UPB1;NTAQ1;ASPG;NIT1;HDAC4;HINT3;ASAH2;AMDHD2;ASRGL1;SIRT4;HDAC11;HDAC3;SUDS3;HDAC5;FAAH;SIRT7;MIER2;HDAC10
prerank,transforming growth factor beta binding (GO:0050431),-0.35806166051595945,-1.115537272580344,0.29457364341085274,0.6772988620451253,1.0,8/23,11.34%,ACVRL1;ENG;TGFBR1;THBS1;CD109;TWSG1;LRRC32;VASN
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.5266803762112713,1.1149052110971824,0.3519108280254777,0.933194646382502,1.0,6/11,20.22%,GNPTAB;PTDSS1;PIGN;SGMS2;DPAGT1;PIGO
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.5071513459609038,1.1125239882227789,0.3595166163141994,0.9365857850599817,1.0,2/13,8.20%,GPSM2;GDI2
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.4365257576065487,-1.1116702269560572,0.3072289156626506,0.6777432504283097,1.0,6/12,11.69%,SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC9A9;SLC9A7
prerank,ATPase binding (GO:0051117),0.37622176079232644,1.1114225773716682,0.32798165137614677,0.935352837424655,1.0,19/71,19.55%,ANK1;ANK2;EGFR;PSEN1;RALB;PPP3CA;SELENOS;PIH1D1;NCSTN;FBL;ESR1;TAF9;SNX10;PDE4D;GABARAPL2;USP25;NKD2;DNAJC10;RDX
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.35152751851645064,1.110987869594849,0.22548028311425683,0.9319387008191562,1.0,71/269,20.72%,PRDX6;UBE2T;GLMN;ERBB3;BCL2;PTPN22;HM13;CBS;PRKN;EGFR;ERLIN2;FBXW7;BLZF1;TRAF4;FBXO7;SPOP;SCN5A;YWHAZ;LAPTM4B;RALB;NAE1;PACRG;BAG5;BRCA1;UBE2K;UCHL1;ANKRA2;CASC3;HIF1A;SYT11;CUL3;SLF2;GPR37;NGFR;UBE2J2;HDAC6;PATZ1;PRKACA;PER1;NEDD8;DET1;RPA2;SUMO1;RTN4;WASHC1;JKAMP;CCDC50;GABARAPL2;UBB;UBOX5;TP53;KCNH2;USP25;DBT;CUL4B;USP2;RIPK1;MID1;MDM2;NKD2;DNAJA1;HSPA9;POLR2A;MAGEC2;UBE2L3;RRAGA;BCL10;UBE2G1;JUN;HSPD1;USP13
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.4279426111071287,-1.1105336128619514,0.31805157593123207,0.6716463575788292,1.0,4/13,16.45%,PIK3C2A;PIP5K1B;PIK3C2B;PIP4K2B
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3654488837570165,-1.1067249628988143,0.3164983164983165,0.672990434862001,1.0,6/20,17.19%,SLC30A10;SLC39A8;SLC30A1;SLC39A6;SLC39A3;SLC39A10
prerank,hexosaminidase activity (GO:0015929),0.509194801801132,1.105828063304934,0.36749633967789164,0.9446110015706636,1.0,7/12,25.35%,NAGA;SPAM1;HYAL1;CEMIP;OGA;HEXB;CEMIP2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.47345355312675,1.1043472438160036,0.3463203463203463,0.9445717768866659,1.0,5/18,14.58%,SOSTDC1;ACVR1;TGFBR2;LTBP1;BMPR1A
prerank,delayed rectifier potassium channel activity (GO:0005251),0.4255769769718232,1.1026535481714455,0.34863523573200994,0.9453061235309206,1.0,10/32,25.33%,KCNA2;KCNA1;KCNA6;KCNH2;KCNA5;KCNS3;KCNQ3;KCNC1;KCNA4;KCNQ5
prerank,TBP-class protein binding (GO:0017025),0.4609214878607965,1.101578014477721,0.35097493036211697,0.9438899298903516,1.0,10/21,21.48%,DRAP1;GTF2B;ESR1;TAF11;AHR;PSMC1;TAF1;RUVBL2;YEATS2;THRA
prerank,G protein-coupled receptor binding (GO:0001664),0.35763922417502386,1.098834784790458,0.31413612565445026,0.948782875191544,1.0,21/132,15.46%,PTCH1;PTCH2;GNA14;BICD1;PRKN;GPRC5B;GPRASP2;WNT5A;NPB;FZD7;ARHGEF11;PACRG;FLNA;USP33;DVL1;GNAI1;MYOC;PENK;HOMER2;PDCD6IP;HOMER1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.36597325565094585,1.098629354239415,0.3005405405405405,0.9444557238739463,1.0,17/100,9.37%,RAG2;PLEKHA5;PLEKHA4;SESTD1;IQGAP2;WIPI1;OSBPL5;MAPKAP1;LAPTM4B;GBF1;RPH3A;ARHGAP9;GAB2;BBS5;HIP1;DENND1C;LANCL2
prerank,cGMP binding (GO:0030553),-0.4313514634317318,-1.0955835655761519,0.33236994219653176,0.6928393872329596,1.0,2/11,12.23%,PDE5A;PDE2A
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.4223583635056454,1.094060922347272,0.33872976338729766,0.9553406854758847,1.0,6/35,10.44%,PKDCC;PEAK1;TEC;CSK;FYN;STYK1
prerank,ATPase regulator activity (GO:0060590),0.4069854114303007,1.0921936469074955,0.35877862595419846,0.9568624074410077,1.0,12/38,18.99%,HSPH1;TSC1;DNAJB4;BAG5;DNAJB6;AHSA1;KATNB1;DNAJC19;DNAJA2;DNAJA1;FNIP1;DNAJC10
prerank,retinoid X receptor binding (GO:0046965),0.5085204995954131,1.0917188402793423,0.36322188449848025,0.9535577907836756,1.0,6/11,21.33%,TACC1;RARG;NRIP1;MED25;PPARG;NSD1
prerank,phospholipase binding (GO:0043274),0.49529535989771895,1.0905145525210633,0.36148148148148146,0.952821426939074,1.0,2/13,8.15%,PRKN;FYN
prerank,MAP kinase phosphatase activity (GO:0033549),0.5035727805758193,1.090473616317228,0.3942161339421613,0.9481186413959523,1.0,4/12,20.24%,DUSP4;DUSP6;DUSP16;DUSP1
prerank,glutamate receptor binding (GO:0035254),-0.38051687846630927,-1.090261158896414,0.3280757097791798,0.6975622049410984,1.0,8/17,18.17%,SHANK3;SHISA6;NSF;SHANK2;CAMK2A;SQSTM1;GNAS;SHISA7
prerank,acetyltransferase activity (GO:0016407),0.41780100422554534,1.0900199658940963,0.3385012919896641,0.9450003264228022,1.0,9/31,18.54%,KAT2B;NAA16;PAFAH1B3;KAT8;GTF2B;DBT;SMARCE1;NAA10;NAA15
prerank,cadherin binding (GO:0045296),0.341830763519787,1.089342846687906,0.2678034102306921,0.9427033062304179,1.0,75/315,16.82%,DCHS1;CDH19;STXBP6;PTPRH;PRDX6;ANK3;OLFM4;TBC1D10A;EGFR;PTPRT;ACVR1;PAK4;FMNL2;CNN3;PLIN3;PACSIN2;PSEN1;BZW2;CDH10;RPL23A;CDH22;CTNNA2;SPTBN1;CDH8;YWHAZ;UBAP2;GOLGA3;BAIAP2;EPS8L1;PLEC;CTNNA3;LRRFIP1;EPS15;FASN;ZC3H15;FLNB;FLNA;PPP1R13L;PTPN1;CDH20;CDH7;VAPA;SLK;PTPRJ;CBL;UBFD1;PTPN11;GLOD4;EMD;PPP1CA;RAB1A;CDK5R1;PDXDC1;AHSA1;SCRIB;CKAP5;LYPLA2;NCK1;CORO1B;SNX1;RTN4;IQGAP1;CDC42EP1;ITGB1;CLIC1;JUP;PKP2;NOP56;FSCN1;GCN1;CDH18;DIAPH3;OLA1;ANLN;CTTN
prerank,potassium ion antiporter activity (GO:0022821),-0.3968036374797243,-1.0890222575934985,0.3654485049833887,0.692192355408519,1.0,6/15,11.69%,SLC9A6;SLC9A2;SLC9A8;SLC24A3;SLC9A9;SLC9A7
prerank,outward rectifier potassium channel activity (GO:0015271),0.5059038852711808,1.088973641270366,0.3652312599681021,0.9391347707043834,1.0,6/11,21.03%,KCND1;KCND2;KCND3;KCNT2;KCNA5;PKD2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4169024151025116,-1.0877697198846061,0.32710280373831774,0.6867712989766513,1.0,6/13,11.69%,SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC9A9;SLC9A7
prerank,O-acyltransferase activity (GO:0008374),0.41423193055504576,1.0875568542687737,0.36222509702457956,0.939095403752899,1.0,2/30,2.69%,PRDX6;MBOAT2
prerank,neurexin family protein binding (GO:0042043),0.518122187030022,1.0874553581690476,0.38769230769230767,0.9349220108035141,1.0,2/10,5.87%,CEL;NLGN1
prerank,endopeptidase activator activity (GO:0061133),-0.44351376122719177,-1.0870552015450439,0.3286118980169972,0.6801268575100827,1.0,8/10,36.21%,PSMD14;APH1B;PSENEN;ADRM1;PSME3;VSIR;PSME2;NLRC4
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5002616935490365,1.0864076342296862,0.3748006379585327,0.9295577360616947,1.0,2/11,8.64%,HSPH1;BAG5
prerank,adenyl nucleotide binding (GO:0030554),0.5002616935490365,1.0864076342296862,0.3748006379585327,0.9295577360616947,1.0,2/11,8.64%,HSPH1;BAG5
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.41031169664279565,1.085294956881965,0.361323155216285,0.9241269827913045,1.0,14/34,22.23%,NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5;NDUFV1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.41031169664279565,1.085294956881965,0.361323155216285,0.9241269827913045,1.0,14/34,22.23%,NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5;NDUFV1
prerank,RNA polymerase II complex binding (GO:0000993),0.412352164622984,1.0843944224297037,0.35199004975124376,0.922482781798196,1.0,11/32,17.58%,WAC;ZNF326;ERCC5;RPRD1A;URI1;GTF2B;ELP2;ELP4;HNRNPU;CDC73;NCOA3
prerank,galactosyltransferase activity (GO:0008378),-0.42655987518025906,-1.083630800996674,0.3430232558139535,0.6804225942584066,1.0,5/11,19.26%,B4GALT7;B4GALT1;B4GALT2;A4GALT;B4GALT4
prerank,beta-tubulin binding (GO:0048487),0.41639944949649843,1.0830799228206,0.3579617834394904,0.9224864490684143,1.0,7/31,15.07%,DLEC1;FGF13;PACRG;EMD;CDK5R1;ARL8A;GABARAPL2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.46050753517124243,1.08304520546489,0.3905579399141631,0.9181622641537251,1.0,1/18,1.40%,HSD17B7
prerank,G protein-coupled receptor activity (GO:0004930),0.34030176586769173,1.0829569319428567,0.3063700707785642,0.9140233490768704,1.0,34/239,18.18%,FFAR4;SSTR1;LGR6;MRGPRF;GPR63;RHO;HRH1;LPAR1;GPR65;GPR173;PTH2R;P2RY14;LGR5;TSHR;ADGRB3;MAS1;GRM5;GPR37;GPR88;S1PR3;ADGRL3;GLP2R;DRD2;P2RY12;P2RY1;ADGRG2;XPR1;TM2D1;MC5R;OPRK1;APLNR;S1PR2;GPR161;PTAFR
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4003925506405287,1.0825857164174224,0.3590686274509804,0.9107783080648356,1.0,5/42,5.30%,CDKN2B;KAT2B;CCNJ;CCNC;CKS1B
prerank,SUMO transferase activity (GO:0019789),0.47077056006049767,1.0803146633037544,0.37409024745269287,0.9139016903569903,1.0,6/16,25.98%,RANBP2;CBX4;PIAS2;MDM2;UBE2I;TOPORS
prerank,phosphatase inhibitor activity (GO:0019212),0.4482653485497708,1.079083032909279,0.3792134831460674,0.9136005701640659,1.0,4/20,11.71%,LGALS3;URI1;ENSA;ANP32E
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.47843735934079773,1.07689185360811,0.3878787878787879,0.9164319428798141,1.0,2/13,1.42%,BMP5;PYCARD
prerank,triglyceride lipase activity (GO:0004806),0.4448943817476144,1.0760162448153772,0.3782312925170068,0.9149460610108964,1.0,2/20,11.36%,CEL;LIPC
prerank,iron ion binding (GO:0005506),-0.29107502360880483,-1.0751081312656483,0.2804878048780488,0.6933538134341585,1.0,19/48,21.89%,AOX1;PHF2;ABCE1;PHYH;FBXL5;FTH1;EGLN2;FTL;TET1;CDO1;ALKBH3;TYW5;ETHE1;FXN;EGLN3;CYP2R1;ACO2;JMJD6;DNAJC24
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.40607541924520124,-1.072020529697586,0.3625,0.6923310131047161,1.0,6/12,19.60%,PHF2;KDM1A;KDM4C;KDM4D;KDM3B;HR
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.33120012238050445,1.0720193197314192,0.24724724724724725,0.9234050936976669,1.0,124/597,20.91%,OSR2;ETV1;SOX6;NKX6-2;KLF15;MEOX1;ETV4;MEOX2;CREB3L1;GLI2;LHX5;TLX3;DDX11;SOX8;PRDM16;TGIF2;HOXB8;ZBTB20;SOX9;SUV39H1;HIVEP1;ZBTB37;HOXA7;EGR3;MBD4;TFCP2;KDM5B;RFX2;SOX11;ZNF276;GLI1;E2F2;PHOX2A;HOXD3;RFX3;CREB3L2;RORC;MLX;GATA6;TBX18;MEN1;CHD3;ATMIN;RARB;SOX5;MBD2;RARG;XPA;TFAM;BRCA1;CARM1;SOX12;BBX;ARID4B;KLF5;PRDM9;ERBB4;ATF2;NFATC3;NFE2L2;MCM4;ESR1;SP1;TAF2;TAF9;SFPQ;CREBZF;RUNX1;PER3;ZNF250;KLF13;NR6A1;XRCC6;AHR;ATF5;PER1;GATA3;SNCA;ORC1;TAF7;PAX3;DHX33;CREM;IRX5;HOXB7;ABL1;POU3F1;MEIS3;SP3;TP53;KCNH2;NFIX;HNRNPU;SREBF2;GABPB1;GABPB2;FOXJ1;PAX2;RNF10;NR5A1;BATF;IRF3;ASH2L;ORC4;KLF16;RFX7;EGR1;PPARG;STAT3;FOXJ3;CENPC;BCOR;JUN;ORC2;NR1D2;ONECUT2;KMT2D;TFE3;HSPD1;SNAI1;JDP2;PBX1;NFKB1;ZBED4
prerank,phospholipase C activity (GO:0004629),0.4272094393817809,1.0710690871499784,0.39018087855297157,0.9221837817346988,1.0,2/25,4.99%,CHRM3;PLCB1
prerank,glucose transmembrane transporter activity (GO:0005355),0.45812874719544067,1.0701944347364414,0.394109396914446,0.9207381309664472,1.0,3/17,10.80%,SLC5A3;MFSD4A;SLC2A2
prerank,chemokine binding (GO:0019956),0.42179666833673146,1.0698234265801645,0.4,0.9176043638867655,1.0,5/30,15.04%,FGF2;CCR2;ACKR3;ACKR4;ITGB1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.39720555714209604,1.0682985505579747,0.3951219512195122,0.9181748077851636,1.0,11/40,17.25%,SUV39H1;METTL9;THUMPD3;SETD3;COMT;AS3MT;FBL;LRTOMT;THUMPD2;MEPCE;PCMTD2
prerank,sterol transfer activity (GO:0120015),-0.37369440825271794,-1.0681021637297774,0.34519572953736655,0.6942171650905874,1.0,6/17,12.08%,ABCA1;PLTP;OSBP;OSBPL2;ABCG1;STARD4
prerank,single-stranded telomeric DNA binding (GO:0043047),0.49542559738777653,1.0654625017655819,0.3966565349544073,0.9230186372958498,1.0,7/11,26.30%,STN1;RPA2;TERF2IP;CTC1;RAD50;HNRNPA2B1;NABP2
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3554214481979809,1.0643389667937813,0.3934782608695652,0.9220398928625293,1.0,13/85,13.35%,PRDX6;CEL;PGAP1;H6PD;PLA2G7;PAFAH1B3;LYPLA1;MRPL58;PLA2G12A;LIPC;PLAAT5;PLAAT3;LYPLA2
prerank,fatty acid synthase activity (GO:0004312),0.5116916081689291,1.0637968872002619,0.41910631741140214,0.9195572836939061,1.0,3/10,9.70%,OXSM;ELOVL6;ELOVL5
prerank,Hsp90 protein binding (GO:0051879),0.40549594542155293,1.0627185090617421,0.3907203907203907,0.9187556765053553,1.0,9/33,12.88%,FKBP6;SLC12A2;TSC1;PACRG;PPID;HIF1A;HDAC6;AHSA1;AHR
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4235580961759754,-1.0623111458810441,0.36416184971098264,0.7011593393945196,1.0,5/11,18.23%,LEF1;SRRM2;GATA2;HMGA2;THAP7
prerank,exopeptidase activity (GO:0008238),0.3803744202098593,1.059790949656693,0.4014510278113664,0.9236222947145623,1.0,9/50,9.92%,FAP;DPEP1;KDM8;NAALAD2;LTA4H;DPP10;TRHDE;DPEP2;LNPEP
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.4932196553155301,1.0580372333141854,0.3923865300146413,0.9248324356787355,1.0,5/11,18.15%,PYCARD;CASP6;CASP12;CASP2;CASP7
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5021486345321082,1.0578572772304915,0.40242057488653554,0.921312442658012,1.0,3/11,16.33%,KCND3;KCNJ3;KCNH2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.40279955758578057,-1.0574313843211993,0.3850574712643678,0.7051579778406741,1.0,3/12,2.63%,CDH5;VEGFC;VEGFD
prerank,BMP receptor binding (GO:0070700),0.4784382460439043,1.0568199113943813,0.4076923076923077,0.9204554045921942,1.0,2/12,1.42%,BMP5;PYCARD
prerank,anion transmembrane transporter activity (GO:0008509),0.4880540890505831,1.0546092428241987,0.42208774583963693,0.9234353589491909,1.0,2/12,5.53%,SLC22A3;SLCO2B1
prerank,Tat protein binding (GO:0030957),0.49937876108284157,1.0543079923732532,0.4094368340943683,0.9203484175965801,1.0,1/10,0.79%,MDFIC
prerank,small GTPase binding (GO:0031267),0.33723403703238825,1.0533881676227366,0.3845360824742268,0.919210377848279,1.0,40/169,15.33%,RTKN;DOCK7;HPS6;BICD1;AKAP13;FGD4;RHOBTB3;HACE1;RANBP2;IQGAP2;NOX1;PKN1;PAK1;MAPKAP1;ALS2;MTSS2;CDKL5;AP1G1;RAB34;BRK1;TRIP11;FLNA;RCC1;SIKE1;MYO9B;USP33;NGFR;BICD2;RIMS1;RHOH;WASF1;USP6NL;CCDC186;TBC1D20;RAB3GAP2;RAB11FIP3;IQGAP1;CYFIP1;ANKRD27;SGSM1
prerank,clathrin adaptor activity (GO:0035615),0.46264350941123195,1.051483622915792,0.43366619115549215,0.9209376099146669,1.0,4/15,8.90%,STON2;STON1;AP1G1;HIP1
prerank,chemorepellent activity (GO:0045499),0.41628901803197915,1.0505005714836864,0.43466666666666665,0.9198932579739686,1.0,4/25,3.81%,SEMA3E;SEMA6C;NRG3;SEMA3A
prerank,voltage-gated calcium channel activity (GO:0005245),0.39221761717357145,1.0498337416584453,0.41430332922318125,0.9180318302208343,1.0,6/37,6.56%,CACNA1E;CACNA2D1;CACNG7;NCS1;CACNA1A;CACNB4
prerank,double-stranded DNA binding (GO:0003690),0.32489840731277014,1.0477213108032253,0.33733733733733734,0.9205044902388356,1.0,98/531,20.74%,OSR2;ETV1;NKX6-2;KLF15;MEOX1;ETV4;MEOX2;CREB3L1;GLI2;LHX5;TLX3;DDX11;SOX8;TGIF2;HOXB8;ZBTB20;SOX9;EGFR;HIVEP1;ZBTB37;HOXA7;SATB1;EGR3;APTX;TFCP2;KDM5B;RFX2;ERCC5;ZNF276;MBD1;E2F2;PHOX2A;HOXD3;RFX3;SETMAR;RORC;MLX;GATA6;TBX18;MEN1;RARB;RARG;XPA;SOX12;BBX;TDP1;KLF5;REXO4;FBH1;ATF2;NFATC3;PSIP1;ESR1;SP1;MSH6;ZNF250;KLF13;NR6A1;XRCC6;AHR;GATA3;PAX3;CRY1;ZNF638;POLG2;CREM;CGAS;IRX5;HOXB7;ABL1;POU3F1;MEIS3;SP3;NFIX;HNRNPU;SREBF2;PAX2;PCID2;NR5A1;BATF;IRF3;KLF16;CGGBP1;PARK7;ZMYND11;RFX7;EGR1;PPARG;FOXJ3;TOP1;JUN;NR1D2;ONECUT2;RBMS1;TFE3;SNAI1;JDP2;PBX1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.41300492941967615,1.0463726824236748,0.4182058047493404,0.9206313121117918,1.0,4/26,8.82%,LGALS3;PPP1R14C;ENSA;PPP1R8
prerank,thyroid hormone receptor binding (GO:0046966),0.4088500061539188,1.045838000310055,0.4135135135135135,0.9183656589696534,1.0,12/28,22.33%,TACC1;GTF2B;TRIP6;BRD8;MED13;TAF11;TAF7;MED12;NCOA3;MED30;NSD1;MED24
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.4310618461192427,1.045237689240876,0.41217150760719223,0.9164109731976567,1.0,6/20,19.44%,AGPAT2;MOGAT3;AGPAT5;GPAT3;GPAT4;LPCAT2
prerank,protein kinase C binding (GO:0005080),-0.28059410086639935,-1.0432117918267954,0.37349397590361444,0.7334442745882351,1.0,12/43,18.82%,GRK5;PARD6G;PDLIM5;PRKCB;RACK1;ADCY4;CAVIN3;SQSTM1;TIRAP;TRPV4;HSPB1;DACT2
prerank,BMP binding (GO:0036122),0.4905273024749513,1.0429468255013807,0.44305772230889234,0.919240593713191,1.0,1/11,0.51%,SOSTDC1
prerank,DNA secondary structure binding (GO:0000217),0.40578827011646174,1.0426665826799077,0.4292929292929293,0.916178730129172,1.0,8/31,17.46%,KMT2A;ERCC5;MEN1;MSH6;XRCC3;ABL1;BLM;WRN
prerank,N-acetyltransferase activity (GO:0008080),0.4401990674071988,1.042237723600176,0.42441054091539526,0.9135600629955469,1.0,7/19,26.46%,KAT2B;SMARCE1;NAA10;NAT8L;ATAT1;SAT1;NAA50
prerank,Hsp70 protein binding (GO:0030544),0.39383823686628994,1.04209658403772,0.41460234680573665,0.9102268999251055,1.0,12/31,24.31%,PRKN;TSC1;PACRG;PPID;GPR37;SNCA;FICD;DNAJA1;DNAJC10;IQCG;DNAJC8;PPEF2
prerank,GTP binding (GO:0005525),0.3311951163706968,1.0418904506894127,0.4221991701244813,0.9070496946506481,1.0,55/172,24.38%,RHOJ;RASEF;RHOD;RND3;RAB38;RAP2B;ADSS1;RHOBTB3;RAB14;ARL3;RALB;ARL1;RAB21;BMS1;RAP1A;RAB39A;RABL3;LANCL2;TUBB6;RHOT2;ARL5C;ARL2;MRAS;ARF4;ANXA6;RAB22A;RHOC;RHOH;ATL3;GNAI1;ARL8A;RAB4A;TRIM23;GTPBP10;EIF2B2;RAC3;RAB7A;TUBA1A;RHOT1;NRAS;KRAS;RRAGA;RHOU;RABL6;GLUD1;AGAP2;RAP2A;GBP2;RAB6A;RAP2C;ARL8B;RAB2A;GNL3;TUBA1B;REM1
prerank,GTPase regulator activity (GO:0030695),0.33229085299874717,1.0412871250574585,0.409919028340081,0.9051650890173157,1.0,46/212,16.62%,ARHGAP24;SIPA1L1;DLC1;ARHGAP32;RTKN;ARHGAP19;TBC1D10A;GPSM2;NPRL2;RANBP2;ELMOD2;NF1;IQGAP2;PLCB1;RGS11;RASA1;ALS2;CHN1;MTSS2;ARHGAP9;VAV3;ARHGEF10L;TBCK;ADGRB3;DOCK1;ARHGAP11A;ARL2;MYO9B;RIMS1;OPHN1;STXBP5;ACAP2;RHOH;USP6NL;TBC1D20;RAB3GAP2;ELMOD3;ARFGAP3;ARFGAP1;IQGAP1;ARHGAP44;SGSM1;RIC8B;RAP1GAP;ARFGEF1;ELMOD1
prerank,PDZ domain binding (GO:0030165),0.3595523819477156,1.037727394511552,0.4284064665127021,0.9118782468037452,1.0,12/61,8.44%,PTEN;TBC1D10A;PRKN;GRIA1;ATP2B3;PSEN1;SDC2;GRID2;NLGN1;FZD7;ACOX1;CADM1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.3836550583009868,1.0367009581482645,0.42,0.9113722673820261,1.0,8/37,14.00%,IARS2;EPRS1;FARSA;SARS2;FARSB;FARS2;YARS1;HARS1
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.42291439288088095,-1.0364148766489212,0.39378238341968913,0.7423327622535988,1.0,4/10,16.28%,B4GALT7;B4GALT1;B3GALT2;B3GALT1
prerank,neuropeptide hormone activity (GO:0005184),0.42288459637564924,1.036235843723996,0.4287652645861601,0.9090692799861125,1.0,1/22,1.03%,CRH
prerank,protein tyrosine kinase binding (GO:1990782),0.35583770932920794,1.0351609553996908,0.4227733934611049,0.9086152958419013,1.0,14/71,10.88%,SHC4;LRP4;CBLB;ACVR1;PTPN2;NRG3;PHYHIP;SOCS5;ALKAL2;GRB14;PTPN1;GRM5;CBL;PTPN11
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4242292216319161,1.0342970077477058,0.4486111111111111,0.907348474028403,1.0,2/21,5.18%,CHRNA4;GRIK2
prerank,SH3 domain binding (GO:0017124),0.362039453307787,1.0337200339940062,0.435632183908046,0.9053389953735167,1.0,7/62,4.54%,SGIP1;ENAH;PTPN22;CBLB;PRKN;WIPF1;NCF1
prerank,ubiquitin binding (GO:0043130),0.3554622735414975,1.0328915497044384,0.4336283185840708,0.9041635788626301,1.0,18/73,17.98%,RAD23B;PRKN;MVB12B;FBXW7;CKS1B;FBXO7;UCHL1;RNFT1;USP33;UCHL3;TOLLIP;VPS36;MVB12A;PLAA;USP25;N4BP1;MDM2;NBR1
prerank,endopeptidase inhibitor activity (GO:0004866),0.3491887597545039,1.0314742943508861,0.4427645788336933,0.9045271389858883,1.0,13/82,15.59%,A2M;LXN;NGF;RECK;PRNP;CSTB;UCHL5;SERPINE2;BIN1;UBE2Z;PROS1;USP14;UBE2O
prerank,antiporter activity (GO:0015297),0.42930703262085335,1.0288089197753447,0.4297520661157025,0.9086389861690305,1.0,8/20,17.20%,SLC35C2;SLC35E2B;SLC35E2A;SLC35A1;SLC25A10;SLC25A11;SLC35E1;SLC35E3
prerank,solute:proton symporter activity (GO:0015295),0.4520475142793612,1.0279798773328654,0.4498567335243553,0.9074288042464985,1.0,2/16,5.13%,SLC17A5;SLC36A2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.3950461694592175,-1.0269656098271627,0.4166666666666667,0.7574716770203271,1.0,3/12,5.61%,IGF1;IGF2;INSR
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.42938594070071207,1.026054539488518,0.44986072423398327,0.9096222198980345,1.0,5/18,16.18%,DPEP1;MT3;PRDX3;SNCA;XIAP
prerank,phospholipase activity (GO:0004620),0.3521006719951195,1.025245094777115,0.43615819209039547,0.9084845027271637,1.0,16/67,21.01%,PRDX6;PLBD1;LYPLA1;PLA2G12A;LIPC;PLAAT5;PLAAT3;LYPLA2;PNPLA8;SEC23IP;GPLD1;ABHD6;GDPD3;PLA2G4E;DDHD1;ABHD16A
prerank,endopeptidase regulator activity (GO:0061135),0.3765089682284123,1.0243145083237237,0.45443499392466585,0.907715923765645,1.0,7/40,14.63%,A2M;RECK;CSTB;UCHL5;PROS1;APH1A;USP14
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.32280062645185204,1.0236038247817312,0.448692152917505,0.9062707345757279,1.0,49/254,20.84%,OSR2;ETV1;KLF15;ETV4;MEOX2;CREB3L1;PRDM16;MYC;SOX9;HOXA7;TFCP2;SOX11;RFXANK;E2F2;HOXD3;ZBTB16;ATMIN;SOX12;HIF1A;KLF5;ATF2;NFATC3;ESR1;SP1;ZNF112;RUNX1;ATF5;GATA3;SALL2;MDM4;HOXB7;MEIS3;TP53;NFIA;FOXJ1;MDM2;IRF3;PRRX1;KLF7;EGR1;STAT3;PRDM2;FOXJ3;JUN;MEIS1;ONECUT2;MITF;ZSCAN21;NFKB1
prerank,NADP binding (GO:0050661),-0.3051742549758587,-1.0225248960062756,0.4056603773584906,0.761471895941909,1.0,10/32,17.22%,NOS3;CRYZL1;LBR;ME1;PGD;GMDS;NOS1;NNT;SPR;QDPR
prerank,protein kinase binding (GO:0019901),0.3147295479180431,1.0223648816021753,0.42042042042042044,0.9064336494105701,1.0,109/479,19.02%,ROR2;SHC4;BCL2L14;DNM1;UTRN;CNKSR2;RHOD;BICD1;ANK2;CDKN2B;KAT2B;SOX9;DUSP4;RND3;PRKN;ACVR1;PTPN2;RHOBTB3;IRAK3;PHYHIP;MAPK7;GPRC5B;PRKCSH;NBEA;MAPKAPK3;MAPKAPK2;PPP1R15A;PRKAR1B;DUSP6;CKS1B;FBXO7;SLC12A2;PDE3B;SCN5A;PKN1;SOCS1;YWHAZ;MAPKAP1;SPRED2;FAM83H;CSK;NELL2;PRKAB2;SPRED1;GATA6;UFL1;FOXM1;TBL2;LAX1;BAG5;ANKRA2;PTPN1;HIF1A;SV2A;SYN1;PIH1D1;GRM5;SPRED3;HINT1;SIKE1;ATF2;PTPRJ;SLC12A4;PTPN11;ESR1;CDC25B;DVL1;CDK5R1;RHOC;ERCC6L2;UNC5C;RHOH;TPCN2;PRKACA;PRDX3;SPAG9;CALM1;PKD1;IQGAP1;ITGB1;TICAM1;DACT1;CALM2;PKP2;ABL1;ACSL3;STX1B;TP53;CCND2;JTB;SUFU;FAM83F;TRAP1;MYH6;FBXO5;RAC3;RPTOR;NBR1;TPRKB;DCX;CSPG4;USP37;GYS1;DUSP16;MAPRE3;KCNA5;INKA1;MAP3K11;GRB2
prerank,copper ion binding (GO:0005507),0.37048231311637325,1.022114971366602,0.4433734939759036,0.9036808932444607,1.0,11/42,18.89%,CUTA;PRNP;MT3;AOC1;LOXL3;GPC1;SNCA;SUMF1;TP53;PARK7;SNCB
prerank,GTPase binding (GO:0051020),0.3252880545340232,1.0220078830078196,0.4487704918032787,0.900471228118287,1.0,44/194,15.33%,RTKN;DOCK7;HPS6;BICD1;AKAP13;FGD4;EPRS1;RHOBTB3;HACE1;RANBP2;IQGAP2;SPTBN1;NOX1;PKN1;PAK1;RASA1;MAPKAP1;ALS2;MTSS2;CDKL5;AP1G1;RAB34;BNIP3;BRK1;TRIP11;FLNA;RCC1;SIKE1;MYO9B;USP33;NGFR;BICD2;RIMS1;RHOH;WASF1;USP6NL;CCDC186;TBC1D20;RAB3GAP2;RAB11FIP3;IQGAP1;CYFIP1;ANKRD27;SGSM1
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.35115135320805724,-1.020526200361245,0.4512987012987013,0.7586307045243617,1.0,6/18,13.34%,SMAD6;SMAD7;ENG;TGFBR1;TGFB2;USP15
prerank,Wnt-activated receptor activity (GO:0042813),0.45156739366589477,1.020234849964161,0.44807121661721067,0.9020755660158919,1.0,4/15,15.69%,ROR1;FZD7;PKD1;FZD9
prerank,general transcription initiation factor binding (GO:0140296),0.40872803887195686,1.0183820170393363,0.46621621621621623,0.9038398308738851,1.0,13/25,27.49%,DRAP1;GTF2B;ESR1;TAF11;AHR;PSMC1;TAF1;RUVBL2;YEATS2;THRA;TBP;DR1;RELA
prerank,cytokine receptor binding (GO:0005126),0.3451857126417422,1.017510308120271,0.4683684794672586,0.9029264149638462,1.0,13/83,13.98%,PYCARD;CRLF1;FADD;VEGFA;PXDN;SPRED2;SPRED1;IL18;TRIP6;TYK2;IL6ST;PRLR;TGFBRAP1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3198529663654458,-1.0145440045387117,0.45528455284552843,0.7657538189647912,1.0,7/24,11.42%,DAPK1;CAMK2G;CAMK1D;MKNK2;CAMK1;CAMK4;CAMK2A
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.4186101199809492,1.0128795444091847,0.45616438356164385,0.9119455363827453,1.0,7/20,19.29%,USP50;SENP3;UFSP2;SENP2;USP25;USP21;SENP1
prerank,mRNA binding (GO:0003729),0.3179220203754645,1.011914463658209,0.4803229061553986,0.9111786512867748,1.0,86/249,26.12%,PABPC5;RBFOX1;CSTF3;RBMS3;CELF5;QKI;TRA2B;ELAVL4;DXO;PABPC1;CPSF6;ETF1;HNRNPAB;METTL3;LUC7L2;SRBD1;UNK;ZC3H12B;CPEB3;KHDRBS3;PPP1R8;DCP1B;NCBP1;EIF4G1;PCBP4;CPEB1;ADARB1;RBM4B;DAZAP1;RBM46;CELF6;DHX33;KHSRP;SRSF6;NOVA1;YTHDC1;LUC7L;EIF4ENIF1;TP53;FUBP1;HNRNPU;N4BP1;SRRM3;RNPS1;RC3H1;SSB;SF1;AUH;CLUH;PARK7;SYNCRIP;RBFOX3;MARF1;CNBP;RBMS1;FUBP3;HNRNPC;CELF4;ZFP36;EIF4G3;RBFOX2;HNRNPL;FYTTD1;DDX6;SNIP1;YBX3;PTBP2;RIDA;ZC3H12C;RBM25;DENR;XPO5;TUT1;PCBP2;GNL3;THOC5;G3BP2;FMR1;YTHDF3;NSRP1;CIRBP;RBM15;RBM4;RNF20;HNRNPA2B1;CPEB4
prerank,mRNA 3'-UTR binding (GO:0003730),0.3401254977738231,1.011783966368579,0.459070796460177,0.9081149484025743,1.0,27/79,26.12%,PABPC5;RBMS3;ELAVL4;PABPC1;EXOSC8;CPEB3;ZFP36L2;PCBP4;CPEB1;DAZAP1;KHSRP;TP53;HNRNPU;RNPS1;RC3H1;AUH;RBMS1;HNRNPC;ZFP36;YBX3;TUT1;FMR1;CIRBP;RBM4;RNF20;HNRNPA2B1;CPEB4
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.4615697374420941,1.0091726666126208,0.45454545454545453,0.9117157905444369,1.0,1/11,4.19%,CHRNA4
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.36063561803777056,-1.0077066445183966,0.4166666666666667,0.7753805971773529,1.0,3/15,2.95%,PI4KA;PIK3R3;PIK3C2A
prerank,voltage-gated chloride channel activity (GO:0005247),0.48416735791856264,1.0076795254466415,0.4662480376766091,0.9124619985576116,1.0,2/10,3.49%,CLCN5;ANO6
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.382448306463568,-1.0071468196808462,0.43059490084985835,0.7688855083594258,1.0,3/12,12.06%,NOCT;CNOT1;PAN2
prerank,adrenergic receptor binding (GO:0031690),0.4392905747499599,1.0056357447950652,0.4725925925925926,0.9147156261727766,1.0,4/16,12.27%,SAV1;UCHL1;MAGI2;PDE4D
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4364434672045992,1.001964115215032,0.4578488372093023,0.9211405076132043,1.0,5/15,19.44%,AGPAT2;AGPAT5;GPAT3;GPAT4;LPCAT2
prerank,peptide hormone receptor binding (GO:0051428),0.462170268938543,1.001891329619112,0.48527131782945737,0.9179301151300284,1.0,1/11,3.59%,PTHLH
prerank,protein phosphorylated amino acid binding (GO:0045309),0.37016892386412226,1.001882166282454,0.46410891089108913,0.9145737991591323,1.0,18/42,26.85%,FBXW7;RASA1;SAMSN1;PIK3R1;PTPN11;ABL1;SH3BP2;GRB2;YES1;BCAR3;VAV2;NCK2;HCK;CRK;LDLRAP1;SYK;SHC3;PIN1
prerank,semaphorin receptor binding (GO:0030215),0.4048348896999278,1.0017301678414716,0.4578313253012048,0.9116202793622148,1.0,3/23,3.81%,SEMA3E;SEMA6C;SEMA3A
prerank,cyclic nucleotide binding (GO:0030551),-0.3236074910680291,-0.999755969280342,0.45075757575757575,0.7801027943522184,1.0,4/21,12.23%,PDE5A;RAPGEF4;PDE4A;PDE2A
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.35208862521515727,-0.9995224353730573,0.45151515151515154,0.7726793204432478,1.0,1/15,0.66%,PLA2G4A
prerank,DNA replication origin binding (GO:0003688),0.40731657222607387,0.9995105084406726,0.46321525885558584,0.9143736566484805,1.0,8/23,24.34%,DDX11;MCM4;ORC1;ORC4;ORC2;HSPD1;KAT7;ORC3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.46162896801165876,0.9984373117093774,0.4621212121212121,0.9140012859315947,1.0,5/12,31.04%,TRAF4;TRAP1;TRAF6;TRIM37;TRAF3
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.46379465569862,0.9974740908526875,0.493993993993994,0.9132974688168154,1.0,5/11,21.94%,SLC25A23;SLC35B3;SLC25A25;SLC25A24;SLC17A9
prerank,glycerophospholipid flippase activity (GO:0140333),-0.40349556924840135,-0.9963261328781015,0.4624624624624625,0.7727442798040068,1.0,8/11,17.92%,ATP10A;ABCA3;ABCA4;ATP11A;ATP8B2;ABCB4;ATP8A1;ATP10B
prerank,cation transmembrane transporter activity (GO:0008324),0.3555181453710661,0.9955225832867934,0.4727488151658768,0.9152477653316815,1.0,5/48,6.24%,SLC22A3;SLC25A2;SLC1A5;SLC36A2;SLC25A38
prerank,growth factor activity (GO:0008083),0.3413719710085712,0.9949191742286236,0.484304932735426,0.9134519467400031,1.0,10/74,12.41%,FGF2;FGF10;NGF;NRG3;VEGFA;BTC;AMELX;GDNF;FGF7;GRN
prerank,damaged DNA binding (GO:0003684),0.3654515569958441,0.994774591106952,0.488862837045721,0.9105659644742707,1.0,9/44,14.02%,APTX;ERCC5;MPG;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2
prerank,androgen receptor binding (GO:0050681),-0.3082379443430272,-0.9943455354410925,0.4391304347826087,0.7700190228628818,1.0,7/25,11.47%,FOXP1;KDM1A;PRKCB;SNW1;DDX5;KDM4C;PRMT2
prerank,Toll-like receptor binding (GO:0035325),0.46077973865286725,0.9942622642474674,0.4939209726443769,0.908541925078927,1.0,3/11,14.82%,TLR1;TOLLIP;UNC93B1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.30609896972002487,0.9931538513526388,0.533,0.9081875566867497,1.0,105/831,14.33%,RORA;EBF2;OSR2;ETV1;SOX6;NKX6-2;KLF15;MEOX1;EBF4;ETV4;MEOX2;GLI2;LHX5;TLX3;SOX8;PRDM16;MYC;TGIF2;DMRT2;EBF1;ZNF25;HOXB8;ZBTB20;SOX9;HIVEP1;OTP;ZBTB37;HOXA7;SATB1;EGR3;TFCP2;NFX1;FOXP2;RFX2;SOX11;RFXANK;ZEB1;GLI1;E2F2;PGBD1;PHOX2A;HOXD3;TRPS1;RFX3;ZFP14;RORC;MLXIPL;MLX;ZBTB16;TWIST2;GATA6;TBX18;E2F6;FOXM1;LRRFIP1;ZSCAN20;GTF2B;MKX;ZBTB41;RARB;SOX5;RARG;SOX12;BBX;ZNF569;HIF1A;CHD2;KLF5;ZBTB6;ZBTB38;ZNF260;ZSCAN26;ATF2;NFATC3;ZKSCAN8;NFE2L2;ESR1;SP1;MYT1;ZNF112;RBAK;HDAC6;RUNX1;NRIP1;ZFHX4;ZGPAT;PATZ1;FOXP4;ZNF250;KLF13;SIX5;NR6A1;ZBTB1;ATF5;PER1;GATA3;ZNF83;ZEB2;SALL2;ZBTB39;NACC2;KDM6A;PAX3;HIVEP3;ZFHX2
prerank,hyaluronic acid binding (GO:0005540),0.47615659456648024,0.9928005935853181,0.4836193447737909,0.9059090372142978,1.0,1/10,1.28%,CHODL
prerank,myosin V binding (GO:0031489),0.43650755474030106,0.9891137797618105,0.4956647398843931,0.9125480944444209,1.0,7/15,25.09%,RAB14;RAB3D;RAB3A;RAB3B;RAB39B;RAB6A;RAB27B
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4505811423202223,0.9881323165429093,0.5030674846625767,0.911816274566495,1.0,3/13,6.65%,SOX9;PRKAR1B;CSK
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3262603324428045,-0.987786731517965,0.4520547945205479,0.7783438141770106,1.0,8/21,13.38%,PDE5A;PDE8B;PDE8A;PDE1A;PDE3A;PDE4A;PDE2A;PDE1C
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3135017687636167,-0.9854188419003412,0.4568345323741007,0.7769793473010401,1.0,9/23,14.68%,PDE5A;PDE8B;PDE8A;PDE1A;PDE3A;PDE4A;PDE2A;PDE1C;ADPRM
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.47007347289982393,0.9837507440078207,0.4880382775119617,0.9200305999507038,1.0,2/10,10.43%,APOBEC1;ADARB2
prerank,ribonuclease P activity (GO:0004526),0.4590462061325384,0.9829140545129044,0.47878787878787876,0.9188676483656645,1.0,6/11,27.45%,RPP38;PRORP;POP1;RPP21;RPP30;RPP14
prerank,ribonuclease activity (GO:0004540),0.34362882076919815,0.9827368161785619,0.5034883720930232,0.9161864464451588,1.0,8/56,10.65%,INTS11;RNASE6;NOB1;EXOSC8;ZC3H12B;PPP1R8;EXOSC2;RCL1
prerank,kinase binding (GO:0019900),0.3021790115638039,0.9826193296628263,0.5515515515515516,0.9133289462195219,1.0,103/434,19.31%,SHC4;BCL2L14;DNM1;UTRN;CNKSR2;RHOD;PTPN22;BICD1;ANK2;CDKN2B;KAT2B;GSN;RND3;PRKN;EGFR;PTPN2;RHOBTB3;IRAK3;GPRC5B;NBEA;PPP1R15A;CKS1B;FBXO7;SLC12A2;DLG2;SCN5A;SOCS1;YWHAZ;MAPKAP1;LAPTM4B;SPRED2;FAM83H;PRKAB2;SPRED1;GATA6;UFL1;FOXM1;TBL2;LAX1;BAG5;FLNA;ANKRA2;TRIP6;PTPN1;HIF1A;SV2A;SYN1;PIH1D1;SPRED3;SIKE1;ATF2;PTPRJ;SLC12A4;PTPN11;ESR1;TOLLIP;CDC25B;DVL1;CDK5R1;RHOC;ERCC6L2;TAX1BP1;UNC5C;SGO1;RHOH;TPCN2;PRKACA;PRDX3;ATF5;PER1;CALM1;PKD1;IQGAP1;TICAM1;CALM2;ACSL3;STX1B;EIF4ENIF1;TP53;CCND2;JTB;SUFU;FAM83F;TRAP1;MYH6;FBXO5;RAC3;PIP5K1A;RPTOR;TPRKB;DCX;CSPG4;USP37;GYS1;PIK3IP1;HTT;PARK7;MAPRE3;KCNA5;INKA1;GRB2;POLR2A;STAT3
prerank,GTPase activator activity (GO:0005096),0.30998186070496864,0.9820308430375762,0.5542168674698795,0.9117329907944669,1.0,74/313,17.83%,ARHGAP24;SIPA1L1;DLC1;ARHGAP32;ARHGAP19;TBC1D10A;DENND2A;AKAP13;FGD4;FRMD7;NPRL2;ARHGEF28;NUCB1;RANBP2;ELMOD2;NF1;IQGAP2;PLCB1;DOCK5;ARHGEF10;RGS11;RASA1;ALS2;CHN1;MTSS2;EPS8L1;DOCK10;ITSN1;RAP1A;EIF2B5;ARHGAP9;RGL1;VAV3;ARHGEF10L;LAMTOR2;ARHGEF11;TBCK;ADGRB3;DENND1C;DOCK1;FARP2;ARHGAP11A;RCC1;SPATA13;MYO9B;OPHN1;DNMBP;RCC1L;STXBP5;ACAP2;USP6NL;TBC1D20;RAB3GAP2;ELMOD3;ARFGAP3;ARFGAP1;IQGAP1;ANKRD27;RAB3IL1;ARHGAP44;CYTH3;ELMO1;SGSM1;RIC8B;RAP1GAP;ARFGEF1;ELMOD1;ARHGEF4;HPS1;RALGAPB;EIF2B2;DENND10;GARNL3;RGS16
prerank,lysine-acetylated histone binding (GO:0070577),-0.3198140036991385,-0.98167602880956,0.47985347985347987,0.7713325547259499,1.0,10/20,21.08%,MLLT3;BRD7;ZMYND8;BRD9;BRD2;ATAD2B;BAZ2A;THAP7;YEATS4;BRDT
prerank,acetylation-dependent protein binding (GO:0140033),-0.3198140036991385,-0.98167602880956,0.47985347985347987,0.7713325547259499,1.0,10/20,21.08%,MLLT3;BRD7;ZMYND8;BRD9;BRD2;ATAD2B;BAZ2A;THAP7;YEATS4;BRDT
prerank,cation:chloride symporter activity (GO:0015377),0.47202666440874796,0.9801761790028837,0.4984126984126984,0.9131346045682237,1.0,3/10,10.69%,SLC12A3;SLC12A2;SLC12A4
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3022312864265792,0.9770089423127791,0.6166166166166166,0.918229735687041,1.0,137/731,20.84%,RORA;EBF2;ETV1;SOX6;NKX6-2;KLF15;MEOX1;EBF4;ETV4;MEOX2;CREB3L1;GLI2;TLX3;SOX8;PRDM16;MYC;TGIF2;DMRT2;EBF1;ZBTB20;SOX9;HIVEP1;ZBTB37;HOXA7;SATB1;EGR3;TFCP2;FOXP2;RFX2;SOX11;ZEB1;GLI1;E2F2;PGBD1;HOXD3;RFX3;ZFP14;CREB3L2;RORC;MLXIPL;MLX;ZBTB16;GATA6;TBX18;E2F6;LRRFIP1;ZSCAN20;MKX;ZBTB41;RARB;SOX5;RARG;SOX12;ZNF569;HIF1A;CHD2;KLF5;ZBTB6;ZBTB38;ZNF260;ZSCAN26;ATF2;NFATC3;ZKSCAN8;NFE2L2;ESR1;SP1;MYT1;ZNF112;HDAC6;RUNX1;NRIP1;ZFHX4;ZGPAT;PATZ1;FOXP4;ZNF250;KLF13;SIX5;NR6A1;AHR;ZBTB1;PER1;GATA3;ZNF83;ZEB2;SALL2;ZBTB39;NACC2;KDM6A;PAX3;HIVEP3;ZFHX2;CREM;IRX5;HOXB7;ZNF235;POU3F1;MEIS3;KLF9;SP3;TP53;NFIX;NFIA;HNRNPU;SREBF2;ZKSCAN1;FOXJ1;PAX2;HEYL;NR5A1;ZNF496;BATF;IRF3;KLF16;ZNF697;PRRX1;RFX7;KLF7;EGR1;PPARG;STAT3;RUVBL2;FOXJ3;TOP1;MED8;JUN;MEIS1;NR1D2;ONECUT2;TFE3;MITF;SNAI1;ZSCAN21;JDP2;PBX1;NFKB1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.34720666501840725,0.9767937246596736,0.5052386495925495,0.9156000623846534,1.0,8/53,11.65%,SLC1A3;SLC25A2;SLC1A5;SLC36A2;SLC25A38;SLC43A1;SLC7A7;SLC7A8
prerank,protein serine/threonine kinase activity (GO:0004674),0.3036845483698138,0.9753698185828548,0.569,0.9161461778937217,1.0,70/334,15.69%,WNK2;PRKCA;STK32B;PRKCQ;STK36;EGFR;ACVR1;ALPK1;MAP4K4;PAK4;IRAK3;ARAF;MAPK7;WNK3;EIF2AK3;SIK2;RPS6KA4;MAST2;MAPKAPK3;PAK5;MAPKAPK2;DYRK4;TESK2;ACVR1C;TNIK;PKN1;PAK1;CDK13;CDKL5;CDK8;CDKL3;TGFBR2;ATP23;PRKAB2;DYRK1B;PDK3;CDK6;LIMK1;GAK;CDK15;CDK19;AKT3;MAPK9;TLK2;STK39;PASK;SGK3;SGK2;SLK;MAPK14;PKMYT1;STK32A;MAPK1;TAOK3;STK33;TBK1;CSNK1G1;PRKACA;CSNK1A1;CDK16;TRIO;NEK7;TTBK1;RPS6KA2;MAP3K4;BMPR1A;ATM;PIM2;CSNK1G2;HTATIP2
prerank,CoA hydrolase activity (GO:0016289),0.423740194548378,0.9750099615153097,0.5071022727272727,0.9139438179964068,1.0,6/16,25.76%,ACOT11;HIBCH;ACAA2;ACOT8;ACOT9;NUDT7
prerank,ribosomal small subunit binding (GO:0043024),-0.344950639417527,-0.9741388231468023,0.4966216216216216,0.7816718851538962,1.0,5/17,15.42%,MTIF2;NPM1;ABCE1;NME1;MTIF3
prerank,nuclear receptor binding (GO:0016922),0.32038297439448443,0.9739241516405783,0.5499462943071965,0.9135641690113758,1.0,35/111,20.28%,NCOA1;RNF6;TACC1;WIPI1;PKN1;DDX54;GTF2B;PPID;TRIP6;NCOA2;BRD8;HIF1A;MED13;ESR1;TAF11;DCAF1;NRIP1;TMF1;STRN;PRPF6;LCOR;NCOR2;TAF7;CRY1;MED12;JUP;MED25;SMARCE1;NCOA3;MED30;PARK7;TAF1;TACC2;SMARCA4;PHB2
prerank,calcium-release channel activity (GO:0015278),-0.33339070098391343,-0.9733090512235945,0.4880546075085324,0.7763575219226624,1.0,3/17,9.80%,ITPR1;RASA3;MCOLN1
prerank,nuclear receptor coactivator activity (GO:0030374),0.34748155640122214,0.9726689691957701,0.5220417633410673,0.9136713693165306,1.0,21/52,25.29%,FGF2;NCOA1;TACC1;PKN1;ZMIZ1;CARM1;NCOA2;BRD8;MED13;TMF1;MED12;NCOA3;MED30;RNF4;DCAF6;MED24;WDR77;CCDC62;ZMIZ2;NCOA7;ENY2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3470518524139215,0.9715377055349347,0.5143198090692124,0.9134065758047512,1.0,17/49,21.22%,CPNE8;C2CD5;ANXA9;SYT1;RPH3A;SYT11;SYT12;MCTP1;ANXA6;DOC2B;CPNE7;SYT2;DYSF;PLA2G4E;CPNE1;SYT13;CPNE3
prerank,metalloexopeptidase activity (GO:0008235),0.3455944464640092,0.9686774823224163,0.5372781065088758,0.917392131263863,1.0,12/51,15.67%,DPEP1;AGBL3;LTA4H;MMP15;AGBL2;TRHDE;LNPEP;MMP16;AGBL4;AGBL1;CPD;RNPEPL1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3870432059517451,0.9675276850652409,0.5254237288135594,0.917257475082737,1.0,4/24,9.37%,PLEKHA5;SESTD1;OSBPL5;LANCL2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.4312156299707092,0.9658880710223945,0.5060240963855421,0.9181328337134789,1.0,4/14,17.66%,NCF1;NOX1;NCF2;AIFM1
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.25645447385476733,-0.9652305867216265,0.5384615384615384,0.7888775826266613,1.0,15/49,15.05%,MPPED2;ATP1A2;PPP1CB;PPP1CC;PXYLP1;DUSP3;LHPP;SAMHD1;SBF1;ARMT1;ACP6;DUSP10;PGAM5;PTPRO;PRUNE1
prerank,endoribonuclease activity (GO:0004521),0.35988584420919134,0.9642740634865377,0.5025510204081632,0.9189191173525493,1.0,5/32,10.65%,INTS11;NOB1;ZC3H12B;ENDOV;RCL1
prerank,SUMO binding (GO:0032183),0.4309749856264707,0.9621203073251062,0.5194029850746269,0.9210710723861509,1.0,6/13,22.25%,UBA2;CBX4;RNF111;USP25;RNF4;TDG
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3993954220982504,-0.9617605811669722,0.5083333333333333,0.7901748029118502,1.0,3/10,4.84%,PRKAG2;PKIA;PRKAR1A
prerank,nucleoside-diphosphatase activity (GO:0017110),0.42815753785592536,0.9615442104802593,0.514820592823713,0.9194207466287427,1.0,2/12,5.29%,NUDT15;ENTPD2
prerank,histone methyltransferase activity (GO:0042054),0.3708153202023376,0.960649082371052,0.529113924050633,0.918595756072661,1.0,8/32,11.23%,SUV39H1;EED;MEN1;CARM1;SETD2;PRDM9;FBL;PRMT1
prerank,microtubule motor activity (GO:0003777),0.33838545016577376,0.9603996890551741,0.5047281323877069,0.9162413006162033,1.0,12/51,18.85%,DNAH2;KIF20B;KIF19;STARD9;KIF21A;DYNC1I1;KIF5C;DYNC1I2;KIF22;KIF3A;KIF2A;KIF21B
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.29596586705358074,0.9574461576621345,0.6746746746746747,0.9203918486874173,1.0,135/732,20.84%,RORA;EBF2;ETV1;SOX6;NKX6-2;KLF15;MEOX1;EBF4;ETV4;MEOX2;GLI2;TLX3;SOX8;PRDM16;MYC;TGIF2;DMRT2;EBF1;ZBTB20;SOX9;HIVEP1;ZBTB37;HOXA7;SATB1;EGR3;TFCP2;FOXP2;RFX2;SOX11;ZEB1;GLI1;E2F2;PGBD1;HOXD3;RFX3;ZFP14;RORC;MLXIPL;MLX;ZBTB16;GATA6;TBX18;E2F6;LRRFIP1;ZSCAN20;MKX;ZBTB41;RARB;SOX5;RARG;SOX12;ZNF569;HIF1A;CHD2;KLF5;ZBTB6;ZBTB38;ZNF260;ZSCAN26;ATF2;NFATC3;ZKSCAN8;NFE2L2;ESR1;SP1;MYT1;ZNF112;HDAC6;RUNX1;NRIP1;ZFHX4;ZGPAT;PATZ1;FOXP4;ZNF250;KLF13;SIX5;NR6A1;AHR;ZBTB1;PER1;GATA3;ZNF83;ZEB2;SALL2;ZBTB39;NACC2;KDM6A;PAX3;HIVEP3;ZFHX2;CREM;IRX5;HOXB7;ZNF235;POU3F1;MEIS3;KLF9;SP3;TP53;NFIX;NFIA;HNRNPU;SREBF2;ZKSCAN1;FOXJ1;PAX2;HEYL;NR5A1;ZNF496;BATF;IRF3;KLF16;ZNF697;PRRX1;RFX7;KLF7;EGR1;PPARG;STAT3;RUVBL2;FOXJ3;TOP1;MED8;JUN;MEIS1;NR1D2;ONECUT2;TFE3;MITF;SNAI1;ZSCAN21;JDP2;PBX1;NFKB1
prerank,hydro-lyase activity (GO:0016836),0.355915091965908,0.9569260791049181,0.539119804400978,0.918598709842243,1.0,10/41,19.72%,CYP2S1;CBS;HADHA;UROS;CDYL;PCBD2;EHHADH;AUH;PARK7;HACD2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.4135241850753326,0.9557917720859963,0.5226628895184136,0.9184022324827914,1.0,5/17,25.42%,THEM4;ACOT11;ACAA2;ACOT8;ACOT9
prerank,cardiolipin binding (GO:1901612),-0.38875003158040555,-0.9554473982685728,0.5071225071225072,0.7974305205894929,1.0,5/10,29.46%,STOML2;GSDMD;GSDME;UQCC3;MME
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.4364609004518485,0.9549599329649768,0.5198776758409785,0.9174543901335965,1.0,4/12,12.27%,PDE7B;PDE4B;PDE3B;PDE4D
prerank,nucleotidyltransferase activity (GO:0016779),0.4032341832583104,0.9536002331031773,0.537463976945245,0.9177867244397208,1.0,9/19,23.92%,PAPSS2;TUT4;CGAS;PNPT1;REV1;NUDT5;TENT2;TUT1;MOCS3
prerank,5'-nucleotidase activity (GO:0008253),0.4224932960658241,0.9535393033243954,0.5112781954887218,0.9149903582583863,1.0,4/13,18.94%,NT5DC2;NT5C2;NT5C3B;NT5C
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.43464652127585046,0.9529731691983481,0.5454545454545454,0.9133749982184517,1.0,5/12,21.94%,SLC25A23;SLC35B3;SLC25A25;SLC25A24;SLC17A9
prerank,lipase activity (GO:0016298),0.35092504119940093,0.952365192240282,0.5575757575757576,0.9119012692413277,1.0,9/43,21.01%,CEL;PLBD1;LYPLA1;LIPC;PNPLA8;SEC23IP;ABHD6;DDHD1;ABHD16A
prerank,3'-5' DNA helicase activity (GO:0043138),-0.3444561865038501,-0.9496234926965608,0.47157190635451507,0.8047077020574982,1.0,4/16,9.72%,NAV2;RECQL5;ERCC3;MCM6
prerank,histone deacetylase activity (GO:0004407),-0.3156373082787578,-0.9495384539387162,0.5236486486486487,0.7976637356917382,1.0,10/19,25.38%,HDAC8;SIRT3;HDAC4;HDAC11;HDAC3;SUDS3;HDAC5;SIRT7;MIER2;HDAC10
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.3809139720834087,-0.9487935136344576,0.5377906976744186,0.7924735629467714,1.0,5/11,13.02%,NDUFAF7;PRMT7;PRMT2;PRMT5;PRMT8
prerank,estrogen receptor binding (GO:0030331),0.36154393377560073,0.9480114791621533,0.5532734274711169,0.9192289774306719,1.0,10/32,13.89%,NCOA1;TACC1;WIPI1;DDX54;PPID;ESR1;DCAF1;NRIP1;STRN;LCOR
prerank,nuclear import signal receptor activity (GO:0061608),0.42466095865806397,0.9468775800941551,0.5324675324675324,0.9189203014756462,1.0,7/15,19.50%,IPO9;KPNB1;KPNA6;KPNA1;TNPO3;KPNA3;IPO5
prerank,gap junction channel activity (GO:0005243),-0.3092761452690041,-0.9463777416609697,0.5419847328244275,0.7908885160692635,1.0,4/22,11.12%,GJA1;GJB6;GJC1;GJD3
prerank,secondary active transmembrane transporter activity (GO:0015291),0.34102119763751304,0.9446807627911751,0.5712589073634204,0.9213829622820088,1.0,13/51,17.20%,SLC28A1;ANKH;SLC16A10;SLC35C2;SLCO2B1;SLC35E2B;SLC35E2A;SLC7A8;SLC35A1;SLC25A10;SLC25A11;SLC35E1;SLC35E3
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.33522773964778974,-0.94447583245889,0.49673202614379086,0.7883736043008212,1.0,3/14,11.45%,SLC26A7;SLC26A2;SLC25A30
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.40150478990113886,0.9443021821339513,0.520336605890603,0.9193776335355061,1.0,5/16,22.25%,BST1;NEIL1;SMUG1;CD38;TDG
prerank,GTPase activity (GO:0003924),0.2969068017303236,0.9439190532294841,0.6069600818833163,0.9174574200226701,1.0,41/192,18.98%,RHOJ;GNA14;DNM1;RHOD;GNG3;RND3;RAB38;RAP2B;RHOBTB3;RAB14;RALB;ARL1;RAB21;BMS1;RAP1A;RABL3;RHOT2;ARL2;MRAS;GSPT2;TBCC;RAB22A;RAB1A;MTG1;RHOC;RHOH;ATL3;GNAI1;ARL8A;RAB3A;RAB4A;TRIM23;OPA1;GTPBP10;RAP1GAP;RAC3;RAB7A;RHOT1;NRAS;KRAS;RAB3B
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.3420698268618252,-0.9423760471941035,0.5372168284789643,0.7864634068031264,1.0,6/14,16.11%,USP7;USP9X;OTUD5;MINDY2;USP15;MINDY3
prerank,deubiquitinase activity (GO:0101005),0.3192850164398152,0.9423616172188397,0.566017316017316,0.9181920265631816,1.0,24/88,19.36%,USP50;USP35;USP11;MINDY4;OTUD7B;UCHL5;OTULIN;UCHL1;USP46;MYSM1;USP33;UCHL3;USP32;USP48;USP40;USP14;USP25;USP21;USP1;USP2;USP37;OTUD4;OTUD7A;USP5
prerank,histone acetyltransferase binding (GO:0035035),0.3836791288888037,0.9421944162977174,0.5402777777777777,0.915720517556974,1.0,8/21,24.33%,HIF1A;TAF7;KANSL1;CITED2;TP53;EGR1;KANSL1L;MEF2A
prerank,wide pore channel activity (GO:0022829),-0.3051052607867184,-0.9392348044175592,0.5568627450980392,0.7872727309766279,1.0,4/23,11.12%,GJA1;GJB6;GJC1;GJD3
prerank,protein heterodimerization activity (GO:0046982),0.2967198306715939,0.9388254292323284,0.6288343558282209,0.920387623657765,1.0,32/178,17.47%,TENM2;TENM3;ERBB3;BCL2;ERBB2;IRAK3;EXT1;UBA2;FBXO7;METTL3;MLXIPL;MLX;PAFAH1B3;NAE1;MTTP;HIP1;HIF1A;RCC1;VAPA;UBA3;KATNB1;AHR;ZBTB1;TRMT112;TAF7;SNX1;ITGB1;FZD9;TP53;ABCG4;CHUK;RALGAPB
prerank,zinc ion binding (GO:0008270),0.2949253536896298,0.9368073188544477,0.6452261306532663,0.9219063655042535,1.0,59/293,19.35%,RAG2;GLI2;CSRP1;DHH;DPEP1;CBLB;PRKN;KMT2A;EPRS1;SEC24D;PDXK;KDM5B;MBD1;ITGB1BP2;ZEB1;MT3;GRIN2B;HHIP;LTA4H;AOC1;TRIM2;RPH3A;GTF2B;CHD3;TRHDE;PTPN1;SEC24C;LNPEP;MMP16;USP33;MYT1;RBAK;SIRT6;ZFPM2;PHF8;KPNB1;HPF1;SNCA;GRIN2A;ADAM33;MDM4;TRAF7;PAPPA2;BAZ1B;BLM;RCHY1;TP53;TET3;ADH5;RBSN;SEC24A;RC3H1;MDM2;ZMYND11;KLF7;EGR1;TAB3;PPARG;PRDM2
prerank,microtubule binding (GO:0008017),0.29363863549840896,0.9360852090899683,0.6427850655903128,0.9206970273166573,1.0,48/222,18.85%,SGIP1;SAXO2;DNM1;FGF13;KIF20B;KIF19;MAP4K4;MAP1B;GAS2L3;ARL3;MAST2;STARD9;PRNP;EML1;CCDC170;MACO1;NDE1;KIF21A;CEP57;CAPN6;CEP295NL;TUBGCP5;VAPA;DYNC1I1;KIF5C;MID2;CLASP1;HDAC6;APC2;RMDN2;KATNB1;CKAP5;MDM1;KIF22;TPGS1;OPA1;GABARAPL2;MAP6D1;NAV3;EML5;MID1;DCX;KIF3A;CAMSAP1;MAPRE3;HOOK2;KIF2A;KIF21B
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.41287551281647306,0.9350776377149661,0.5544117647058824,0.9201386921904877,1.0,3/14,11.62%,PTEN;MTMR14;MTMR12
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3548956715339203,0.9348664515542251,0.5475285171102662,0.9177948334608674,1.0,6/34,7.84%,RAG2;IQGAP2;MAPKAP1;GBF1;ARHGAP9;GAB2
prerank,C-C chemokine receptor activity (GO:0016493),0.390475219981488,0.9343910198647973,0.5704607046070461,0.916009620659159,1.0,3/21,14.22%,CCR2;ACKR3;ACKR4
prerank,calcium channel activity (GO:0005262),0.31544202231600227,0.933706840271767,0.5868131868131868,0.9148300429100527,1.0,17/84,18.72%,CACNA1E;CACNA2D1;CACNG7;ANXA9;NCS1;CACNA1A;PSEN1;CACNB4;SLC24A5;ANXA6;TPCN2;TRPC5;PKD1;CACNA2D2;CACNA2D4;SLC24A4;SLC24A2
prerank,MAP-kinase scaffold activity (GO:0005078),0.4252444890698538,0.9333508723544086,0.5489614243323442,0.9128630452252428,1.0,4/11,14.85%,AKAP13;KSR1;SPAG9;IQGAP1
prerank,protein phosphatase regulator activity (GO:0019888),0.33080226471452256,0.9326416358815228,0.5908558030480656,0.9117306713455126,1.0,8/53,8.96%,LGALS3;PPP1R15A;RCAN1;ENSA;PPP2R3A;RCAN3;SHOC2;PPP2R2A
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3595014670419428,-0.9304967310968478,0.5333333333333333,0.801250619174646,1.0,4/12,14.66%,SLC6A6;SLC38A7;SLC38A5;SLC36A4
prerank,N-acyltransferase activity (GO:0016410),0.35399668097897863,0.9302213180392263,0.5656050955414013,0.9143779581799248,1.0,10/32,22.17%,CERS3;CERS6;PLAAT5;PLAAT3;SMARCE1;NAA10;GLYAT;PLA2G4E;CERS2;NAT8L
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.37695806243944596,0.9300066939887995,0.5662650602409639,0.9120394773071671,1.0,8/21,22.95%,PRRC1;AKAP6;WASF1;PRKACA;ARFGEF1;AKAP1;PJA2;WASF3
prerank,disordered domain specific binding (GO:0097718),0.3733379430501409,0.925120598876851,0.5640326975476839,0.9197182901001972,1.0,7/23,17.91%,KCNA1;FYN;CALM1;CALM2;TP53;NCOA3;MDM2
prerank,guanyl ribonucleotide binding (GO:0032561),0.29140008521151595,0.923930797224373,0.6591606960081884,0.9194639639927433,1.0,59/196,24.38%,RHOJ;RASEF;RHOD;RND3;RAB38;RAP2B;ADSS1;RHOBTB3;RAB14;ARL3;RALB;ARL1;RAB21;BMS1;RAP1A;RAB39A;RABL3;LANCL2;TUBB6;RHOT2;ARL5C;ARL2;MRAS;ARF4;ANXA6;RAB22A;RHOC;RHOH;ATL3;GNAI1;ARL8A;RAB4A;TRIM23;GTPBP10;EIF2B2;RAC3;RAB7A;TUBA1A;RHOT1;NRAS;KRAS;RAB3B;RRAGA;PDE11A;RHOU;RABL6;GLUD1;AGAP2;PDE10A;RAP2A;GBP2;RAB6A;RAB18;RAP2C;ARL8B;RAB2A;GNL3;TUBA1B;REM1
prerank,ribosomal large subunit binding (GO:0043023),0.43051458058389225,0.9238559898977741,0.5553822152886115,0.9168701467744748,1.0,3/11,14.36%,CPSF6;EIF6;DHX33
prerank,O-methyltransferase activity (GO:0008171),0.44017280092822686,0.9230115241138904,0.5560821484992101,0.9159705182900402,1.0,4/10,19.46%,COMT;LRTOMT;MEPCE;CMTR2
prerank,cytochrome-c oxidase activity (GO:0004129),-0.321936507497677,-0.9214009305416939,0.5457413249211357,0.8156224185009808,1.0,5/15,16.97%,COX6B1;COX6A1;COX4I1;COX5A;COX5B
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.39629245767362475,0.9206527198434095,0.5716332378223495,0.9156834933038628,1.0,3/17,3.30%,EFNA4;EPHB6;EPHB2
prerank,ephrin receptor activity (GO:0005003),0.39629245767362475,0.9206527198434095,0.5716332378223495,0.9156834933038628,1.0,3/17,3.30%,EFNA4;EPHB6;EPHB2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.35603908756877967,0.92011741709813,0.5702592087312415,0.9142199988499798,1.0,5/29,6.86%,CDKN2B;KAT2B;PRKAR1B;SPRED2;SPRED1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.3140851254696347,0.9197228084274071,0.6100766703176341,0.9124014235145871,1.0,26/83,21.87%,USP50;USP35;USP11;OTUD7B;UCHL5;OTULIN;UCHL1;USP46;MYSM1;USP33;UCHL3;USP32;USP48;USP40;USP14;USP25;USP21;USP1;USP2;USP37;OTUD4;OTUD7A;USP5;USP13;JOSD1;USP31
prerank,adenylate cyclase binding (GO:0008179),0.4307824995549665,0.9195830113619138,0.5703245749613601,0.9099743951401502,1.0,5/10,27.89%,AKAP6;CALM1;CALM2;ADCY5;AKAP12
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.41640465330174103,0.919349860776439,0.5816023738872403,0.9077732591991915,1.0,4/13,22.61%,IDI1;SREBF2;EHHADH;ECH1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.33202909282781773,0.9190580267833001,0.6075205640423031,0.9057637921431656,1.0,16/49,23.35%,ZFAND2B;RAD23B;ZRANB3;OTUD7B;EPS15;HDAC6;ZBTB1;ZFAND6;OTUD7A;TAB3;TNIP2;WDR81;UBQLN4;UBQLN1;TAB2;UBQLN2
prerank,vitamin D receptor binding (GO:0042809),0.4109344243096381,0.9190024012217305,0.5693848354792561,0.9032721313633679,1.0,6/14,22.33%,MED13;TAF11;TAF7;MED12;MED30;MED24
prerank,phosphotyrosine residue binding (GO:0001784),0.3476950843511408,0.918958589964064,0.5851197982345523,0.900716277554237,1.0,16/37,26.51%,RASA1;SAMSN1;PIK3R1;PTPN11;ABL1;SH3BP2;GRB2;YES1;BCAR3;VAV2;NCK2;HCK;CRK;LDLRAP1;SYK;SHC3
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2842026277112285,0.9173454696912438,0.744,0.9015689885684111,1.0,92/431,18.81%,WNK2;PYGL;RHOJ;RASEF;RHOD;STK36;PEAK1;RND3;RAB38;RAP2B;ACVR1;ADSS1;MAP4K4;RHOBTB3;IRAK3;PDXK;WNK3;RAB14;SIK2;ARL3;RPS6KA4;MAST2;GSS;UBA2;KSR1;CDKL5;RALB;ARL1;RAB21;BMS1;PDK3;CDK6;SARS2;RAP1A;RAB39A;RABL3;TBCK;ACLY;AKT3;TLK2;LANCL2;TUBB6;RHOT2;SYN1;PXK;ARL5C;ARL2;EIF4G1;MRAS;MYO9B;HSPA4;ARF4;PI4K2A;MSH6;ANXA6;RAB22A;RHOC;DDX25;RHOH;ATL3;GNAI1;ARL8A;SRR;PNPLA8;RAB4A;HARS1;AK6;P2RY1;TRIM23;RTEL1;BMPR1A;GTPBP10;ABL1;ABCB9;PAPOLA;BLM;OLA1;NDUFA13;ABCD2;HNRNPU;FICD;ABCF1;EIF2B2;RAC3;SMC4;RAB7A;TUBA1A;HSPA9;PEX1;RHOT1;NRAS;KRAS
prerank,syntaxin binding (GO:0019905),0.31680901309386417,0.9154423698755049,0.6333333333333333,0.903045464904499,1.0,12/61,13.46%,SNAP23;STXBP4;PTPN2;SYNPR;CACNA1A;SYT1;SNAP29;TMED10;VPS11;SYT12;STXBP5;STX8
prerank,double-stranded RNA binding (GO:0003725),-0.22267246602896573,-0.91522117519602,0.6384615384615384,0.8233723358782871,1.0,12/70,12.41%,DDX60;SIDT1;RFTN1;DGCR8;STRBP;AGO1;ACTN1;IFIH1;TFRC;ELAVL1;OAS2;AGO3
prerank,metalloaminopeptidase activity (GO:0070006),0.4053279311870866,0.9145878466067118,0.5676077265973254,0.902190788338796,1.0,6/16,15.67%,LTA4H;MMP15;TRHDE;LNPEP;MMP16;RNPEPL1
prerank,phospholipase inhibitor activity (GO:0004859),0.44151605118580356,0.9126171622629974,0.5741935483870968,0.9039479287630829,1.0,3/10,18.89%,ANXA9;SNCA;SNCB
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3128711609420315,-0.911308897339324,0.578125,0.8255260825899451,1.0,9/16,38.47%,CDO1;ETHE1;ALOX12;BCO2;PIR;HGD;ALOXE3;HAAO;ALOX5
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.2949352043068296,0.9097872645359614,0.6708203530633438,0.9073609361229724,1.0,43/147,21.27%,DENND2A;AKAP13;FGD4;FRMD7;ARHGEF28;NUCB1;DOCK5;ARHGEF10;ALS2;EPS8L1;DOCK10;ITSN1;RAP1A;EIF2B5;RGL1;VAV3;LAMTOR2;ARHGEF11;DENND1C;DOCK1;FARP2;RCC1;SPATA13;DNMBP;RCC1L;RAB3GAP2;ANKRD27;RAB3IL1;CYTH3;ELMO1;RIC8B;ARFGEF1;ARHGEF4;HPS1;EIF2B2;DENND10;FNIP1;WDR41;DENND5A;RAB3GAP1;CCDC88A;SOS1;VAV2
prerank,pyrophosphatase activity (GO:0016462),0.322900095659161,0.9056317922309278,0.6448931116389549,0.9132662543023075,1.0,11/50,12.73%,NUDT15;DXO;RNGTT;ENTPD2;BNIPL;NUDT1;NUDT22;PLPP4;NUDT10;NUDT9;NUDT3
prerank,myosin binding (GO:0017022),0.3196137197152772,0.9055935127967888,0.6178861788617886,0.9107443224036097,1.0,18/55,22.70%,PYCARD;GSN;RAB14;SPATA6;RAB3D;STXBP5;RAB3A;MYOC;KIRREL1;MOBP;ARFGEF1;TRAK2;NKD2;RAB3B;RAB39B;LLGL1;TRIOBP;RAB6A
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.338543397524544,0.9040543519558697,0.6007416563658838,0.9112326309933908,1.0,14/35,28.11%,DTWD1;ELAC1;GATB;TRMT12;MRPL58;DTWD2;MTFMT;TRIT1;LCMT2;ALKBH1;NT5C3A;DUS4L;FTO;TRMT5
prerank,ATPase activator activity (GO:0001671),0.3709097807864345,0.9035247759722008,0.5970744680851063,0.909713304543736,1.0,7/20,18.99%,DNAJB4;DNAJB6;AHSA1;DNAJC19;DNAJA2;DNAJA1;DNAJC10
prerank,NF-kappaB binding (GO:0051059),-0.28536098170209473,-0.9032304175850188,0.6106870229007634,0.8371262694887673,1.0,10/24,27.04%,NFKBIA;NPM1;GSK3B;ANXA4;COMMD7;COMMD6;HDAC3;RNF25;BRMS1;SETD6
prerank,protein phosphatase activator activity (GO:0072542),-0.3379681876522721,-0.9024038963484952,0.5887573964497042,0.8323065197032194,1.0,3/13,5.12%,PHACTR4;IGFBP3;PTPA
prerank,glycine binding (GO:0016594),0.41583810189632225,0.9016988271052422,0.5877742946708464,0.9107454599382043,1.0,3/11,19.90%,GRIN2B;SRR;GLRB
prerank,R-SMAD binding (GO:0070412),-0.31163378733999514,-0.9006941410377562,0.5762081784386617,0.8295420651376715,1.0,4/18,12.71%,SMAD6;DDX5;RGCC;RANBP3
prerank,histone demethylase activity (GO:0032452),0.3601293709452674,0.8994492941020635,0.6077922077922078,0.912779882098641,1.0,6/27,14.04%,KDM8;KDM5B;KDM4B;JARID2;PHF8;KDM6A
prerank,E-box binding (GO:0070888),0.33484507777483774,0.8981694657027235,0.6257822277847309,0.9127135317096514,1.0,9/34,20.67%,MYC;ZEB1;AHR;PER1;GATA3;SREBF2;PPARG;MITF;SNAI1
prerank,1-phosphatidylinositol binding (GO:0005545),0.3960250376275927,0.8969725314153374,0.6076134699853587,0.912507156083448,1.0,4/15,12.41%,SESTD1;WDFY3;SNX10;ZFYVE9
prerank,phosphatidic acid binding (GO:0070300),0.38177230619159264,0.8957229491146314,0.6182336182336182,0.9125035402737798,1.0,5/19,14.99%,SESTD1;PACSIN2;MAPKAP1;GRAMD1B;OPA1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.28051112656911986,0.8934525111158098,0.7292929292929293,0.9146667661855856,1.0,45/232,18.02%,PDZRN3;RNF157;CBLB;PRKN;DTX4;HACE1;TRIM44;NFX1;RNF6;ZNRF2;NEURL4;UFL1;TRIM2;TRIM11;CBX4;PELI1;RNFT1;FBXO27;PIAS2;VPS11;NEURL1B;CUL3;UHRF2;CBL;HUWE1;RNF121;TRIM41;MYLIP;FBXO17;MEX3C;RNF24;NEDD4L;AREL1;NEURL3;UBE2O;RNF19A;RNF111;RCHY1;XIAP;KCMF1;RNF10;RNF167;RC3H1;MDM2;TRIM9
prerank,RNA methyltransferase activity (GO:0008173),0.37153540326248174,0.8922699271951141,0.6080114449213162,0.9144065629944821,1.0,5/19,15.92%,METTL3;TRMT12;TGS1;FBL;MEPCE
prerank,kinase activator activity (GO:0019209),-0.2692730389425686,-0.8917250479191837,0.6756756756756757,0.8426381215732833,1.0,9/30,13.05%,PRKAG2;WNK1;MADD;GPRC5C;RGCC;RPLP1;MARK2;SPDYA;NCKAP1L
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.350535401620638,-0.8902542532384985,0.5771428571428572,0.839200047261771,1.0,5/11,22.89%,ITPR1;TRPC6;TRPC3;TRPC7;CYTH2
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.3995358715101419,0.8902298619512719,0.6113475177304964,0.9160971332695459,1.0,3/13,10.49%,PDGFRA;VEGFA;PTPRJ
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3027726341232253,0.8892376589894369,0.6429378531073446,0.9156488829714742,1.0,24/69,25.66%,CERS3;KAT2B;CERS6;NAA16;KAT8;GTF2B;ZDHHC8;MOGAT3;PLAAT5;HHAT;PLAAT3;DBT;NAA10;GLYAT;NAA15;PLA2G4E;CERS2;ZDHHC21;PORCN;SCP2;ZDHHC13;DGAT2;ZDHHC15;ZDHHC17
prerank,protein homodimerization activity (GO:0042803),0.27409498056830317,0.8885598122467384,0.854,0.9144326364095209,1.0,110/589,18.64%,SOX6;TENM2;AADAT;TENM3;PDGFRA;FAP;GLIPR2;PYCARD;KIF20B;BCL2;KYNU;HM13;CBS;PSPH;PTPRT;ACVR1;KMT2A;EPRS1;VEGFA;IRAK3;PDXK;FOXP2;ERCC5;NTRK2;GSS;EXT1;HSPB6;AOC1;NAGA;ALS2;CADM3;SETMAR;MLXIPL;MLX;ZBTB16;MKLN1;CARD9;TBX18;S100A6;PNPO;PAFAH1B3;LRRFIP1;FGFR1;BNIP3;ACOX1;PDLIM4;RABL3;CADM1;FLNA;XPA;CEP57;RPE;S100A16;HIP1;CRYAB;SNX6;ZBTB38;PRDM9;ERBB4;SLK;GDNF;MYO9B;MID2;GLCE;SP1;GALM;MSH6;SFPQ;PHETA2;NR6A1;GGCT;AHR;ZBTB1;SRR;EXD2;NACC2;SYNDIG1;HARS1;NFS1;BMPR1A;SNX1;RAB11FIP3;PDCD6IP;JUP;CHMP4C;ABCB9;FZD9;BLM;RCHY1;FECH;RAP1GAP;KCNH2;ABCG4;ALDH1A3;ABCD2;PPCS;FICD;RIPK1;ACSL6;CHUK;WRN;MID1;GSTZ1;TRIM9;IRF3;NUDT5;CAT;PGRMC1;PEX11A;PARK7
prerank,lysophospholipase activity (GO:0004622),-0.2941351550058135,-0.8885003310403289,0.6294964028776978,0.8365884878202478,1.0,6/20,18.44%,PLA2G4A;PNPLA6;MGLL;ASPG;ABHD12;LYPLAL1
prerank,fibroblast growth factor binding (GO:0017134),-0.28344834556259085,-0.8876813421837007,0.6568265682656826,0.8316813886773635,1.0,7/21,15.26%,KL;RPS19;THBS1;RPS2;FGFR2;API5;FGFR4
prerank,neuropeptide receptor binding (GO:0071855),0.3928755425674473,0.8868031957741882,0.5984962406015037,0.9152224330592451,1.0,3/14,25.69%,NMU;NPY;SHANK1
prerank,cell adhesion mediator activity (GO:0098631),0.3569503655185853,0.8864594008054807,0.6517006802721088,0.9133988267169104,1.0,6/24,9.58%,LRRC4C;NTNG1;CNTN6;CNTN2;PALLD;DSCAM
prerank,protein phosphatase 1 binding (GO:0008157),-0.28635788845155297,-0.8852676197209239,0.6075085324232082,0.8302006409877711,1.0,5/21,11.07%,PHACTR4;PPP1R16B;PPP1R3B;SH3RF2;PPP1R11
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.3772133525386684,0.8833847498546245,0.6181046676096181,0.9166165287218573,1.0,3/16,11.62%,PTEN;MTMR14;MTMR12
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3359548041408461,0.8829489214529446,0.6212121212121212,0.9148755416571288,1.0,5/32,11.65%,SLC1A5;SLC36A2;SLC25A38;SLC43A1;SLC7A8
prerank,manganese ion binding (GO:0030145),-0.23421391671812108,-0.8819802767680475,0.7371428571428571,0.8308201703347203,1.0,11/48,16.05%,MPPED2;ABL2;ME1;MTPAP;PRIMPOL;MGAT1;IMPA1;B4GALT7;ADPRM;MPPE1;B4GALT1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3489133138397692,0.8802788574721152,0.6210106382978723,0.9175814222582228,1.0,12/27,26.27%,POLR2B;POLRMT;POLR1B;POLR2G;MED21;POLR1D;POLR1C;TENT2;POLR2A;POLR3K;POLR2F;POLR3F
prerank,GABA receptor binding (GO:0050811),-0.3490184182685081,-0.8795393187019684,0.6243093922651933,0.829811634575621,1.0,6/11,21.08%,TRAK1;GABARAP;PLCL2;JAKMIP1;SHISA7;ARFGEF2
prerank,RNA binding (GO:0003723),0.27012408501811,0.8794101107814055,0.944,0.916814374649027,1.0,352/1321,22.93%,DCN;LGALS3;PABPC5;RBFOX1;DNM1;CSTF3;CSRP1;RBMS3;DDX11;S100A4;NQO1;DHX34;DHX8;C1D;LRP1;CELF5;HNRNPDL;QKI;GPATCH4;EPRS1;FNDC3B;APTX;TRMT10B;WDR36;TRA2B;NFX1;PRRC2B;ZNF326;DXO;CCDC9;PABPC1;FARSA;ANKHD1;CPSF6;RPL23A;RBM33;ETF1;CSTB;ZNFX1;GOLGB1;NOP2;LTA4H;SPTBN1;ZMAT3;ATXN2;POLR2B;RP9;YWHAZ;HNRNPAB;MRPL14;MRPL32;TUFM;UBAP2;CDK13;NGRN;METTL3;MRPL16;PLEC;BRIX1;UCHL5;EIF1B;DHX35;NUDT1;XRN2;SON;NOL8;BMS1;LUC7L2;SRP9;SARS2;LRRFIP1;EIF3C;TUT4;SAMSN1;MRTO4;IBA57;SRBD1;ZC3H8;DHX30;TBL2;DDX54;UNK;FASN;CHD3;UTP6;ZC3H15;ZC3H12B;FLNB;GDI2;CPEB3;SRSF11;ADK;GOT2;RBM10;KHDRBS3;MRPS35;MRPS28;FLNA;TFAM;HEATR1;DDX24;BRCA1;PEG10;PPP1R8;S100A16;FARS2;RCAN3;APOBEC1;ANXA11;NSUN5;DCP1B;CKAP4;TRIP6;ZFP36L2;CASC3;PTPN1;CHD2;ALKBH5;REXO4;NCBP1;R3HDM1;EXOSC2;PNLDC1;FIP1L1;RSRC2;ENDOV;HDAC2;EIF4G1;ADARB2;PSIP1;HUWE1;DUSP11;PCBP4;UBFD1;FBL;CLNS1A;RIMS1;FKBP4;RPP38;PRMT1;COL14A1;GSPT2;SFPQ;MRPL28;SNRNP40;EBNA1BP2;UPF1;SPATS2;CCDC137;YARS1;RBM27;ZC3H18;MEX3C;RCC1L;HNRNPA3;DDX25;LSM3;CCDC86;GRN;XRCC6;DHX57;KPNB1;PRPF6;ADARB1;HSP90B1;CFAP20;RBM4B;DALRD3;DAZAP1;POLRMT;SPOUT1;RBM46;CCDC47;MSI1;DDX42;EIF1AX;EIF1;PUS7;POLR2G;CELF6;DHX32;DHX33;KHSRP;SRSF6;RBM7;GLRX3;NOVA1;SUMO1;NDUFV3;YTHDC1;RBM45;RTN4;ZNF638;SEC23IP;DDX10;WDR46;ELP5;NIP7;RNMT;SLTM;XPOT;GTPBP10;DDX27;LUC7L;TNS1;NOP56;EIF4ENIF1;FSCN1;KYAT3;UBE2O;GCN1;PSMC1;SEC63;PURG;NIFK;MEPCE;GTF2E2;RPS27L;SMG6;PUS1;CSNK1E;POP1;RAVER2;SLC25A11;SNRPA;PNPT1;SF3A1;NOC4L;FUBP1;HNRNPU;DDX56;ZYX;EIF4A2;NXF1;AKAP1;RPSA;N4BP1;ABCF1;SRRM3;TRAP1;RNPS1;RPP21;UBA1;RC3H1;PCID2;SSB;SF1;FUS;POLR1G;CAST;PKN2;BOP1;HSPA9;MRPS30;SART1;CLUH;OTUD4;NUDT5;NAA15;AATF;PARK7;ACAA2;SYNCRIP;DDX23;GIGYF2;RBFOX3;GRB2;POLR2A;PNISR;UBAP2L;UBE2L3;TENT5A;STAT3;CNBP;BZW1;IPO5;RPN1;TOP1;HNRNPUL1;RDX;ZNF106;SRRM1;PSTK;FAM120A;MRPS14;VIRMA;SREK1;BCCIP;CSDE1;MCRS1;JUN;UBTF;NSUN2;DDX31;RBMS1;DBR1;FUBP3;HNRNPH2;MYO5A;HSPD1;PEF1;HNRNPC;CELF4;ZFP36;DHX40;EIF4G3;R3HDM2;ZBED4;MRPL1;ZCCHC9;RBFOX2;DAP3;CPNE3;MRPS9;HNRNPL;SSBP1;MRPS31;MKRN1;SSRP1;AFF2;PTCD3;PYM1;HARS2;FYTTD1;SRSF3;FDPS;DDX6;NOL10;NPM3;DYNC1H1;SNIP1;VIM;RPS11;NUP42;AHNAK;YBX3;ALDH6A1;ALKBH1;PTBP2;DDX4;HNRNPUL2;ALKBH8;SMC1A;SNRNP200;RIDA;EXOSC3;ZC3H12C;EDF1;DHX29;RBMX2;SF3B2;DDX50
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.33082576979954537,0.8782217913697894,0.6355498721227621,0.9167017008383231,1.0,18/35,27.49%,MYC;DRAP1;GTF2B;PIH1D1;TAF4;TP53;PARK7;TAF1;RUVBL2;SMARCA4;UBTF;SNAPC3;RRN3;TBP;SMARCB1;HDAC1;DR1;RELA
prerank,omega peptidase activity (GO:0008242),0.29756561634258905,0.8774989307448466,0.6829004329004329,0.9156385378253553,1.0,26/89,21.87%,USP50;USP35;USP11;OTUD7B;UCHL5;OTULIN;UCHL1;USP46;MYSM1;USP33;UCHL3;USP32;USP48;USP40;USP14;USP25;USP21;USP1;USP2;USP37;OTUD4;OTUD7A;USP5;USP13;JOSD1;USP31
prerank,aminopeptidase activity (GO:0004177),0.34830538188410565,0.8765159063912249,0.6256756756756757,0.9149691297913125,1.0,6/26,10.26%,KDM8;LTA4H;MMP15;TRHDE;LNPEP;MMP16
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3675471153320251,0.8721078484515912,0.6229985443959243,0.9207371649557934,1.0,5/17,23.12%,DTYMK;AK3;AK5;AK8;CMPK1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.41677284266035014,0.8713850932658492,0.6172839506172839,0.9195430853195011,1.0,2/10,2.58%,PRDM16;SUV39H1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.3567590661621774,-0.8703777929262302,0.6270270270270271,0.8414709414517751,1.0,2/10,1.40%,CACNA1C;CACNB2
prerank,RNA polymerase binding (GO:0070063),0.3714550605485882,0.8693829031194132,0.6171428571428571,0.9208146793680001,1.0,8/18,27.66%,BIN1;BRCA1;TCERG1L;PKN2;ZFP36;CCNT2;TCERG1;ANP32B
prerank,3'-5' exonuclease activity (GO:0008408),0.3178763087982575,0.8693563232746683,0.679658952496955,0.9184030288349194,1.0,13/45,22.82%,USB1;REV3L;XRN2;REXO4;EXOSC2;PNLDC1;EXD2;POLG;PNPT1;WRN;CNOT6L;EXOSC3;RAD50
prerank,carboxypeptidase activity (GO:0004180),0.3268137869637876,0.8676124308762108,0.6575,0.9193199161268257,1.0,6/35,13.92%,AGBL3;NAALAD2;AGBL2;AGBL4;AGBL1;CPD
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2957593674023655,0.8671354630311713,0.6853070175438597,0.9177444302365239,1.0,14/75,17.11%,HSD17B7;HSD17B11;H6PD;AKR1B10;HADHA;RDH10;PHGDH;DHRS3;HIBADH;KCNAB2;CBR3;UGDH;ADH5;EHHADH
prerank,phosphatase activity (GO:0016791),0.2962079370467322,0.8633892994194041,0.6771653543307087,0.9219564633937822,1.0,20/73,20.77%,PTPN22;ACP5;DUSP4;PSPH;APTX;ACP2;BPNT2;PTPRJ;DUSP11;PLPP4;PPP1CA;PLPPR4;HDHD2;MDP1;MINPP1;DUSP16;NT5C;PLPPR2;DUSP12;PTPMT1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3528596199159288,0.8632778145008634,0.6376210235131397,0.9197413009552229,1.0,6/21,17.19%,POLN;POLE2;REV3L;POLE3;POLG;REV1
prerank,telomeric DNA binding (GO:0042162),0.32908296583145535,0.8628553977001826,0.6501950585175552,0.9180981826412058,1.0,14/32,28.11%,UPF3A;STN1;UPF1;XRCC6;BLM;SMG6;TERF2IP;WRN;CTC1;RAD50;ACD;HNRNPA2B1;SMG1;TELO2
prerank,MAP kinase activity (GO:0004707),0.38553491473046314,0.8624560591172192,0.6386292834890965,0.9163980627078078,1.0,4/14,11.33%,MAPK7;MAPK9;MAPK14;MAPK1
prerank,phospholipase activator activity (GO:0016004),0.4097323271555917,0.8622477825679067,0.6445131375579598,0.9144162979771205,1.0,1/10,8.15%,FYN
prerank,ribonuclease P RNA binding (GO:0033204),0.4034395636455254,0.8610643614320395,0.6451127819548872,0.914167788734914,1.0,5/10,27.45%,RPP38;POP1;RPP21;RPP30;RPP14
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.38743116616970436,0.8568666622223104,0.6464339908952959,0.9191722842162725,1.0,6/12,27.49%,GTF2B;TAF1;RUVBL2;TBP;HDAC1;RELA
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3538501952899915,-0.8559722885198263,0.6336898395721925,0.8648109260621815,1.0,2/10,2.48%,CD200;CXADR
prerank,nuclear localization sequence binding (GO:0008139),-0.2956183421210108,-0.853511337332353,0.6883561643835616,0.8631740632374935,1.0,5/18,11.25%,NFKBIA;KPNA4;BRAP;RANBP6;NUP214
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3934044981350171,0.8534763301039049,0.6484018264840182,0.9227484805681855,1.0,2/12,6.03%,PYCARD;APAF1
prerank,C-C chemokine binding (GO:0019957),0.3516005639189888,0.8521073424980137,0.6671105193075899,0.9227886096103151,1.0,4/22,20.78%,CCR2;ACKR3;ACKR4;ZFP36
prerank,histone deacetylase binding (GO:0042826),0.28382994955695945,0.8504316819500982,0.7236842105263158,0.9235131840322671,1.0,16/88,16.20%,KAT2B;PRKN;PKN1;MTA2;ANKRA2;HDAC2;SP1;HDAC6;SFPQ;RBBP4;NACC2;LCOR;NCOR2;DACT1;MTA3;TP53
prerank,store-operated calcium channel activity (GO:0015279),-0.3462180368181184,-0.8500840350265204,0.6561604584527221,0.863331831420084,1.0,5/10,25.07%,TRPC6;ORAI2;TRPC3;TRPC7;ORAI3
prerank,ubiquitin protein ligase activity (GO:0061630),0.2664377274581743,0.8496985932230392,0.8068756319514662,0.9223837818190095,1.0,44/228,18.02%,PDZRN3;RNF157;CBLB;PRKN;DTX4;HACE1;TRIM44;NFX1;RNF6;ZNRF2;NEURL4;TRIM2;TRIM11;PELI1;UBE2K;RNFT1;FBXO27;VPS11;NEURL1B;CUL3;UHRF2;CBL;HUWE1;RNF121;TRIM41;MYLIP;FBXO17;MEX3C;RNF24;NEDD4L;AREL1;NEURL3;UBE2O;RNF19A;RNF111;RCHY1;UBOX5;XIAP;KCMF1;RNF10;RNF167;RC3H1;MDM2;TRIM9
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2646602305676418,0.8490100634572341,0.790273556231003,0.9212807341649847,1.0,51/248,19.35%,RHOJ;GNA14;DNM1;KIF20B;RHOD;GNG3;RND3;RAB38;RAP2B;RHOBTB3;RAB14;RALB;ARL1;RAB21;BMS1;RAP1A;CHD3;RABL3;RHOT2;ARL2;MRAS;DYNC1I1;MYO19;GPR88;GSPT2;TBCC;RAB22A;RAB1A;MTG1;RHOC;RHOH;ATP2B1;ATL3;GNAI1;ARL8A;RAB3A;RAB4A;TRIM23;OPA1;GTPBP10;RAP1GAP;ABCG4;ABCD2;RAC3;RAB7A;RHOT1;KIF2A;NRAS;KRAS;RAB3B;RUVBL2
prerank,pre-mRNA binding (GO:0036002),0.3325965859093261,0.8483994972327203,0.6766304347826086,0.919991045921735,1.0,8/28,21.26%,CELF5;TRA2B;RNPC3;SRSF6;RBM7;HNRNPU;CELF4;HNRNPL
prerank,chemokine receptor activity (GO:0004950),0.34509769967497944,0.8472080969826165,0.675392670157068,0.9196131971850324,1.0,3/24,14.22%,CCR2;ACKR3;ACKR4
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2955742784205706,0.8465285633286415,0.6918671248568156,0.9185154166830659,1.0,11/55,18.72%,ANXA9;ATP2B3;PSEN1;SLC8A2;SLC24A5;ANXA6;ATP2B1;TRPC5;PKD1;SLC24A4;SLC24A2
prerank,myosin II binding (GO:0045159),0.40420725037943883,0.8444074364218318,0.6520376175548589,0.9197613737428222,1.0,4/10,22.35%,GSN;STXBP5;LLGL1;TRIOBP
prerank,AMP binding (GO:0016208),0.3912818022119088,0.8435493663920955,0.6515151515151515,0.918991078124458,1.0,2/11,2.67%,PYGL;ACSS2
prerank,metallocarboxypeptidase activity (GO:0004181),0.3346507150913658,0.8434751914206896,0.6719160104986877,0.9168020263586936,1.0,5/26,13.92%,AGBL3;AGBL2;AGBL4;AGBL1;CPD
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.3014847181727053,0.8424791842185722,0.6948356807511737,0.916144066526202,1.0,4/48,5.46%,PIEZO2;CALHM6;ATP6V1B2;SLC12A2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.3317436072056056,-0.841798488997782,0.6780626780626781,0.8728020322561588,1.0,2/11,14.45%,DDAH2;PADI2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.26287940635292206,-0.8396231263783617,0.7165354330708661,0.870631674421999,1.0,6/24,15.21%,ZDHHC14;ZDHHC3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,ATP binding (GO:0005524),0.2639202563488584,0.8394753591307662,0.8388721047331319,0.9189248910683407,1.0,54/266,18.42%,WNK2;PYGL;STK36;PEAK1;ACVR1;MAP4K4;RHOBTB3;IRAK3;PDXK;WNK3;SIK2;RPS6KA4;MAST2;GSS;UBA2;KSR1;CDKL5;PDK3;CDK6;SARS2;TBCK;ACLY;AKT3;TLK2;LANCL2;SYN1;PXK;EIF4G1;MYO9B;HSPA4;PI4K2A;MSH6;DDX25;SRR;PNPLA8;HARS1;AK6;P2RY1;RTEL1;BMPR1A;ABL1;ABCB9;PAPOLA;BLM;OLA1;NDUFA13;ABCD2;HNRNPU;FICD;ABCF1;EIF2B2;SMC4;HSPA9;PEX1
prerank,adenylyltransferase activity (GO:0070566),-0.27374798928837746,-0.8390896840048978,0.7235494880546075,0.8652329733648009,1.0,8/21,19.43%,NMNAT2;MTPAP;NMNAT1;OAS2;KARS1;FLAD1;TENT4A;TENT4B
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.3997236513568341,0.8381542761591363,0.6785714285714286,0.9188653643961744,1.0,4/10,15.27%,RPE;GLCE;GALM;GNE
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.3809886506062047,0.8367983531517843,0.6796407185628742,0.9188712935809711,1.0,4/12,14.58%,ACVR1;TGFBR2;LTBP1;BMPR1A
prerank,lipase activator activity (GO:0060229),0.397999262557179,0.8362365174662382,0.6970172684458399,0.9175322814616422,1.0,1/10,8.15%,FYN
prerank,acylglycerol lipase activity (GO:0047372),-0.3306902107188966,-0.8347877488633683,0.6840579710144927,0.8674497394181151,1.0,5/11,24.87%,MGLL;ABHD2;ABHD12;FAAH;LIPE
prerank,calcium-activated potassium channel activity (GO:0015269),0.39240134985988967,0.83159663204163,0.6619496855345912,0.923082315217465,1.0,3/11,17.09%,KCNMB2;KCNMB3;KCNMA1
prerank,carboxy-lyase activity (GO:0016831),-0.25898941333002257,-0.8300613250402951,0.706766917293233,0.8697345733031346,1.0,7/23,19.74%,ECHDC1;AZIN1;AMD1;DDC;ODC1;PPCDC;BCKDHA
prerank,tRNA methyltransferase activity (GO:0008175),-0.29317195032907245,-0.8288782812206013,0.6789297658862876,0.8659183552903644,1.0,4/16,8.47%,TRMT9B;FTSJ1;METTL2A;METTL2B
prerank,GDP binding (GO:0019003),0.2899323940885885,0.828708950692724,0.731995277449823,0.9256024776132507,1.0,21/63,23.86%,RASEF;RAP2B;RAB14;ARL3;RALB;RAB21;RAP1A;MRAS;RAB22A;GNAI1;RAB4A;TRIM23;RAB7A;NRAS;KRAS;RAB3B;RAP2A;RAB18;RAP2C;ARL8B;RAB2A
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.36097024903049835,0.8276810875908154,0.6717325227963525,0.924983760235606,1.0,4/14,23.12%,DTYMK;AK5;AK8;CMPK1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.37583273628460817,0.827453017136425,0.676602086438152,0.9230884476692334,1.0,4/14,18.68%,KCND3;KCNJ3;KCNH2;KCNA5
prerank,DNA polymerase activity (GO:0034061),0.335225330284123,0.825831301471049,0.6941015089163237,0.9234196783172769,1.0,6/22,17.19%,POLN;POLE2;REV3L;POLE3;POLG;REV1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3328803586483597,0.8257941000043998,0.6905405405405406,0.9212173344483161,1.0,4/25,14.19%,POR;SQLE;MTRR;CYP27A1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.30575933216062934,-0.8254111531243673,0.7134328358208956,0.8661051398433071,1.0,6/14,27.47%,SDHB;CIAO3;ACO1;ACO2;RSAD2;EXO5
prerank,5'-3' exonuclease activity (GO:0008409),0.36268260490064674,0.8236895801141314,0.6642120765832106,0.9223352934411646,1.0,2/14,6.72%,DXO;XRN2
prerank,phosphatidylinositol binding (GO:0035091),0.27586343195196394,0.8224620661511098,0.764961915125136,0.9222835894330677,1.0,14/91,12.41%,RAG2;SESTD1;DPEP1;PITPNB;NCF1;WDFY3;SH3YL1;RPH3A;HIP1;DENND1C;PASK;SNX10;MREG;ZFYVE9
prerank,GABA receptor activity (GO:0016917),-0.2609422991227197,-0.8195166944133513,0.7473684210526316,0.8702243353189378,1.0,6/21,23.65%,GPR156;GABRG1;GABRA5;GABRB1;GABRE;GABRB2
prerank,motor activity (GO:0003774),0.28324968916240295,0.8189651952540877,0.7620730270906949,0.925941144213926,1.0,13/60,18.85%,DNAH2;KIF20B;KIF19;STARD9;KIF21A;DYNC1I1;KIF5C;GPR88;DYNC1I2;KIF22;KIF3A;KIF2A;KIF21B
prerank,transition metal ion binding (GO:0046914),0.2560066393807759,0.8179218008455409,0.91991991991992,0.9254053109757482,1.0,76/397,19.45%,RAG2;GLI2;CSRP1;DHH;DPEP1;CBLB;PRKN;CUTA;KMT2A;EPRS1;SEC24D;PDXK;KDM5B;PRNP;MBD1;ITGB1BP2;ZEB1;MT3;GRIN2B;HHIP;LTA4H;AOC1;AGMO;LOXL3;TRIM2;GALNT1;SCD5;RPH3A;GTF2B;CHD3;TRHDE;PTPN1;SEC24C;LNPEP;MMP16;USP33;MYT1;RBAK;GPC1;SIRT6;ZFPM2;PHF8;SOD2;KPNB1;HPF1;EXD2;GALNT3;SNCA;GRIN2A;ADAM33;MDM4;TRAF7;PAPPA2;BAZ1B;ABL1;PAPOLA;BLM;RCHY1;TP53;TET3;ADH5;RBSN;SEC24A;WRN;RC3H1;MDM2;PCK2;PARK7;ZMYND11;KLF7;SNCB;EGR1;TAB3;PPARG;PRDM2;FAM20C
prerank,hormone receptor binding (GO:0051427),0.36168506809326206,0.8174120895584595,0.7149253731343284,0.9240253625959489,1.0,3/14,17.32%,PTHLH;TYK2;NPPC
prerank,ubiquitin-protein transferase activity (GO:0004842),0.25408886345567694,0.8165564294404098,0.8987975951903807,0.9232176347186156,1.0,88/346,23.06%,UBE2T;PDZRN3;RNF157;CBLB;PRKN;DTX4;UBE2E2;HACE1;TRIM44;NFX1;KLHL13;RNF6;FBXO7;ZNRF2;DDB2;NEURL4;TRIM2;TRIM11;HECTD3;PELI1;BRCA1;UBE2K;RNFT1;FBXO27;VPS11;NEURL1B;CUL3;UBE2Z;UHRF2;CBL;HUWE1;RSPRY1;UBE2J2;RNF121;TSPAN17;TRIM41;MYLIP;FBXO17;MEX3C;AKTIP;RNF24;MALT1;TRIM23;NEDD4L;TRAF7;AREL1;NEURL3;UBE2O;RNF19A;RNF111;CDC23;RCHY1;XIAP;UBE2Q1;KCMF1;MIB1;RNF182;CUL4B;RNF10;RNF167;RC3H1;MDM2;FBXO22;TRIM9;ANKRD39;RNF4;TAF1;UBE2L3;TRIM35;TRAIP;FBXO11;BCOR;UBE2G1;UBE2E1;RNF13;ANAPC4;MKRN1;RNF114;RNFT2;UBE2D3;TTC3;UBR3;FBXO44;PJA2;RNF123;SIAH1;COP1;RNF2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.3293988927913539,-0.8159678996439071,0.6988304093567251,0.8705033254687653,1.0,5/11,17.60%,MAP3K5;MAP3K20;MAP3K7;MAP3K1;TAOK2
prerank,translation initiation factor activity (GO:0003743),0.3065651818123927,0.8144419239388051,0.7254150702426565,0.924394463940156,1.0,8/36,17.53%,EIF1B;EIF3C;EIF2B5;EIF3M;EIF4G1;EIF1;EIF4A2;EIF2B2
prerank,exoribonuclease activity (GO:0004532),0.37606811604269297,0.8129500196445871,0.6847662141779789,0.9244206727432992,1.0,2/12,10.02%,EXOSC8;EXOSC2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.3717652537123708,0.8086482474107918,0.7048929663608563,0.92908783315567,1.0,2/13,4.33%,TRMT10B;THUMPD3
prerank,SH2 domain binding (GO:0042169),0.31479078420509143,0.8085776635117874,0.730718954248366,0.926980000727151,1.0,1/31,0.29%,DLC1
prerank,miRNA binding (GO:0035198),-0.24563308138758955,-0.8084873527390591,0.7777777777777778,0.877222780173687,1.0,7/30,12.41%,YBX1;AGO1;ZC3H7B;DDX21;ELAVL1;TUT7;AGO3
prerank,amino acid:sodium symporter activity (GO:0005283),0.3774468434976512,0.8070649613292035,0.6897590361445783,0.9269302890631528,1.0,1/11,0.97%,SLC1A3
prerank,exonuclease activity (GO:0004527),0.29433999199110433,0.8062010473524442,0.7376237623762376,0.9260817382522174,1.0,10/46,17.46%,DXO;REV3L;XRN2;EXOSC8;REXO4;EXOSC2;EXD2;AEN;POLG;WRN
prerank,adenyl ribonucleotide binding (GO:0032559),0.25183177925509115,0.8031926534340545,0.9046184738955824,0.9287171069144503,1.0,55/291,17.66%,WNK2;PYGL;STK36;PEAK1;ACSS2;ACVR1;MAP4K4;RHOBTB3;IRAK3;PDXK;WNK3;SIK2;RPS6KA4;MAST2;PDE4B;GSS;UBA2;KSR1;CDKL5;PDK3;CDK6;SARS2;TBCK;ACLY;AKT3;TLK2;LANCL2;SYN1;PXK;EIF4G1;MYO9B;HSPA4;PI4K2A;MSH6;PDE4D;DDX25;SRR;PNPLA8;HARS1;AK6;P2RY1;RTEL1;BMPR1A;ABL1;ABCB9;PAPOLA;BLM;OLA1;NDUFA13;ABCD2;HNRNPU;FICD;ABCF1;EIF2B2;SMC4
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3123410393094018,0.8006100928027828,0.7088772845953003,0.9306708728447879,1.0,11/27,26.27%,POLR2B;POLRMT;POLR1B;POLR2G;MED21;POLR1D;POLR1C;POLR2A;POLR3K;POLR2F;POLR3F
prerank,ferrous iron binding (GO:0008198),-0.25763088853622435,-0.8000998768267249,0.7816901408450704,0.8853964794054795,1.0,8/21,18.32%,PHYH;FTH1;EGLN2;FTL;CDO1;ALKBH3;FXN;EGLN3
prerank,cholesterol transfer activity (GO:0120020),0.3449585250789906,0.798721058877443,0.7032348804500703,0.9312423769153716,1.0,4/16,13.22%,GRAMD1A;MTTP;GRAMD1C;GRAMD1B
prerank,proton transmembrane transporter activity (GO:0015078),0.2948460589870968,0.7981895264666932,0.745,0.9297897216747392,1.0,8/39,19.03%,CLCN5;ATP6V1B2;UQCRQ;NDUFA4;COX10;SLC9A1;DMAC2L;CYB5A
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.2545326410755407,0.79594299479837,0.8548057259713702,0.9309445733696566,1.0,38/181,20.17%,MDFIC;NCOA1;PTPRT;TACC1;MTA2;BBS5;NCOA2;PIAS2;LDB2;HIF1A;HDAC2;ATF2;NFE2L2;MAPK14;SP1;NRIP1;ZFPM2;NCOR2;CRY1;DACT1;JUP;TAF4;TAF4B;MTA3;TP53;SMARCE1;NCOA3;DNAJA1;PRRX1;TAF1;TACC2;PPARG;STAT3;CPNE1;BCL10;SMARCA4;JUN;BBS7
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.36663612972667253,0.794759630839895,0.7041602465331279,0.9305113237520872,1.0,5/11,21.30%,NUDT1;NUDT10;NUDT3;NUDT5;NUDT11
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.31764230458321463,0.7935018143004543,0.7332457293035479,0.9301012863578008,1.0,3/26,8.43%,B3GNT9;CSGALNACT1;CHSY1
prerank,U6 snRNA binding (GO:0017070),-0.2871993713466554,-0.7925061586448059,0.7701492537313432,0.8918131120662377,1.0,5/14,23.43%,PRPF4;LARP7;EIF5A;SART3;RBM22
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.32203391151654776,-0.7902478832621399,0.7270341207349081,0.8894192709871803,1.0,2/10,9.95%,OTUD5;STAMBPL1
prerank,magnesium ion binding (GO:0000287),0.25276375687429786,0.7861035422756062,0.8417721518987342,0.939158777784466,1.0,22/135,15.71%,IDH2;PSPH;IRAK3;PDXK;SIK2;MAST2;DXO;GSS;PGM1;UBA2;ENDOV;PI4K2A;MSH6;GNAI1;NUDT3;SRR;EXD2;SNCA;IDH3A;OPA1;ABL1;PAPOLA
prerank,vinculin binding (GO:0017166),0.36551372142129596,0.7857301977797146,0.726457399103139,0.9375500155754285,1.0,1/11,1.34%,UTRN
prerank,phosphatidate phosphatase activity (GO:0008195),-0.2926532879156162,-0.782831944832558,0.74375,0.8950379930352755,1.0,3/13,9.64%,PLPP1;LPIN2;PLPP5
prerank,nuclear export signal receptor activity (GO:0005049),0.3734231962653841,0.7827274587786595,0.7382753403933434,0.9398907266424947,1.0,5/11,23.55%,XPO1;EIF4ENIF1;CSE1L;NUP42;XPO5
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.30060442332443693,0.7816088470875159,0.7650834403080873,0.9393624475637626,1.0,10/28,27.45%,ELAC1;ENDOV;RPP38;PRORP;POP1;RPP21;DBR1;RPP30;DROSHA;RPP14
prerank,calcium channel regulator activity (GO:0005246),0.29364600832556925,0.7803745952920471,0.7596034696406444,0.9390854840733107,1.0,9/37,20.79%,CACNG7;NRXN1;SGK3;CALM1;CALM2;STIMATE;SGK1;NPY;STIM2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.3474678131598743,0.7785372722351644,0.7459379615952733,0.93966836915788,1.0,2/14,6.03%,PYCARD;APAF1
prerank,amino acid binding (GO:0016597),-0.22000034656658377,-0.7776544639007268,0.8333333333333334,0.8971575137295049,1.0,11/31,24.07%,NOS3;AARS1;DDAH2;NOS1;ASS1;GCLC;GRIN3A;GLRA2;GRM7;AGXT;CASTOR1
prerank,diacylglycerol kinase activity (GO:0004143),0.36126992109414363,0.7773806414951171,0.7331288343558282,0.9392067711839307,1.0,7/11,28.90%,DGKI;AGK;DGKA;DGKK;DGKD;DGKZ;DGKQ
prerank,hexosyltransferase activity (GO:0016758),0.258022753671104,0.7757935295224812,0.8228941684665226,0.9393155004252514,1.0,20/101,19.48%,HAS2;TMTC2;GBA2;EXT1;ALG9;B3GNT9;CSGALNACT1;CHSY1;POMGNT2;ALG5;TMTC3;RFNG;ALG1;DPY19L2;CHSY3;HYAL1;MTAP;POGLUT2;DPY19L3;ALG6
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2528165128862835,0.7749160144858368,0.8617131062951496,0.9383936421952518,1.0,19/134,14.90%,SLC22A3;SLC1A3;SLC27A1;SLC25A2;SLC1A5;MPC1;SLC25A21;SLC36A2;SLCO2B1;SLC25A38;MPC2;SLC2A2;SLC7A8;SLC35A1;SLC25A23;SLC35B3;SLC16A1;SLC25A15;SLC25A25
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.34491727307307835,0.7735155204607576,0.775766016713092,0.9380806920237312,1.0,2/15,14.22%,CCR2;ACKR4
prerank,calcium:sodium antiporter activity (GO:0005432),-0.3191512245724243,-0.7699917177293437,0.7411764705882353,0.9028746972292786,1.0,3/10,10.18%,SLC8A3;SLC8B1;SLC24A3
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.3430946609997006,0.7690978748897309,0.7705882352941177,0.9421734617197906,1.0,1/14,0.97%,SLC1A3
prerank,dynactin binding (GO:0034452),0.3484704689546461,0.769022722169065,0.7589285714285714,0.9401505458613411,1.0,3/12,10.94%,BICD1;SNX6;BICD2
prerank,ribosome binding (GO:0043022),0.2797669263199467,0.7666525780834781,0.8153098420413123,0.9412035183280856,1.0,17/46,26.79%,ETF1;NAA16;EIF3C;CPEB3;EIF6;GTPBP6;CPEB1;CCDC47;RPSA;NAA10;NAA15;PYM1;FMR1;SEC61A2;YTHDF3;CPEB4;NCLN
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.3562308148949904,0.7659480048142566,0.7570789865871833,0.9400463492959612,1.0,2/12,10.11%,GAB2;PIK3R1
prerank,regulatory RNA binding (GO:0061980),-0.21905591088720575,-0.7640904574995638,0.9018691588785047,0.9054860822300044,1.0,15/38,30.50%,YBX1;AGO1;ZC3H7B;DDX21;ELAVL1;TUT7;AGO3;MATR3;TARBP2;HNRNPA1;ZC3H10;AGO2;PIWIL2;AGO4;DICER1
prerank,protein kinase regulator activity (GO:0019887),0.2538199625549794,0.7639249966579049,0.8389189189189189,0.940553786410839,1.0,8/95,5.84%,CXCL10;FGF13;CCNJ;CCNC;GPRC5B;MT3;PRKAR1B;SOCS1
prerank,water transmembrane transporter activity (GO:0005372),0.3525418123439593,0.7617755978903749,0.7559055118110236,0.941439943147723,1.0,1/11,5.28%,AQP4
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.34068441841123925,0.7616354890211686,0.7507418397626113,0.9395569194846162,1.0,3/15,10.11%,SOCS5;SOCS1;PIK3R1
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.3084014345514614,-0.7611857760554928,0.7896174863387978,0.9037013429183522,1.0,4/10,12.70%,ECHDC1;ECHDC2;ECHDC3;ECI1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.3493410698225031,0.7548618804543841,0.7702909647779479,0.9466320382828922,1.0,1/12,2.15%,NQO1
prerank,glutathione transferase activity (GO:0004364),-0.2407342557671392,-0.7545387678975733,0.8650793650793651,0.9072591995385028,1.0,5/23,14.24%,LANCL1;GSTA4;GSTM1;HPGDS;MGST1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2855363233989672,0.7537712332060686,0.82625,0.9459892789696854,1.0,9/34,20.01%,SUV39H1;SETD3;MEN1;SETD2;PRDM9;KMT2E;SETD4;N6AMT1;SETDB1
prerank,MAP kinase kinase activity (GO:0004708),0.318752726306896,0.7462430374658249,0.7735294117647059,0.9537329885335775,1.0,3/15,10.90%,MAPKAPK3;MAP2K4;MAPK14
prerank,death domain binding (GO:0070513),0.3492118925498636,0.7459385876539694,0.787556904400607,0.9520299334544843,1.0,3/11,17.17%,BCL2;CRADD;RIPK1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.3470405032802482,0.7431362260544029,0.7948328267477204,0.953630431278083,1.0,2/11,8.82%,PPP1R14C;PPP1R8
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.2785352465725379,0.7400212540464796,0.8189873417721519,0.9554381288532238,1.0,10/34,19.59%,CKS1B;CAB39L;ALS2;CDK5R1;CALM1;IQGAP1;CDK5R2;CALM2;DBF4;CAB39
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.3552430147335051,0.7393875843230214,0.7909090909090909,0.9541324737997731,1.0,4/10,18.15%,CASP6;CASP12;CASP2;CASP7
prerank,phosphatase activator activity (GO:0019211),0.3323512654482861,0.7360020139243987,0.7908396946564885,0.9562533321790634,1.0,7/14,26.36%,PPP1R15A;CALM1;CALM2;BMP2;PPP2R5A;PPP2R5E;PPP2R5C
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.3370786516853933,0.7354754707120523,0.7993920972644377,0.9548252376496235,1.0,11/11,66.32%,HCN1;HCN2;KCNA10;CNGA1;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4;CNGB1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.24453061381569907,-0.7354509101671296,0.8710801393728222,0.9257936486624382,1.0,3/19,9.80%,ITPR1;RASA3;MCOLN1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.27381771191840154,-0.7349971288490224,0.8215384615384616,0.9203778654830895,1.0,5/12,23.65%,GABRG1;GABRA5;GABRB1;GABRE;GABRB2
prerank,protein kinase activator activity (GO:0030295),0.2559767886859768,0.7311927468240917,0.8553240740740741,0.9579664047726428,1.0,17/60,22.43%,ERBB3;FGF13;GPRC5B;MT3;CAB39L;ALS2;GRM5;CDK5R1;CALM1;IQGAP1;CALM2;RPTOR;DBF4;CAB39;AGAP2;TAOK1;NRG1
prerank,mRNA methyltransferase activity (GO:0008174),0.3347647851871252,0.7311492170969109,0.7956318252730109,0.9559203787534711,1.0,5/12,25.13%,METTL3;RNMT;CMTR2;NSUN2;TRMT61B
prerank,Notch binding (GO:0005112),-0.23560635399275312,-0.7302606103027003,0.8593155893536122,0.9204011797265179,1.0,8/22,21.39%,SNW1;JAG1;JAG2;NOTCH4;KCTD10;DTX1;DNER;TCIM
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.2810737760712071,0.7290668266379988,0.824203821656051,0.9563266419433402,1.0,10/32,23.57%,KDM8;KDM4B;ALKBH5;P4HTM;HSPBAP1;PHF8;TET3;RIOX2;ALKBH1;TET2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.25655904187051415,0.7267197254508161,0.8423529411764706,0.957144407556372,1.0,7/60,8.56%,PTEN;DUSP4;LRRC40;PPP3CB;PPP3CA;PPM1B;PPM1J
prerank,alpha-actinin binding (GO:0051393),-0.22349111600979712,-0.7230173995624788,0.8860759493670886,0.9231108931985571,1.0,2/24,0.87%,CACNA1C;PDLIM5
prerank,retinoic acid receptor binding (GO:0042974),0.3104019708073589,0.7226823381066936,0.8128571428571428,0.9599152055182847,1.0,6/17,21.33%,TACC1;RARG;NRIP1;MED25;PPARG;NSD1
prerank,carboxylic acid binding (GO:0031406),-0.20357282638136603,-0.7216492810297827,0.9210526315789473,0.9188262628876194,1.0,9/38,20.46%,NOS3;EPDR1;PHYH;SESN2;NOS1;GCLC;GRIN3A;GLRA2;GRM7
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.29307790029791436,0.7212098798905866,0.8022130013831259,0.959625015599345,1.0,2/22,5.16%,DUSP4;DUSP6
prerank,P-type ion transporter activity (GO:0015662),0.3332719161577585,0.7211435182658541,0.7916041979010495,0.9576085836767213,1.0,2/12,12.51%,ATP2B3;ATP2B1
prerank,DNA polymerase binding (GO:0070182),0.30305906394620935,0.7151200160589325,0.8235294117647058,0.962814086746518,1.0,8/18,27.73%,RTEL1;POLG2;SMG6;FANCI;SMARCA4;ACD;NABP2;LONP1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.2663534548712479,0.7150953731128051,0.8611449451887941,0.9607625190563032,1.0,2/38,7.57%,A2M;SERPINE2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.2704231326577571,-0.7106187858032007,0.8554216867469879,0.9254318488604228,1.0,8/13,34.72%,DNASE1L1;DNA2;GEN1;DICER1;ZGRF1;DNASE1L2;EXO1;FAN1
prerank,mannosyltransferase activity (GO:0000030),0.2895047565480093,0.7081673128957695,0.8282548476454293,0.9667761923928906,1.0,8/21,18.79%,TMTC2;ALG9;TMTC3;ALG1;DPY19L2;ALG8;DPM1;DPY19L3
prerank,thioesterase binding (GO:0031996),0.33276797178795203,0.7076980852130857,0.8307453416149069,0.9652034130179711,1.0,1/11,4.70%,TRAF4
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.32137751157324723,0.7074259485867879,0.8165869218500797,0.9634537772873669,1.0,6/12,23.80%,PAPOLA;TENT2;TENT5A;TENT5D;TENT5C;TUT1
prerank,palmitoyltransferase activity (GO:0016409),-0.20999292080791776,-0.6975730690476603,0.9176954732510288,0.9330280025993974,1.0,6/28,15.21%,ZDHHC14;ZDHHC3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,actinin binding (GO:0042805),0.28172242407937675,0.6910805329906122,0.8457223001402524,0.9794515187169898,1.0,7/21,21.03%,CSRP1;PDLIM4;MAGI1;KCNA5;PPARG;NFKB1;PKD2
prerank,ligand-gated anion channel activity (GO:0099095),-0.23432756317734377,-0.6900246152233208,0.9239130434782609,0.9343898736518195,1.0,6/17,23.65%,GABRG1;GABRA5;GLRA2;GABRB1;GABRE;GABRB2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.29017173261138496,0.6867370590282529,0.852112676056338,0.9823769204945351,1.0,3/18,10.11%,SOCS5;SOCS1;PIK3R1
prerank,rRNA binding (GO:0019843),0.25218427179555497,0.6842196043899961,0.8876811594202898,0.9829114273953756,1.0,4/42,6.44%,TST;MRPS18A;NGRN;MRPL16
prerank,tRNA binding (GO:0000049),0.24648285220813582,0.681680023262091,0.8950542822677925,0.9834457920321297,1.0,15/43,24.75%,TRMT10B;SARS2;FARS2;DALRD3;ELP5;XPOT;PUS1;SSB;PSTK;NSUN2;ALKBH1;ALKBH8;PTCD1;DARS2;CARS1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.28192374208093424,0.6813747007403391,0.8605898123324397,0.9816609510993378,1.0,7/22,22.91%,ZRANB3;OTUD7B;ZBTB1;OTUD7A;TAB3;WDR81;TAB2
prerank,channel activity (GO:0015267),0.24899662790346622,0.680046939107135,0.9032258064516129,0.9809351947347021,1.0,2/41,5.28%,BCL2;AQP4
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.21053276485492362,-0.6793740218704113,0.9120370370370371,0.9382835662507194,1.0,9/27,26.06%,DCUN1D3;RNF144B;DCUN1D1;AUP1;SIAH2;SIAH3;RNF125;ANKIB1;ZMYM2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3182020890702936,0.6771178936459766,0.8465189873417721,0.9819045269244088,1.0,3/10,18.54%,NAA16;NAA10;NAA15
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3084724637620428,0.6726416367497562,0.8448540706605223,0.9845560499992365,1.0,5/11,27.32%,NAA16;NAA10;NAA15;NAA50;NAA40
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2318978662872991,0.6707907544967792,0.9272116461366181,0.9842971438046677,1.0,10/70,18.00%,HAS2;EXT1;B3GNT9;CSGALNACT1;CHSY1;POMGNT2;RFNG;CHSY3;HYAL1;POGLUT2
prerank,DNA-binding transcription factor binding (GO:0140297),0.2133110235168604,0.6675616308541786,0.9785495403472931,0.9853759089869867,1.0,32/189,20.17%,PRDM16;MYC;BCL2;CRTC1;TLE1;YWHAZ;MTA2;BBS5;PIAS2;LDB2;HDAC2;ATF2;NFE2L2;SP1;TAF9;ZFPM2;CREM;DACT1;MTA3;TP53;TLE3;CTBP1;TLE4;CGGBP1;PRRX1;PARK7;PSMD9;TAF1;PPARG;STAT3;JUN;BBS7
prerank,ATP hydrolysis activity (GO:0140603),0.24414705699556352,0.6644307729051012,0.9226118500604595,0.9863678268755667,1.0,13/41,25.83%,KIF20B;RHOBTB3;CHD3;MYO19;ATP2B1;ABCG4;ABCD2;RUVBL2;DDX4;CHD1L;HSPA1A;MYO18A;SMCHD1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.2551687807335312,0.6643918644635358,0.8883116883116883,0.9843187910550338,1.0,6/34,16.26%,USB1;XRN2;EXOSC2;PNLDC1;EXD2;PNPT1
prerank,methyltransferase activity (GO:0008168),0.24075100320404916,0.6613229636166068,0.926060606060606,0.9851448460795303,1.0,11/46,20.26%,SUV39H1;COMT;METTL3;AS3MT;PRMT1;COQ5;LRTOMT;MEPCE;AMT;N6AMT1;NSUN2
prerank,MHC class II protein complex binding (GO:0023026),0.30766758499289065,0.6584483190052777,0.8711566617862372,0.9857619248225268,1.0,3/11,17.78%,ANXA11;CD74;MS4A1
prerank,kinesin binding (GO:0019894),0.2583501577240731,0.6560123260048908,0.904228855721393,0.9859976366566234,1.0,6/27,17.50%,ARHGEF10;AP1G1;SNCA;SPAG9;CLSTN1;AP1AR
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.2924392320828446,0.6514747339042255,0.8759231905465288,0.9881787594477348,1.0,7/13,28.23%,GABRG2;GLRB;GABRA3;GABRA2;GABRG3;GABRA4;GLRA3
prerank,signaling receptor complex adaptor activity (GO:0030159),0.24287970551226754,0.6506776456657336,0.917283950617284,0.9868308310433548,1.0,7/38,14.46%,SAV1;GAB2;PIK3R1;PTPN11;MAGI2;NCK1;SPAG9
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.3069999884231709,0.6481753389265584,0.8464,0.9871294097923338,1.0,1/11,6.90%,AKR1B10
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.25628056639902125,0.6477937857121157,0.9056122448979592,0.9853845259752364,1.0,2/29,3.14%,SLC1A5;SLC25A21
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.25452627698313707,0.6475504277808737,0.9002624671916011,0.983545366313883,1.0,7/29,17.67%,GBA2;GALC;CTBS;GANC;MOGS;PGGHG;ABHD10
prerank,pseudouridine synthase activity (GO:0009982),0.2995493525248348,0.6467006045211859,0.8671641791044776,0.9822449776032594,1.0,3/13,16.00%,PUSL1;PUS7;PUS1
prerank,inward rectifier potassium channel activity (GO:0005242),0.2629786388710413,0.6422848996935439,0.9094540612516645,0.9839923074854084,1.0,7/24,25.52%,KCNK1;KCNJ3;KCNJ10;KCNH2;KCNK6;KCNJ13;KCNN2
prerank,GABA-A receptor activity (GO:0004890),-0.21357081562828661,-0.6421140125318687,0.9324324324324325,0.9623082301082853,1.0,5/18,23.65%,GABRG1;GABRA5;GABRB1;GABRE;GABRB2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.23075246142415937,0.6364160154264524,0.9371980676328503,0.9867863553457498,1.0,7/46,14.08%,EXT1;B3GNT9;MGAT3;PIGP;POMGNT2;PIGA;RFNG
prerank,hormone activity (GO:0005179),0.22794442615068083,0.636304532832842,0.9427570093457944,0.9848587439077998,1.0,2/54,3.59%,CRH;PTHLH
prerank,RNA cap binding (GO:0000339),-0.23203397389472746,-0.6344587470705181,0.9483870967741935,0.9618266098180566,1.0,4/16,21.16%,LSM1;NCBP3;EIF3D;EIF4E3
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.2929871058117303,0.6284544490501675,0.889751552795031,0.9891914178709442,1.0,1/12,6.39%,B3GNT9
prerank,kinase inhibitor activity (GO:0019210),0.2389551246231198,0.6273393558221092,0.929305912596401,0.9880687133113265,1.0,5/33,13.86%,SOCS1;TAOK3;RHOH;NCK1;SNCA
prerank,signal sequence binding (GO:0005048),0.23974802047615645,0.626397701869811,0.9340796019900498,0.986711712634876,1.0,14/35,25.49%,TOMM20;KDELR2;KPNB1;KPNA6;KDELR3;KPNA1;POM121;CAT;KPNA3;IPO5;CEMIP;PEX5L;TNPO2;SEC61A2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.24141758628255797,0.6228729459683435,0.9267015706806283,0.9874710449709293,1.0,6/33,16.26%,USB1;XRN2;EXOSC2;PNLDC1;EXD2;PNPT1
prerank,nuclease activity (GO:0004518),0.22388255304981386,0.6209438084958876,0.943577430972389,0.98685886232218,1.0,8/52,17.46%,RNASE6;ERCC5;SETMAR;XRN2;REXO4;AEN;N4BP1;WRN
prerank,peptidoglycan binding (GO:0042834),-0.25385912980704256,-0.6205189392385352,0.9073033707865169,0.9646290756564284,1.0,6/10,43.34%,PGLYRP1;NOD1;NOD2;JCHAIN;NLRP3;TLR2
prerank,mannose binding (GO:0005537),-0.2313050170462918,-0.616251746512811,0.928125,0.961221574429104,1.0,9/12,54.92%,CLN5;ACR;COLEC11;LMAN1L;CLEC4D;LMAN2;LMAN2L;CLEC6A;CD207
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.2702402588408748,0.6155191288369071,0.9040902679830748,0.9886984255355373,1.0,3/16,16.23%,SLC1A5;SLC25A10;SLC25A11
prerank,protein kinase inhibitor activity (GO:0004860),0.22291916693901792,0.6128042291599579,0.9528535980148883,0.988552014306715,1.0,17/42,30.70%,SOCS1;SPRED2;SPRED1;TAOK3;NCK1;SNCA;RPTOR;INKA1;INKA2;SPRY4;CIB1;CDKN1A;CDKN1B;CDKN1C;CAMK2N1;PARVA;CAMK2N2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.2353411307757641,0.6073523910628229,0.9379947229551451,0.9902938417349724,1.0,6/28,16.87%,MAPKAPK3;MAP2K4;MAPK14;PRKACA;RPS6KA2;SGK1
prerank,death receptor activity (GO:0005035),0.2832206214993255,0.6070868827119026,0.922360248447205,0.988486860055933,1.0,2/11,10.82%,TNFRSF10B;NGFR
prerank,N-methyltransferase activity (GO:0008170),0.2516208133316366,0.6054240192874489,0.9338028169014084,0.9876493111387147,1.0,5/20,19.47%,SETD3;FDXACB1;PRMT1;RNMT;N6AMT1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.2902232967772055,0.6034741036211345,0.9167950693374423,0.9869296256438663,1.0,5/10,26.91%,GABRG2;GABRA3;GABRA2;GABRG3;GABRA4
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.23901677460273552,0.6023788632211428,0.9271523178807947,0.9857276407337129,1.0,3/24,14.03%,DTYMK;AK3;AK5
prerank,cAMP binding (GO:0030552),0.27855180978697347,0.5967488478391801,0.9329173166926678,0.9873796883261824,1.0,4/11,21.87%,PDE4B;PDE4D;HCN1;PDE10A
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.18998754071190074,-0.5872661540906141,0.9794238683127572,0.9702284094892863,1.0,5/22,15.82%,ATP6V0C;ATP6V0D1;ATP6V0A4;ATP2A3;ATP6V0A2
prerank,single-stranded RNA binding (GO:0003727),0.21271151515999626,0.5840795543619448,0.9580246913580247,0.9928012558280859,1.0,7/43,16.71%,DDX11;ENDOV;ADARB2;POLR2G;RBM7;PUS1;HNRNPU
prerank,snoRNA binding (GO:0030515),0.22459765310762303,0.5771191717593892,0.9514066496163683,0.994534310248375,1.0,4/30,8.70%,NUDT1;BMS1;UTP6;HEATR1
prerank,kinase activity (GO:0016301),0.18878959773297255,0.5764584234229302,0.9957582184517497,0.9929508634125964,1.0,22/109,20.89%,MAP4K4;PDXK;NEK1;PAPSS2;PI4KB;CDKL5;STK39;DGKI;PKMYT1;CDK5R1;ETNK1;RFK;SHPK;ABL1;TRRAP;PKN2;AGK;TAF1;PSTK;BCKDK;CERKL;HYKK
prerank,CARD domain binding (GO:0050700),0.25049833000536587,0.5637351238163124,0.9458646616541353,0.9972334614865661,1.0,6/14,26.11%,CARD9;BCL10;CARD11;CARD16;MAVS;CARD10
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.261216119072473,0.5636759166700097,0.9553846153846154,0.9952864175123065,1.0,2/12,14.87%,NCBP1;CYFIP1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.2457519329785045,0.5631246133102584,0.9495091164095372,0.9916383085588512,1.0,7/16,27.84%,ATP6V1B2;ATP6V1C1;ATP6V0E2;ATP6V0E1;TCIRG1;ATP6V1D;ATP5F1B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.2457519329785045,0.5631246133102584,0.9495091164095372,0.9916383085588512,1.0,7/16,27.84%,ATP6V1B2;ATP6V1C1;ATP6V0E2;ATP6V0E1;TCIRG1;ATP6V1D;ATP5F1B
prerank,muscle alpha-actinin binding (GO:0051371),0.24863366107797402,0.5605977695721783,0.9580318379160637,0.9908441791640981,1.0,3/15,14.41%,PDLIM4;PALLD;LDB3
prerank,NADPH binding (GO:0070402),0.24926384216421876,0.5535604961122375,0.95,0.9920639290926153,1.0,4/13,24.18%,MTRR;CBR3;DECR1;HMGCR
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.18788383447553825,0.550526854475006,0.9932885906040269,0.9913289645321566,1.0,24/74,27.57%,PDXK;PAPSS2;PI4KB;ADK;DGKI;ETNK1;RFK;SHPK;FGGY;GNE;GALK2;AGK;HK2;FAM20C;HYKK;HK1;NT5C3A;DGKA;FCSK;DGKK;GK;PIK3CA;PIK3C3;DGKD
prerank,histone methyltransferase binding (GO:1990226),0.25401919626437475,0.5458284510548778,0.967948717948718,0.9912390553423227,1.0,3/11,15.90%,LCOR;NOP56;LCORL
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.20621631306866897,0.5450768927374667,0.9778325123152709,0.9896233736397081,1.0,13/33,29.91%,PRKN;UBA2;TOLLIP;RNF19A;PARK7;SIAH1;PPARA;DCUN1D5;UBE3D;TCERG1;TRAF6;ARIH1;RNF217
prerank,MHC class I protein binding (GO:0042288),-0.20594829150448601,-0.536796977709077,0.9797297297297297,0.9821764045607609,1.0,2/13,17.65%,TAPBP;TUBB4B
prerank,transferrin receptor binding (GO:1990459),0.2465338314075139,0.5211947707465614,0.9576399394856279,0.9960841590992434,1.0,3/10,22.44%,SNX1;CHUK;SNX4
prerank,nucleotide diphosphatase activity (GO:0004551),0.2195742440164269,0.4905950036119656,0.9868035190615836,1.0,1.0,6/14,28.84%,NUDT10;NUDT3;NUDT6;NUDT11;FHIT;NUDT13
prerank,lysine N-methyltransferase activity (GO:0016278),0.20067580708486543,0.4841331098654306,0.9916550764951322,1.0,1.0,2/20,9.84%,SETD3;SETD2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.2157262123375826,0.4689340713469284,0.9842022116903634,1.0,1.0,3/11,22.47%,NEIL1;HMCES;ALKBH1
prerank,single-stranded DNA helicase activity (GO:0017116),0.19898156610960466,0.467591816448993,0.9929577464788732,1.0,1.0,2/19,13.00%,CHTF18;HELQ
prerank,titin binding (GO:0031432),0.2034787153815819,0.4613348241080715,0.9894578313253012,0.9997784346261384,1.0,3/13,21.84%,CALM1;CALM2;CAMK2D
prerank,snRNA binding (GO:0017069),0.1677237710795255,0.45767540550251307,1.0,0.9984013393311305,1.0,13/42,28.21%,RNPC3;SNRPB2;RBM7;MEPCE;SNRPA;HNRNPU;SF3B3;CDK9;TUT1;CCNT2;SNRPA1;LSM7;EFTUD2
prerank,lipid phosphatase activity (GO:0042577),0.18737190560674818,0.41913842961797865,0.9896142433234422,1.0,1.0,5/14,26.99%,PLPPR4;PLPPR2;PLPPR1;EPHX2;SGPP1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.1838438363042935,0.38650043108917465,1.0,1.0,1.0,10/10,81.63%,EXD2;MGME1;DCLRE1A;TATDN1;FEN1;APEX1;EXO1;POLD1;DCLRE1C;DCLRE1B
prerank,MHC protein binding (GO:0042287),0.1561238269435984,0.3719310853873915,1.0,0.9992659038199835,1.0,5/20,29.47%,ABCB9;CD74;TAP1;ATP5F1B;ATP5F1A
